var title_f0_20_320="Inferior segmental atrophy";
var content_f0_20_320=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inferior segmental optic disc atrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inferior segmental optic disc atrophy typical of previous ischemic insult.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karl C Golnik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_320=[""].join("\n");
var outline_f0_20_320=null;
var title_f0_20_321="Apical 3 chamber echo HCM";
var content_f0_20_321=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/79426/ap2chhcm_conv.mp4?title=Apical+3+chamber+echo+HCM\" style=\"width:383px;height:276px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apical 3 chamber (long axis) echocardiogram in a patient with hypertrophic cardiomyopathy (HCM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 426px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The apical two chamber view from a 2 dimensional echocardiogram shows a thickened intraventricular septum (IVS), almost total obliteration of the left ventricle (LV) during systole, and systolic anterior movement of the mitral valve (MV) and obstruction of the LV outflow tract in systole.",
"    <div class=\"footnotes\">",
"     LA: left atrium.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_321=[""].join("\n");
var outline_f0_20_321=null;
var title_f0_20_322="Comminuted distal femoral fracture";
var content_f0_20_322=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Comminuted distal femoral fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Significantly comminuted fractures of the distal femur that do not involve the growth plate (A) are often best stabilized with plate fixation (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Klane White, MD and Kimberly Stone, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_322=[""].join("\n");
var outline_f0_20_322=null;
var title_f0_20_323="Emedastine: Drug information";
var content_f0_20_323=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Emedastine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?5/42/5796?source=see_link\">",
"    see \"Emedastine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F164561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Emadine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F164584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, Second Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F164564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Allergic conjunctivitis: Ophthalmic: Instill 1 drop in affected eye up to 4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F164576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;3 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F164565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15822398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15822399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F164548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as difumarate [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Emadine&reg;: 0.05% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F164550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Emadine&reg; is for topical ophthalmic use only,",
"     <b>",
"      not",
"     </b>",
"     for injection. Soft contact lenses should not be worn during treatment if eyes are red; if there is no redness, wait 10 minutes following emedastine instillation before inserting contact lenses. Do not allow dropper tip to touch eyelids or surrounding area of the eye.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F164549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of allergic conjunctivitis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F164582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hyperemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Abnormal dreams",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Dermatitis, keratitis, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Taste (unpleasant)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision, corneal infiltrates, corneal staining, dry eyes, transient burning or stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Rhinitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Tearing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F164553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to emedastine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F164539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bacterial keratitis: Inadvertent contamination of multiple-dose ophthalmic solutions has caused bacterial keratitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Contact lens wearers: Contains benzalkonium chloride which may be absorbed by contact lenses; remove contact lenses prior to use and wait 15 minutes before reinserting.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For topical ophthalmic use only.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F164543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F164545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13494666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic events have not been observed in animal reproduction studies. Systemic absorption is limited following ocular administration.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F164566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F164554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Emadine Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.05% (5 mL): $109.26",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F164555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Daren (JP);",
"     </li>",
"     <li>",
"      Emadine (AT, BE, BG, BR, CH, CL, CZ, DE, DK, EE, FI, FR, GB, GR, HK, HN, IE, IL, IT, KP, MT, NL, NO, PK, PL, PT, RU, SE, SK, TH, TR, TW, ZA);",
"     </li>",
"     <li>",
"      Remicut SR (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F164538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Selective histamine H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor antagonist for topical ophthalmic use",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F164552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Ocular: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Oral: Plasma: 3-4 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8778 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-180.241.123.62-A6501CF067-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_323=[""].join("\n");
var outline_f0_20_323=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164561\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164584\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164564\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164576\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164565\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15822398\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15822399\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164548\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164550\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164549\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164582\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164553\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164539\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299256\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164543\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164545\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13494666\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164566\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164554\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164555\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164538\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164552\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8778\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8778|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/42/5796?source=related_link\">",
"      Emedastine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_20_324="G protein structure";
var content_f0_20_324=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63760&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 480px\">",
"   <div class=\"ttl\">",
"    Structure of a G protein coupled receptor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 460px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The molecular structure of a G protein coupled receptor includes seven membrane spanning domains, a carboxy end (COOH) and an amino end (NH3). The amino end, which is glycosylated (in green) resides on the outside of the cell and for most peptide hormones participates in binding. The carboxy end is located inside the cell and contains many sites of phosphorylation (in red). These regions are phosphorylated by regulatory proteins and often assist in receptor desensitization.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael A Shetzline, MD, PhD and Rodger A Liddle, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_324=[""].join("\n");
var outline_f0_20_324=null;
var title_f0_20_325="Heparin: Patient drug information";
var content_f0_20_325=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Heparin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     see \"Heparin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"     see \"Heparin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Hep-Lock;",
"     </li>",
"     <li>",
"      HepFlush&reg;-10",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Hepalean&reg;;",
"     </li>",
"     <li>",
"      Hepalean&reg; Leo;",
"     </li>",
"     <li>",
"      Hepalean&reg;-LOK",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to thin the blood so that clots will not form.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691756",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat blood clots.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691335",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower the number of heart attacks in patients who have unstable angina or mild heart attacks.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702237",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to heparin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to pork products, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfite allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703347",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bleeding problems or low platelet count.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697760",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care to stop injury and avoid falls or crashes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698390",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weak bones with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fall or crash when you hit your head. Talk with your doctor even if you feel fine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695987",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein or into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site where you give the shot with each shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025629\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11753 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-6C4A8C19E1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_325=[""].join("\n");
var outline_f0_20_325=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178752\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178753\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025621\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025620\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025625\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025626\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025628\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025623\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025624\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025629\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025630\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=related_link\">",
"      Heparin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=related_link\">",
"      Heparin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_20_326="Pyrethrins: Patient drug information";
var content_f0_20_326=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pyrethrins: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/9/12436?source=see_link\">",
"     see \"Pyrethrins: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F215847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      A-200&reg; Lice Treatment Kit [OTC];",
"     </li>",
"     <li>",
"      A-200&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Licide&reg; [OTC];",
"     </li>",
"     <li>",
"      Pronto&reg; Complete Lice Removal System [OTC];",
"     </li>",
"     <li>",
"      Pronto&reg; Plus Lice Killing Mousse Plus Vitamin E [OTC];",
"     </li>",
"     <li>",
"      Pronto&reg; Plus Lice Killing Mousse Shampoo Plus Natural Extracts and Oils [OTC];",
"     </li>",
"     <li>",
"      Pronto&reg; Plus Warm Oil Treatment and Conditioner [OTC];",
"     </li>",
"     <li>",
"      RID&reg; Maximum Strength [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F215848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pronto&reg; Lice Control;",
"     </li>",
"     <li>",
"      R &amp; C&trade; II;",
"     </li>",
"     <li>",
"      R &amp; C&trade; Shampoo/Conditioner;",
"     </li>",
"     <li>",
"      RID&reg; Mousse",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691932",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat lice.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702829",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pyrethrins, piperonyl butoxide, ragweed, chrysanthemums, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698317",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Scalp irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use carefully.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705558",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Spray:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        Do not use on people or animals.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For use on non-washable items only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Spray on infested part and let dry all the way.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vacuum rugs and carpets. Throw away vacuum cleaner bags after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All other products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696239",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash all bedding, towels, and recently worn clothes in hot water or have them dry cleaned.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cream, oil, and shampoo:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wet hair or affected part with water before putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694462",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lightly coat hair or affected part.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696280",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Work into hair and scalp or affected skin gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on for 10 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695278",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not cover while this drug is on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After 10 minutes, use a little warm water and soap or shampoo on hair and lather.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695595",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse fully.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694829",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry with a towel.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use special nit comb or tweezers to get rid of dead nits (lice eggs) from hair.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705394",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Foam:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wet hair or affected part with water before putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694462",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lightly coat hair or affected part.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696280",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Work into hair and scalp or affected skin gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on for 10 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695278",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not cover while this drug is on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After 10 minutes, use a little warm water and soap or shampoo.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694829",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry with a towel.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use special nit comb or tweezers to get rid of dead nits (lice eggs) from hair.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705403",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Gel and liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wet hair or affected part with water before putting on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694462",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lightly coat hair or affected part.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696280",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Work into hair and scalp or affected skin gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695285",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on for 10 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695278",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not cover while this drug is on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After 10 minutes, use a little warm water and soap or shampoo.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696254",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694829",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry with a towel.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use special nit comb or tweezers to get rid of dead nits (lice eggs) from hair.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699260",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect foam from heat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11518 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-8C269A7C77-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_326=[""].join("\n");
var outline_f0_20_326=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215847\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F215848\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026021\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026020\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026025\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026026\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026028\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026023\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026024\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026029\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026030\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/9/12436?source=related_link\">",
"      Pyrethrins: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_20_327="Thyrotropin (TSH)-secreting pituitary adenomas";
var content_f0_20_327=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Thyrotropin (TSH)-secreting pituitary adenomas",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/327/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/327/contributors\">",
"     Roy E Weiss, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/327/contributors\">",
"     Samuel Refetoff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/327/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/327/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/327/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/327/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/20/327/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyrotropin (TSH)-secreting pituitary adenomas are a rare cause of hyperthyroidism. They account for less than 1 percent of all functioning pituitary tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], and much less than 1 percent of all cases of hyperthyroidism. Nevertheless, the diagnosis should be considered in all hyperthyroid patients, especially those with a diffuse goiter and no extrathyroidal manifestations of Graves' disease.",
"   </p>",
"   <p>",
"    This topic will review the clinical presentation, diagnosis, and treatment of TSH-secreting pituitary tumors. Other causes of hyperthyroidism are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4103?source=see_link\">",
"     \"Disorders that cause hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=see_link\">",
"     \"Diagnosis of hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;TSH-secreting adenomas secrete biologically active thyrotropin (TSH) in a more or less autonomous fashion. Thus, TSH secretion usually does not increase much in response to thyrotropin-releasing hormone (TRH) and does not decrease much in response to exogenous thyroid hormone administration. The biological activity of the TSH that is secreted varies considerably; as a result, serum immunoreactive TSH concentrations range from normal (albeit inappropriately high in the presence of hyperthyroidism) to markedly elevated (&gt;500",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 25 percent of the adenomas secrete one or more other pituitary hormones; about 15 percent secrete growth hormone, 10 percent secrete prolactin, and rare tumors secrete gonadotropins [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ]. There have been no reported instances of cosecretion of corticotropin (ACTH) and TSH.",
"   </p>",
"   <p>",
"    Adenomas secreting TSH and growth hormone are equally common in men and women, whereas cosecretion of TSH and prolactin is about five times more common in women than in men. Hyperprolactinemia is not always due to tumor secretion of prolactin; in some patients, it is caused by compression of the pituitary stalk and interruption of tonic hypothalamic inhibition of prolactin secretion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=see_link&amp;anchor=H8#H8\">",
"     \"Causes of hyperprolactinemia\", section on 'Decreased dopaminergic inhibition of prolactin secretion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The molecular basis of TSH-secreting adenomas is not known. While somatic mutations or abnormal oncogene expression could contribute to these tumors as in the case of other pituitary tumors, no such mutations have been described. Molecular analysis of TSH-secreting adenomas has shown:",
"    <br/>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overexpression of the pituitary-specific transcription factor-1 (Pit-1) in 14 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/4-6\">",
"       4-6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Somatic mutations of the thyroid hormone receptor (TR) beta gene in two of six TSH-secreting adenomas [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. In the latter, the mutant TRs did not bind thyroid hormone and interfered with the function of the normal TR, thus providing an explanation for the nonsuppressible nature of at least some of the adenomas.",
"     </li>",
"     <li>",
"      Aberrant expression of an isoform of the thyroid hormone receptor &beta;, TR&beta;4, which inhibited negative regulation of the TSH&alpha; mediated by TR&beta;1 or TR&beta;2 [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Activating mutations in the TRH-receptor gene have not been identified [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;One review summarized the findings in 255 patients with TSH-secreting adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ]. The mean age at presentation was 41 years and 55 percent were women. In contrast, Graves' disease and most other causes of hyperthyroidism are much more common in women.",
"   </p>",
"   <p>",
"    Most patients have the typical symptoms and signs of hyperthyroidism, but a few patients have had mild or even no symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .) The time from onset of symptoms to diagnosis of the pituitary tumor has ranged from 1 to 27 years. Most of the long-standing cases received ablative thyroid treatment at least once and often several times before their adenomas were diagnosed.",
"   </p>",
"   <p>",
"    In addition to hyperthyroidism, other clinical features include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A diffuse goiter &mdash; 95 percent",
"     </li>",
"     <li>",
"      Visual field defects &mdash; 40 percent",
"     </li>",
"     <li>",
"      Menstrual disturbances &mdash; 30 percent",
"     </li>",
"     <li>",
"      Galactorrhea, with or without cosecretion of prolactin &mdash; 30 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LABORATORY AND RADIOLOGICAL EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12895446\">",
"    <span class=\"h2\">",
"     Thyroid function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic biochemical abnormalities in patients with hyperthyroidism caused by a TSH-secreting adenoma are normal or high serum TSH concentrations and high serum total and free thyroxine (T4) and triiodothyronine (T3) concentrations.",
"   </p>",
"   <p>",
"    Among 255 reviewed patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ], the ranges of hormone values were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serum TSH concentrations &mdash; &lt;1.0 to 568",
"      <span class=\"nowrap\">",
"       mU/L",
"      </span>",
"     </li>",
"     <li>",
"      Serum total T4 concentrations &mdash; 11.6 to 53",
"      <span class=\"nowrap\">",
"       micrograms/dL",
"      </span>",
"      (150 to 678",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Serum free T4 concentrations &mdash; 1.6 to 7.7",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (20 to 100",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Serum total T3 concentrations &mdash; 195 to 1300",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (3.0 to 20",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Serum free T3 concentrations &mdash; 0.5 to 2.6",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (8.0 to 40.2",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately 30 percent of patients who had not had any thyroid ablation therapy in the past had serum TSH values within the normal range; however, \"normal\" values are inappropriately high in the presence of high serum T4 and T3 concentrations. Frequent measurements of serum TSH in four patients demonstrated loss of the normal nocturnal surge in TSH secretion, a finding that is compatible with autonomous TSH secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/12\">",
"     12",
"    </a>",
"    ]. Serum TSH concentrations do not increase in response to TRH in the majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3,13\">",
"     3,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12895453\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 85 percent of patients with TSH-secreting pituitary adenomas have a high serum concentration of the alpha-subunit of glycoprotein hormones. The relative increase in serum alpha-subunit is greater than that of serum TSH, resulting in a high molar ratio of serum alpha-subunit to TSH (mean 3.2) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3,13\">",
"     3,13",
"    </a>",
"    ]. We measure alpha-subunit in all patients with a high or nonsuppressed serum TSH and high serum free T4 and T3.",
"   </p>",
"   <p>",
"    Given the difficulty in distinguishing patients with TSH-secreting tumors from resistance to thyroid hormone (RTH), analysis for mutations in the thyroid hormone receptor beta (TR&beta;) gene is indicated in patients with elevated free T4, T3, and nonsuppressed TSH. Although 15 percent of patients with RTH do not have mutations in the TR&beta;, the presence of a mutation rules out the diagnosis of a TSH-secreting tumor. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing alone may be insufficient for the diagnosis and should be complemented by an MRI of the pituitary in select cases and in those in whom genetic testing is negative for a TR&beta; mutation. Magnetic resonance imaging (MRI) of the pituitary should be reserved for those patients with consistently high serum T4 and T3 concentrations and a normal or high serum TSH concentration in whom the alpha subunit is increased and there are no other family members with similar thyroid function tests. The presence of a microadenoma on MRI is not specific for a TSH-secreting tumor and can be seen as an incidental finding in 10 percent of normal individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/14\">",
"     14",
"    </a>",
"    ]. Therefore, a specific diagnosis of a TSH-secreting pituitary adenoma should be based upon endocrine testing and only then confirmed by MRI. Rarely, inferior petrosal sinus sampling may be indicated when MRI of the pituitary is normal.",
"   </p>",
"   <p>",
"    The use of color flow Doppler sonography of the thyroid gland has been shown to distinguish between patients with TSHomas and those with resistance to thyroid hormones (RTH) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/15\">",
"     15",
"    </a>",
"    ]. After a standard T3 suppression test, used for the diagnosis of RTH (50",
"    <span class=\"nowrap\">",
"     micrograms/day",
"    </span>",
"    for days one to three, followed by 100",
"    <span class=\"nowrap\">",
"     micrograms/day",
"    </span>",
"    for days four to six and then 200",
"    <span class=\"nowrap\">",
"     micrograms/day",
"    </span>",
"    for days seven to nine) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/13\">",
"     13",
"    </a>",
"    ], the increased color flow Doppler sonography pattern and peak systolic velocity normalized in 8 of 10 patients with RTH, but not in any of the eight patients with a TSHoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of high serum T4 and T3 concentrations and normal or high serum TSH concentrations in the presence of anatomic evidence of a pituitary tumor by MRI is very strong evidence that the patient has a TSH-secreting pituitary adenoma. However, the tumor could be an incidentaloma, which can be detected by MRI in up to 10 percent of normal subjects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/43/12981?source=see_link\">",
"     \"Incidentally discovered sellar masses (pituitary incidentalomas)\"",
"    </a>",
"    .) Conversely, small pituitary tumors can be missed by MRI or CT. In a few patients, radiolabeled pentetreotide has been useful in detecting the adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/16\">",
"     16",
"    </a>",
"    ]. Two cases of ectopic TSH-secreting adenomas have been reported: one in a nasopharyngeal mass [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/17\">",
"     17",
"    </a>",
"    ] and the other in the vomerosphenoidal junction [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with TSH-secreting adenomas and hyperthyroidism must be distinguished from those with the syndrome of resistance to thyroid hormone (RTH). Patients with RTH have variable tissue hyporesponsiveness to thyroid hormone due to a defect in the thyroid hormone receptor beta gene [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/13\">",
"     13",
"    </a>",
"    ]. Despite their resistance to thyroid hormone in many tissues (including the pituitary gland), some patients with RTH have symptoms and signs of hyperthyroidism, particularly tachycardia, hyperactivity and hyperreflexia, and many have goiter. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/37/1626?source=see_link\">",
"     \"Reduced sensitivity to thyroid hormone\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following findings help to distinguish TSH-secreting adenomas from RTH:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum sex hormone-binding globulin concentration (SHBG) is high in patients with TSH-secreting pituitary adenomas, whereas the values are normal in RTH. This difference reflects the expected action of excess T4 and T3 on hepatic SHBG production in hyperthyroidism, and resistance to the hormones' action in RTH.",
"     </li>",
"     <li>",
"      The serum alpha-subunit concentration is normal in RTH but, as noted above, often high in patients with TSH-secreting adenomas.",
"     </li>",
"     <li>",
"      The serum TSH concentration increases in response to TRH in patients with RTH, but not in most patients with TSH-secreting adenomas.",
"     </li>",
"     <li>",
"      Patients with RTH are more likely to have a fall in serum TSH concentrations in response to T3 (90 percent versus 12 to 25 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other conditions to be distinguished from TSH-secreting adenomas are those in which serum total T4 and T3 concentrations are increased because of increased protein binding of the hormones in serum. These conditions include elevations in serum thyroxine-binding globulin concentrations, familial dysalbuminemic hyperthyroxinemia, in which an abnormal albumin with increased affinity for T4 is produced, and the presence of anti-T4 antibodies. Patients with these conditions are euthyroid, have normal serum TSH concentrations, and usually normal serum free T4 and T3 concentrations when measured by appropriate methods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/53/856?source=see_link\">",
"     \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An occasional patient with long-standing primary hypothyroidism has sufficient hyperplasia of the thyrotroph cells to cause pituitary enlargement. The hyperplasia may be mistaken for a pituitary tumor, but the patients have clinical manifestations of hypothyroidism, low serum T4 and T3 concentrations, and very high serum TSH concentrations. These patients should not be confused with patients with TSH-secreting adenomas. The enlarged pituitary in hypothyroidism shrinks with T4 therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/47/42744?source=see_link\">",
"     \"Disorders that cause hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most appropriate therapy for patients with TSH-secreting pituitary adenomas is transsphenoidal resection of the tumor. Transsphenoidal resection results in cure in about one-third of patients, improvement in one-third, and no change in one-third [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ]. These relatively poor results reflect at least in part the fact that most of the tumors are macroadenomas. Pituitary radiation alone or in conjunction with pituitary surgery has not proven effective [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dopamine agonist therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the relatively poor results of surgery, many patients need additional therapy.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/40/8840?source=see_link\">",
"     Bromocriptine",
"    </a>",
"    (10 to 20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    orally) has proven effective in occasional patients, usually those with concomitant hyperprolactinemia, as has",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/2/7206?source=see_link\">",
"     cabergoline",
"    </a>",
"    , which is often better tolerated and need be given only once or twice weekly in a dose of 0.25 or 0.5 mg orally [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/19\">",
"     19",
"    </a>",
"    ]. Occasional patients have responded to bromocriptine alone [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/20\">",
"     20",
"    </a>",
"    ]. In three such patients, there was no growth of the pituitary tumor over eight years of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Octreotide",
"    </span>",
"    &nbsp;&mdash;&nbsp;The somatostatin analogue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    is effective in nearly all patients. One series evaluated 73 patients treated with octreotide (50 to 750 micrograms given subcutaneously two or three times daily), most of whom had already undergone surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"     3",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum TSH concentration fell by more than 50 percent in 92 percent of patients and became normal in 79 percent.",
"     </li>",
"     <li>",
"      Serum T4 and T3 concentrations fell to normal in 95 percent of patients after one year.",
"     </li>",
"     <li>",
"      The tumor decreased in size in 52 percent after one year.",
"     </li>",
"     <li>",
"      Less than 10 percent developed resistance to the action of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results suggest that, in addition to its use after unsuccessful surgery,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    should be given to patients with large tumors for 6 to 12 months",
"    <strong>",
"     before",
"    </strong>",
"    surgery is performed. A suitable initial dose is 50 micrograms subcutaneously twice daily, increasing to three times daily and then to 100 micrograms three times daily, with additional increments of 50 micrograms per injection as needed; serum TSH and T4 concentrations should be measured at two- to three-week intervals.",
"   </p>",
"   <p>",
"    The side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    include nausea, abdominal discomfort, bloating, diarrhea, glucose intolerance and cholelithiasis. In addition, octreotide is very expensive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7322?source=see_link\">",
"     \"Treatment of acromegaly\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A slow-release formulation of a somatostatin analog,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/34/7717?source=see_link\">",
"     lanreotide",
"    </a>",
"    , has proven effective in patients with TSH-secreting pituitary adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/22\">",
"     22",
"    </a>",
"    ]. In 16 patients, 30 mg lanreotide given intramuscularly two to three times per month for six months resulted in amelioration of hyperthyroid symptoms in all patients and normalization of serum TSH and thyroid hormone concentrations in 13, but no change in tumor size was observed.",
"   </p>",
"   <p>",
"    In one patient with a TSH-secreting tumor cosecreting growth hormone, the use of both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    and a growth hormone receptor antagonist (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/23/24948?source=see_link\">",
"     pegvisomant",
"    </a>",
"    ) was able to normalize IGF-1 as well as thyroid hormone levels [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/23\">",
"     23",
"    </a>",
"    ]. It is not known whether pegvisomant is useful in tumors secreting only TSH.",
"   </p>",
"   <p>",
"    Why some tumors respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    and others do not may be related to the expression of subtypes of somatostatin receptors (SSTRs) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/24\">",
"     24",
"    </a>",
"    ]. Octreotide may inhibit TSH secretion in all tumors that express SSTR2 and the expression of the type 5 receptor may enhance the inhibitory effects of octreotide [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Antithyroid therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antithyroid therapy of any type, radioiodine or drug (eg, thionamide), is",
"    <strong>",
"     not",
"    </strong>",
"    indicated in patients with TSH-secreting adenomas, because sustained reductions in thyroid hormone secretion would be expected to increase TSH secretion and stimulate tumor growth. A beta blocker, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    (80 to 160 mg daily) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    (25 to 50 mg daily), can be given to ameliorate some of the symptoms and signs of hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=see_link\">",
"     \"Beta blockers in the treatment of hyperthyroidism\"",
"    </a>",
"    .) Thyroid surgery should be reserved for patients with symptomatic goiters in whom pharmacotherapy has failed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;While most patients do reasonably well, in one series of 25 patients there were three deaths, including one from metastatic thyrotroph carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/11\">",
"     11",
"    </a>",
"    ]. An additional case of a metastatic TSHoma cosecreting prolactin has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/327/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H759972\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thyrotropin (TSH)-secreting pituitary adenomas are a rare cause of hyperthyroidism, accounting for much less than 1 percent of all cases of hyperthyroidism. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients have the typical symptoms and signs of hyperthyroidism, but a few patients have had mild or even no symptoms. Other clinical features include a diffuse goiter, visual field deficits and, in women, menstrual disturbances and galactorrhea. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The characteristic biochemical abnormalities in patients with hyperthyroidism caused by a TSH-secreting adenoma are normal or high serum TSH concentrations, high serum total and free thyroxine (T4) and triiodothyronine (T3) concentrations, and high serum concentrations of the alpha-subunit of glycoprotein hormones. Magnetic resonance imaging (MRI) of the pituitary should be performed in patients with consistently high serum T4 and T3 concentrations and a normal or high serum TSH concentration in whom the alpha subunit is increased and there are no other family members with similar thyroid function tests. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Laboratory and radiological evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with TSH-secreting adenomas and hyperthyroidism must be distinguished from those with the syndrome of resistance to thyroid hormone (RTH) and those in whom serum total T4 and T3 concentrations are increased because of increased protein binding of the hormones in serum (eg, familial dysalbuminemic hyperthyroxinemia). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/37/1626?source=see_link\">",
"       \"Reduced sensitivity to thyroid hormone\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/53/856?source=see_link\">",
"       \"Euthyroid hyperthyroxinemia and hypothyroxinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The most appropriate therapy for patients with TSH-secreting pituitary adenomas is transsphenoidal resection of the tumor. Transsphenoidal resection results in cure in about one-third of patients, improvement in one-third, and no change in one-third. Because of the relatively poor results of surgery, many patients need additional therapy (eg, dopamine agonists,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A beta blocker, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/49/8986?source=see_link\">",
"       propranolol",
"      </a>",
"      (80 to 160 mg daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"       atenolol",
"      </a>",
"      (25 to 50 mg daily), can be given to ameliorate some of the symptoms and signs of hyperthyroidism. Antithyroid therapy of any type, radioiodine or drug (eg, thionamide), is",
"      <strong>",
"       not",
"      </strong>",
"      indicated in patients with TSH-secreting adenomas because sustained reductions in thyroid hormone secretion would be expected to increase TSH secretion and stimulate tumor growth. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=see_link\">",
"       \"Beta blockers in the treatment of hyperthyroidism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/1\">",
"      Gesundheit N, Petrick PA, Nissim M, et al. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med 1989; 111:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/2\">",
"      Socin HV, Chanson P, Delemer B, et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 2003; 148:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/3\">",
"      Beck-Peccoz P, Brucker-Davis F, Persani L, et al. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996; 17:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/4\">",
"      Delhase M, Vergani P, Malur A, et al. Pit-1/GHF-1 expression in pituitary adenomas: further analogy between human adenomas and rat SMtTW tumours. J Mol Endocrinol 1993; 11:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/5\">",
"      Sanno N, Teramoto A, Matsuno A, et al. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Mod Pathol 1994; 7:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/6\">",
"      Pellegrini I, Barlier A, Gunz G, et al. Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1994; 79:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/7\">",
"      Ando S, Sarlis NJ, Krishnan J, et al. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 2001; 15:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/8\">",
"      Ando S, Sarlis NJ, Oldfield EH, Yen PM. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 2001; 86:5572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/9\">",
"      Tagami T, Usui T, Shimatsu A, et al. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma. J Clin Endocrinol Metab 2011; 96:E948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/10\">",
"      Dong Q, Brucker-Davis F, Weintraub BD, et al. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes. J Clin Endocrinol Metab 1996; 81:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/11\">",
"      Brucker-Davis F, Oldfield EH, Skarulis MC, et al. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 1999; 84:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/12\">",
"      Beckers A, Abs R, Mahler C, et al. Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 1991; 72:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/13\">",
"      Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/14\">",
"      Hall WA, Luciano MG, Doppman JL, et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/15\">",
"      Bogazzi F, Manetti L, Tomisti L, et al. Thyroid color flow Doppler sonography: an adjunctive tool for differentiating patients with inappropriate thyrotropin (TSH) secretion due to TSH-secreting pituitary adenoma or resistance to thyroid hormone. Thyroid 2006; 16:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/16\">",
"      Lamberts SW, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991; 12:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/17\">",
"      Cooper DS, Wenig BM. Hyperthyroidism caused by an ectopic TSH-secreting pituitary tumor. Thyroid 1996; 6:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/18\">",
"      Pasquini E, Faustini-Fustini M, Sciarretta V, et al. Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. Eur J Endocrinol 2003; 148:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/19\">",
"      Mulinda JR, Hasinski S, Rose LI. Successful therapy for a mixed thyrotropin-and prolactin-secreting pituitary macroadenoma with cabergoline. Endocr Pract 1999; 5:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/20\">",
"      Camacho P, Mazzone T. Thyrotropin-secreting pituitary adenoma responsive to bromocriptine therapy. Endocr Pract 1999; 5:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/21\">",
"      Kienitz T, Quinkler M, Strasburger CJ, Ventz M. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 2007; 157:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/22\">",
"      Kuhn JM, Arlot S, Lefebvre H, et al. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 2000; 85:1487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/23\">",
"      Meas T, Sobngwi E, Vexiau P, Boudou P. An unusual somatotropin and thyreotropin secreting pituitary adenoma efficiently controlled by Octreotide and Pegvisomant. Ann Endocrinol (Paris) 2006; 67:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/24\">",
"      Yoshihara A, Isozaki O, Hizuka N, et al. Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy. Endocr J 2007; 54:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/25\">",
"      Horiguchi K, Yamada M, Umezawa R, et al. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment. Endocr J 2007; 54:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/327/abstract/26\">",
"      Brown RL, Muzzafar T, Wollman R, Weiss RE. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. Eur J Endocrinol 2006; 154:639.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7842 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-F7344C3B4D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_327=[""].join("\n");
var outline_f0_20_327=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H759972\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LABORATORY AND RADIOLOGICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12895446\">",
"      Thyroid function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12895453\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dopamine agonist therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Octreotide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Antithyroid therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H759972\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=related_link\">",
"      Beta blockers in the treatment of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22167?source=related_link\">",
"      Causes of hyperprolactinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4103?source=related_link\">",
"      Disorders that cause hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/47/42744?source=related_link\">",
"      Disorders that cause hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/53/856?source=related_link\">",
"      Euthyroid hyperthyroxinemia and hypothyroxinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/43/12981?source=related_link\">",
"      Incidentally discovered sellar masses (pituitary incidentalomas)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/37/1626?source=related_link\">",
"      Reduced sensitivity to thyroid hormone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/9/7322?source=related_link\">",
"      Treatment of acromegaly",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_20_328="MDAS I";
var content_f0_20_328=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 626px\">",
"   <div class=\"ttl\">",
"    Memorial Delirium Assessment Scale (MDAS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 606px; height: 776px; background-image: url(data:image/gif;base64,R0lGODlhXgIIA8QAAP///39/f7+/vz8/PwAAAO/v79/f35+fn8/Pzy8vL19fX29vbx8fH6+vr4+Pj09PTw8PDwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABeAggDAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5QwBQhhApgmly8FAgYmCAUAAoEGAqQlBqEmrD6vOKOVL7MysUoDugMHALoNAAi8AAUKEAQQCr67ugcHuw/AyyLPvQANCQQEDwbMzcy9xdoM0s8PIgsDIgEM2twozwPR8K0pBtYC6kgIC6WmMQkWOBhxT0Q+FwYYBJBGYoApAjD0KSkIBFuATSQCBDihEcACjOhAwuiIw2GVjSWc/50Q8K8GRX45VB5oZVIGyREfWbC8wY6AgofIPhHYmM2BAAcQlh1LwCsAgQELjoXStm7oNWQLFjDIN2Bp03Y/ARTFRgCYU6sDIC7wKeBAgpYlOhqA0IqlqpoAUKkacbDUgE97EcAdIXivphSf6o3odFMFKIMSIUMGTHgwgJsIMJqEaFDxysWpCIsUgcozCcqZSaCSzFcxaoyFXbXES1AAycTrNtoivFcUJsoZA6wmfZh4PcEkMtPufDq0ieIwoBNzzln18U03cYt6LAJ3307Tew9n8aqmw9QlPo3OPd6W3tqkGtNI+w8ZgQUCrGqbSWwE/aob/UfVZVZl808BdxEwm/+CV50TDAEJEAgBXWn5ct8mpDwVF0omKbAAOwYgAAFTADwTQAIgGcOLAAw8oJUICnj4FwkKuBhhAVDFWAABpOx4SQIBDBPAAww4pA4DRToQ4TWRGRDQABupaA0AUrLoIgMwytgbkgMIE6M+m+X1ZJS9KDCQAr1AZOWLADzgIQRwuXUiAgH041EAawa0QAK9nLiAm1RCwIuT6WyUZ1Z8UmljXFAlEOKIkTkApULBAClkgA+tlQ9LYJqiy55DsjmCn4AK8ECoJQKJIpVatvkmXIRCWUqLonYXUIx9mTSAMRoR+VeOyqyJ5QFP2ZnbMnv2wmVmlvbpqwMKnAgMAgo9AK3/oAccZFECZiVQozIEYTlXXlhqJCKJnyZKWLUDcdYRqcpEZYqJq8qJ4rI2/AfAUw8MZdVa40ypr1NQQSjCgE5tNGAJ+lpoSsIjUOWUA09V2IA2WB0c2WU/nUiCANH6YkoBWF7jIGu5CtAAuAKRwGN/C1iDIpolKuMoMUkFScpBJDGAyQNTemQNA59s3FfKK6Mz0KgbJU0lMGHGLALRBygzQIQ3q9lpAw7SNoA0BYwLAF0p+3UZSgygoo/UABBd9kEv90YyNf3QVkBSZ4sVyt15byaNQ2WbVDbTU7eCCkRfd+e0QFyLQBvbbndKwofdBW6nzkKLgGLZ1REuuDok3cw3/+YiICCpWAcerc7NTua9bwlpK9lA0h2ZZ0pf69iZ4bE9h+LQ3CbfrUoB8s2g71NzHYOSAHtqs8nABLRDwCYI6/cywww6ziDFuiNDIPP2kRakNkubEGQAdKFjKaalCPrpx/qkzM4uQSMl69W7CIY1JhXr4jrPKKlaQhj2D8AZLX6dml8zguO62j1EZI4DBbcc8ADgaS2CJKENi7xFCjRVzWwQBGAEB2fACJrNfihBmTo0qI+O9A907KtOCSH4ORMSTmQI8JZTZsVBBTaFQ3Cx3eBsCEJd/SODTNGFYCTXuWPVkCQvdJ1bFqAAdXROda87mOuaqIAGdOlDfWJfCJs0gP8W8Y93QBSZANwHFdy5Ll/Z09BZNhIAVWTjedlLmAIMNjYChGKPZ/IJghyAxwWZwgDRIwXFlOGUVBwDIg5oxVoGEoCg5c0tn1iSA4NRsucgMILQUgG1EAC0EnBrSem7oQhxRjkayUxtJcCiyELJkY18MHNhopne2raAe8RIiylzgJ2WkxdrlYIpt5PcKtPWF1066m0SGWW4RJA02uTwWKl04gNHKLkaQvCGaUtcFovpAFqKQJhEpNIrh9imKQXuiCgpJV+YaD72rTKbW9yZOrKJxbQRo1woaeIBqLiMUGxyjJwYUhbfhTbfaaKTnGRgvpaSJnWQzHpX84l/8jiUi9r/MnppSQApEoKx7OmrKxDqBbFGBKH4bI8qIQ1phjZGEiompAFyotICgFGjthgrL3BaYgQLAKSjlM8Xs0sbtbKFnxIRwBpumd05SHKQZzwmKr05ZgOCBEKCBDVlRMVTORlIMmcQDYJq4hZXPXIjCFjjgiK76QHg5EoBcEtzn0RokGyjjrlowq5bVQc0kdoAf/pnIW/55ggS4AAv2pJbjdukDFNBDnZ4Kpnp3CtXqQg+dQI2rEaV61Y+plbBSo4v5GjAAki21dHWhCRLZR6nTMiAbDGwhla9B2SnihLGcg10DjlAJL8KugeYio4BTU9Z2HosD0ENsyNwAJ485AsH5FSz/5Lr6UB9gR885bYGGtHIw/CBp7wcwFwkOG9dykunOgZDIwfYSwHOe5ERqDc34iWNdBlim1Z0pABbXcioLLmTc2amkjspwFivEYBIxvIiFOHPfCvZm/Yabr/dSeF761vgCLv3lquoJGksWQoIQ3Vv543vxw5UTlXwByUGEHHp/sGfy5iXGqGI8aZUI92W6DLCOe5TtNxZ3xhbA8g3trAJ7lsizyg4W/9oLyZ28mL7hsI2bQkFf5DMlxRHVzgbMUCPu5PikXrXM0YeMY5D7GAs86fGBc4LhpEcY4b4o8k3LpF7pXxnYjQYAeRVsW0QQBEsG+SIJlhaoUc21i0HbcJHRv/w7bxsw606WM/lcC8t3GBYNuDHLSsYIAuKt+lSAwEBDcCnqe9AkTac1wFZfY5lVjLrVds6B4a+ta53zete+/pjGAFPC36znhUIGwW1/vUUBrMbHnzC2cWmwbF/kOwaPFvZS6ixCgJSPjd6ZD0GOIe3WzDuEjSRBRujAkzMEGciNJGYORjGC3KSgoOs2zHV7mpIeHBuNQfjpy0IWSKAkwLBHMc5palMbVqhnuT8xjnBGAx34M0db+cDOLNo+Dl7cXGII6fef/F4S9RUD7sguzU6MU16uIOC8ZRiNODRDnGS05KPrzzWoFF5CdDjD8PAkxPQeQ8KbN6ckROQ56XQuaz/nwOuiB88q7th+Se8SAwMccfgx6pcPaa+sairPOjSKQ7JY6kPYQ+H5UIXC84DsS1g2LVC0Y3WXWu0p1TNiVXpmK+qMsMuZAHpSlnK+75ORZdzNWlMgZL3rACPw76LxSC0KlmMBH+f7LUPUR1s1TbQ98cPpQ0b1IwQRGIVUE0RBPFv71wOgxTfRGESXsQA1mV8Ze9mXcZbgFJU3Sc/oxG03UfE4NHqh7ErCGhYFycqk+cNQFQqKgNfpes7vVC9JNDzPkOaAlLdx+m4RvWC9Fs82Fqw4fwSvAMA0JKW7pfkn4cQ/sqWMi0nh1ROuQNjWcPnePwJOHjOn0b2x+UixHAr/8qwefhUJaCDezXif9NHDUdFCKwTISyyHqZjRT2CVIrDMpICNnXSHQglMovTLtpUApBTNGRnQg7Rgf2BAOCCNBq4L3YGQmgSgguVQiCzEf5EM2oxNBkSgyU4gaa0N0lxU/7UO2yDIphzEKKTM8lFdcRAg4uVYxFCMx+0hNxlAiYhaqUQLXblgfKhgghSMo2TgwdAg8tVOYn1bphVglB0MG63JFnFfqVzOnHDf+5CFFMmf4nVH8FwOqEjhGKRh3aYdeggM5twOHfigXcIP5LRhmcDPI1TTIhQHXCVXreiDijEQwpAPEXSDBu0id1gRh+Ygp04DIu4HEJ0QCgICmX0AP+YoACbID+lmCaehF+zWINsdT6XsVp4gzgFtE0N8YvjFkVX8XMigz9KRFVWxAzhdxM+FDSUeEyBuC/MSEw1oRbrk3hmoWF50YqCwUb9UCejc4ucgSOnMlpqaDa244jVoSIxKBFTVEXoJyjcGCZ5wxkHATeWSEUwpDG7kEXeZo+NgYxdkkPR4osuQ4ggtEp3uEa7YCzpJgj+NDfDqE/rcojWYk4EYUx+dg7e5BAaiYvL4UywxIg0dCAKxX7B1HRadILqFJINqUkbcTfb9TokyX0wsk7ppmpVBC69I09ZdxD41IbmFJIjMJElc0oigE/WeEhbIZO+x4QnQDyuCFE4s13/MJk7JpSOB0GS7FgCqcYwEWOR0QcSArkREGCRQlkPL3NPipGW+oZWCgmUGPg6dLmI89SIyXU21HICERkIQ3JccSkWjfUAK5RUBoAmn1VU9ZctEzRddQNdv8OYIpg3zkVagRWX79RjztVtnQJaY3VuLIJTRAOalakRcgUkMOJHwFRaLYmZXDVuUdU4FFRdl5GC6hBb3bU86jCbvKVFNGkqppkRxnUq1PBU1LBbiuUf+HEqqTldRxEh33VOkKkoPrWae0OZWYQNtoGO/JePrmlXnQWQP6EkDGNHhXmYhaUYZ+kRPyGPPBNcSpKeJeIQuiVV7gkyG9Oe68JUzPMTazEr/7PTD3hJGsQVfpZpXDW5VQeTb3qQa622GH/WC0omZuVFDGVmoSNDaY62ZpAWH4dGDAtGEDIWoXn2ZsznZed3oihGYTa2CuUEa2TmostjCnQCZaUzJTAmYy8aYkdGYhs2Cu5FPMQzZASBYR1mDXxWYCihYPX1oQ/WEsSTHOilbYd1oTe6E5bmYpqGoTxqaa0AaItRZj26VVnWo2tGEWlGDWC2Dr7XYFl1XhlGSBSKmilhUCFaInSaZ7YRX8Szp3pGCnymp2KaXnjaZ0cqYOjXpnnRYIfabiVGaByHaH0Gpo7jX0qHbV2AI4DJjWEAb3iwKrsGYppaqkQAqWFgpXtgOv+7RqSm+qqwGquyOqu0Wqu2equ4mqu6uqu82qu++qvAGqzCOqzEWqzGeqzImqzKuqzM2qzO+qzQGq3SOq3UWq3Weq3Ymq3auq3U+gkOCgXeunYngAoggQrfGnEg4a2iJB2IYXIywBKKIRgUqKhZEK4r1grSJa7Udq5E0KWM4KQzgKpCUFLjU1JWVFKloA1Xpg2DUQD9MmtnkTEWgjGegjF35TAJuzYYAwGCYbAJqw3JkFUNkx8Y8zV8JBY8khYUuy/9ViKP5FbagzEahiMYUzIAEz3UYxX5oRvSEz3osLHCULKxV7IuFVCccbPIqQ2GYhURaxVzhTHKQC01awIJcFb/D0IASwNIVxG1PruU27BRAXMwCEuyD8MgKsuwHlFSKvVIGiUiAMcwTKEuWMgCKvFGN1C3pLZk+PCXQsC3XDAAjTUDeQsEdoW19zA+UJImQ9ERJLsR/WJ5Hwu5o+IThTU9FhItwmEhjZUNUMMg+QE6ECJVLBE98JWwb+EUcoixBkG6InYMmIBIHukTdrowH9NSTmK2snuh2qOgEeIUwTIhGaKwO9tHmCAMBLJbmrBHsGghvUAxoGu06Pe1CtYuwsu0TyFeCJBI16AMrhsMG0MsLQEwS0Is57AWWLJI1IQxCWJd3sOy4fWx5YK7mCtm0ltO2XtWTuMUe8NyJiQ2AZZj/wryG9LlGbhCPJWUuY0qo8khZoomXdZQwLFwXv8ACjJWwE1FaR9DYbEwwaVwCZdwZSV6uAAsHe01MpsQi3IWwiGSwCMlwt0xwAYBpyWmwCR6ZAFMAv/bGTx6XgJ3BA0DMWLLElOGDHRhH3CRSZILICiLCWlhFAXEIPeLsZ/bNqzJFxACrxkrAv0SNCN7xVd1H2nbuU4stiewR1ClUU3srnnRtUdZxWa8L+3gEFZxDGjSCu3gGRCDSJ10x0BMFRSjECMXx8Pru3aRvRCwU6pAx6rqC3I4IncUfFiCJH7UL9LQL1rrMDvSiwpyGPnRDhqBu2P8x1iKFQ0gXzprFcGIM//ooDJuMxTxxQvYwJ5QEmN8cjrCgFOpKw8g0w84dYPLAGZRgieJcx/i+csrzFlNZV9vUU7sqET44wzGlRW3J1yC5cok0FjiyTfZ+yPXkC0hcyIBccuglnyngyNl6CjcWU7pfFSAFZvWjBOsjH3FfCr54KlD8MOozLLaUM1rkQBMkcT6kg7+4xQMkA3gcraccTyI47kaQruRe8otlM+q+9Bh5rNIErMD4tDaM8EagtAtMcUuUx0Qc70+4bRsW4DnBjEg7TB9DBE0C7L8AyUlTUclZQpIu7ZQa27GcjHlBMYomx8UcwDt0CPbkL1LElLt8FZCu7NpsUcVizFDC9NpizH/U0IiwmBJu5J8imNZWXQAxuXLN9SGXFjM7afKfSiPJIGaW3EUVoRGJHAqsdZp7EgTQ9MAo4ug/cZXeEhFzmAnpoPW4DLWp5tcXs0S0UJB+LqiI9BFmjMVnNBa26TWClkE+JxCDMvJQ2HGDbNRNPa+BIO2mltg/5HJUqwhUlG7b/EYID1JDWF5+ZHarZANazFMWFtgGk0lyOlUVlPbHsfGU+PGSfsX0tOkqnUMa1TFk1vRe+xHLU0YktLQwq20BPITCFc1AwJgUQG5+WzJe4Q3a5EWJBNS50TSlpsWaQGXLCvECXsRK5vGNffc+uBLC+M/KAC4qSaoDGAUabgOUJJf/2GdXFltp2Vtk9HghyghXgpRuovYGImJJIrROV9pQ4vLUC3ZRM3nyzEzAIm5U4rSAAbuOJgLzFp0PuJFPAkAAaV8IiieynKZHPldzA3ZQvbct5YHxOm9EztLJzRrGZud3BQDl+5NCvQhDlFivYwUulwzuqk9xIIFvK3txEKx5MepsNoD5TcOF6/NCgYy0a3Nu9P9CU6uIcSCFsBwUTGG5MZFIByCtdHbmxrSyYsaCugr5tJNyKAAMsXrs4lj5iSQDKQBUmWEnCQbIQCDNu5j0A7TL/pw2bdjFXsEynYBw4uE5w+yx+dw1fw3zmnEGc+wGBIl1inUGyZxTfjYj2czF//Dg4uNoQqtNDUouZeT5epeCOsu2RFcUzczUuqu08MGrEWd3h2q4EXBHhkt0za7I1FnKWqD+wMEq8RiC9XDu9G1K7RxgRZf69ETqw26kw3aIFLE8LjI0LFLXVI+gz0US7L73B3HIBHYXlIC9bLW0OOlw+1de7PlTo3ag4MbGw7gzrFna1H/rgqPHu5ORbT4biE0LbMiUrOY0LMw+9YlE9TH6SDSfTFQrFFrnBRDfgzUC+1WcTe4S7Fjvs+XwLb3jkgDEe0DHiPUMiSuZSZUAiUcCXkX0YZEJXdmCSVz5yL+wyI1b0sK8UuL6POb4CbsABIWYSZzMSScEeuchCgIuiv/5dN8CqCa+4IJ5ql7A92kOoSEe1lF9Ccp5KzzQQN+ONnyRBLZUcLzM064LMEdCXdobz8dT1d06r0KjxGugvH2gsr3O8eu5lo5b/9wd//3fO+thY91M+b3by+w7RYbQycdGmcQhwj3kBr4EVf4cV8bEsdyxZFw5orF6Koajs/mkK+uEacKHeb5qRAbgd/4I3N1obH37ir6M5YicClzpWMYYdP6qm84/DtzG1wZImvXhjEKlZ8XDFcc/xALLgf5zQH8pWAQvLFipFEXKJdzsYAhGKEJnYALqa/81G8c5J8Xwc8c40/6Hjz94h8MrJCp3MoID8CxaEAsDzgFoBr/+h8I/5MPAoA4kqV5oqm6joLAwrE8IsV847m+873/A4PCIbFoPCKTyiWz6XxCo9Kp6mBgWalKhEMLdEUDqULjlNWe0YErFewzHLxyXUBsQix8A5Fg7+sDHMQBDLycLCCIFBoROAmeJCTWmQ3OTCo9Alw+NaI4VJIsknSuIKoAVg2KUgUoCLBNbfKg4pgSGpYmzv0YXCEYODjYHCS8AggEDPYa1BwECIsYPPcSCNToIhsWIGSXGOrWbAMouBYMNATbjBQkOLycp/MlmxQ4rPFJx/1GJ75sF/iLdyxfNDgBChAU4ewbMGjkBKhTaKcXgF/xHtpApqwXN3W/KAYK4A8cH3kbmf+d6DauXB1nbKRB+4cLQC9n6mDenAdgGzJdnXCOGKDOpSJ0XY5ps8emXoAa7V4gg7YuUc17JDDCkwqUxLUrKo+JLGgz4bGIO5/S1HmsLAmgEEV8tLdxrE6LRy8tTAFMJ1Oofoy1kFamYh1/aGvsVIpvHjt3aa3uujFpwIMGCsQEYCDywAMBC/IESJAAkTsHexAwaHBggQACyQAF6PxAjADNDRiYjQQAQhkIAPcMGLCGsmU70RhcJlQ5OWfPedYNONAgwRUCrIs5UCBCQZdGtRMIZSAINwDrAoppSnDAwejzLy73KUM8eXDIhNRNXi6mPpzOn9OP9sAgDCAwCXznFAD/QUUEbJNAIP6BJtpzJMQmwGyECCeNeqZVdA4xxzAAHoUJoOMgAh46eF4DAexRmwO3Vdehag5WpB0hAUz3TmcKgNaIOdJR11gDDxiAHI7YHcXHHqGt50dQGc4nxokzljAAeM7IhlmW6a3XHnrlzVQkfCSyKAIBweki44cfTkfGAQIkxyR71+kIJ2hiHDiYCarBKUY7Qx6zhwIJmOWaigC86J6Y+0EU3XTV0blokapNGJkMk/kVqAipudBIKyMY1IgCoHQCCHkFMKDpLSQs8CI5BqS4pB2L0KKIIbTuwWlrJDTXZ3ki1JFgAaja4B2hgTy3QBydTHIJs2sw4AKHuGpi/9wINFa7Kmx26OqpjQ20KGuR0u4RyQKjrgZAt5rYaMKpqV7i7DgiuXeeWdkCEAl87ikwGHWotPrrvuixRhONlq2aoJkPunDZAe2u6gCRJmy7MIWzZjrwTNFtagOq6noMrx3P8nHvIv2KQF15sGxHL3rkEAhXdrJajOlOCtYxrgAcosCFAnvw1kJ0x44iAqBgCbfqLb0mR/IiqKVpqSWMaoqKa3VgZgcxbzayyq+akuKdH15bpoAB5+RRsbZO2to2IFfLwiLWL5CMro1iA2vHJCTLW21tWMdBrSyKjGCz2nBnPQIDBozqt2YtAaDsAIwvUAbi+JoQNr7yDnBZzrXmbf9r51iffasLfuxNiOf30IgKIKJ04qlwhcmySAGhBS00vqSEvrbqpIdiiOaa9z148Eovwrsiq7NBwFEKVMZh8VT/WtjjapUAPTotPgBBixBUk7mS7LBGn+lyF/a1zYEM4JrUU/uOSrQi2HAJ7PPS/zUgusGqqtfsPCByldGU/TJ1PN/Nbye8clKxQocA8PhEVUdDGd9GljcD+CZ/grMW4UK3wU1pA3PZSVW1MKgOGwwpD8GxQQLrJwaAlIB/DoqXBZNDP9Dhyzc23EnAQIaKAYrKOGSwg8KQtaoHLuwADFSiBv1hNLYdrgQF1NQOzSIKGeaLKjO0IL72cbwekkd5+Mv/H49iViqaqY9qSMxZBhUIw6JpSh3FOA/UStAJB7AGddQrBBPz5zQn7kSM70uB4faQIByh5jNbVEgCYtMIWH1GO51zxx6mE5oyoMJrhOgCAhhUNc2cyICFG4AKM5XIBWBrO8J5QHd6J6KF0aJzP6tZ4tIYCM2QI36gJMHEskWtvyHglIukn/uydQBc3i0R7IELAxRpzACSwJIkAlFT5MWOy0QCh5mR21mw+YvRJE0AEDiXH3yUAG+abZSovEJ9pvm1n8WmC6ObISlNwyQSRBGfoKTWNUMTNVFIswwB3V3vYnY8SCbtayToZySY2CboLSA4BPWlcKY5iWO2Qjucyd4D/yKaK0X+JhAQiBoBeBSk0QwKM6RcFTxZaUsWIUIzD4DYIFVAEcSIYydvQUpBaACVFqTpFTkFyAnBcS8DqEMbujDAC3AaNbgkwqktmAmoAGMIkIBkLTmFagt6CpKrLsUacPHYUqkKp55KlSa4cENWK3KTsKZJF1vlKU2ugLISELWqdS0JXN4y17wBpq8RseoAgtlVwbKjBEylAVMjQgqmwoIbNKBKYOlHFTZQVa1u3Ulcd0qDiOT1hm/lK0X6VwLE4OOwd3jLTvdhDXF8tafn2ClIAKKLu+LzGnxQKldHQIDF3nAZXEUtZEnLBsPatqbKXS5zT8Cx97HNCMY7RXRTov8nFkisus29QSbkoEkUaFcHgtwuectr3hu88by8YBkL/uoDyao3vmN9Qmbla9/74je/+t0vf/sbXzfwAA44ADBz04CDBlzXvwpeMIMbLIfusmC6MsAbDDIhYSXtYhHfba/KHOzhD4M4xEDACFjq6wwb5uUxmE3GsGrw0z70hH6KuQpLkmEVoMCWI23J2WbFIZO1vIUoa9krT8KSGPY0NSNkWcgV+sIHmoo4ylKecpT5U6EL8VIkScvTpNJFjJ25I0R78A4EpLO4Hz0qFBmS02lQREAJgSo16fqlmMuDJuHkyJZ/u82w1HObd9CNTgCYTR/89CJo5ovKil40o/17iXf/tYWEOYvWzgprUHXBwl6w9EOrmGYtGi5MY7ChaR3d1iKi/dZgRtMOyTIpgIe1LXkXlLQYcjeCgjU617reNXP7plBVWQ9w7HMf72hBYazNzsi94xzz1LZA9/3SSWfEcKvHhgyMrepZqJiEhbxXuPryOtziHjcTLoHFOF+wjcMiprq0YWxVVaaPCiyc3mooRGfnL5Dxkzb9FGTEatsK1quSdQlpPe8vmQIl5F44wxv+A2AO9CodTRpGyYGa2GjHktx5tzjJqcp46rOaFmQoN9BIA5lqFJzh8q06VQa9lPoPIqNZwPwIbqCONlJdIE0ZsMLr8J8DPeh61em94CJcncpV/6zB5WxXt2HYqrJXs7EVLNPbesO46narYZrJKyiSU9RCBDGIAavRewhgZ/BD6GpfO9vbjgMeRbToqCm62+tu97sLHSDg9iLe++73vwM+8IIfPOELb/jDIz7xil884xvv+MdDPvKSnzzlK2/5y2M+85rfPOc77/nPgz70oh896Utv+tOjPvWqXz3rW+/61y/42libPe3BDfvb477Xyab97BPKYIWH270Ue2rVoz4FgBhfwbYPt9VpQnyHX5jeKDCHlZ6/XVRZ3xuGgHAKCMwLUCABhzHsIT5NroUi4WgH3E8CB2+gvPXTBPw4ELAc8JAScBuPHcsfd/R7ZwI8AsDRnP8CLADX0PFB9gkB9jxdRQDGJWCVZ1WELuSf0vUW0bWFIdACU0VNaDEgVyBgR6gKCogfAbXfaVXWCWhgz9RXaE0gyxSgYkUdB1pgYGgWUC3UTgkSN7gg1xmA8mTV09EC8p2ADuZWCBaXCe7gDdLdC0YgPYBDA94bG0zX2ahd/2FOCXSGCPjbrtjRbEDAFcCUyoTGy+0EKeVSEmBLO8VBdlySujBAYV1URSVCcKBSHDDAG8aVTMlTRcXBQI3hTI2D97zJbHQUiHQUCZFD3KnOLNkSRMWKsNxMRCiAIAJcYRwM27DhNC2OuiTC4lhIbKQNeIgKjwhFNDWSJuIhDTQSx/z/oXa4E5nsxyQeSRvWxiGayWzgEiCaw7loRy3SXCCcSaVkYhm04lmci/JMBimpRyBGxwOxSBzExhsOozGSwyRGBzH4EwlMY2gsACDWhkkVywJUQxiyEx9qwgO8ISBM4x0WljOyokhc4nYgoLhZoYTdT1qIT7V8jBHJi7KkzDz2AAK0yyIUCQ1IT73tI6B8EIU8hw0QZKqoTP/IS60wFYUVAsJEjqtsh+WEjidlhKB0QXaUHy2RICcOmvxxgaAcwAMtwD6qlXfEDEaSX75cgURykMoojLzAWkFOxnNEZKy0Dcn8ij9mkav9Glcc5ML0EDJSDSCgAk7iTCnKzB4sABFl/9JgyF1SYhoqNA4BlME+ztkL8GQp0kJK4gtUZkvMCIhCJMnP1WMJKs140ZLroFHXgAeahJ9x3A8xeBwNiVNwrNRCgsoAMMADzKHwKJSnWBAqPNBlWCQyvGFwOEO92ZIDeA9t7EFBbqLu6BnNPExB8gpK7cFqIEIhaEdjBsCxReZzWUz1cNCZACZBCUvArI/mGKVQ2iVgllxQmgBfzhLnIObF7JuZACYa+SZwrNVfhIgCmMVx4kshbJsYTJum3M8lAIJzOktxGpPZkBBYCN1booA/mhYKPAtoIoy8rOUSIENQiGWqeJLa1AFqVEmmTNftBNBDYtpOiMymFQV/3oJIjv+AwPmjUFYEgWRSRHlDOYVOxSRIVdrRR9IEZaxE4AwGhQGouzTZfpLAFwrn17QKeazPJn7MbfZOI6QnhmVb5kAoelaoFDXlyu0GyzgLhJ4oRbqUb60otzCVH3TlcazaqvCkHbxNjmqhjL7QOBnHegYdeKZEMdgQF8LRZBzJC8gLarwJrh1BGrLGhfzJA4xmIUgDnnRGWGqKEgWWPdgJIWyplnwiQWGQNZyLZzwmO4hEOojHMTnkJ+TcOcAIKjRA+IzkJmFjSUZOG13LofnBaAQgh8apOKoKnYIZhWzJ4BADggVQ3/SgjazPlWEmbxKUlXrG6bSNeMxEl9ZlAGIHU/r/zpsiQKUCirkhKogg2AKw6qgcyqEOyZIUQpnUhmqEUVBMqZq2qXWWS6yaKRyQyKvawQIYKpa6JVx2aEqohTSYgJBun1W4wUTYQ4IVgSsoQvrsxDO0qkTondFMQyDU5CDYxDo4gyqAa4ntFrDIgzKtgRjQXxYUQLt6jEDkAxgUyD3QH2i2hTK8hljGgRsI3EKJ6yA0gBSOgFLYayXkK4t5g5F5H2E0BV0ZhwNg1gukgUrcKxjGqyZEw7bGn0LUZPqtw8JqrDxQKz55bLrOK8b2gzawbFpwLFhYhLLRD8u2gk6ch0BYi5DNDgZeVRzcjgOMa0jYwL/WrEK0S2J9J7RK/9/vHcuGJQHWRkbj8MBm5p5kWMsIOtf+6YDXcu2SUq3/LRiCoSsUGNggpS0L0N/X3gCBzS0WJF+AVQIXrB2T0u3fAu4uoA/v9V7cBu7hIq4RyB7hzh7ZJu7jQm7kSu7kUm7lWq6uLS7jvuvlcm7nStHuMa7vGUFbNR8SAJ+4wRcTlO4uoBbgtu6zRhjVZmwO2F/cGC4QYB8MIKz83Z8J+JzUdGOlKIEVclfeVoTwUozpGIEtLMHdShcRvO0RaG3kPN/F1u328e77+O1pJQCgroAxAJc4OOC1NYECdpYUTsRLQODTGc9VneD07VS5fi8ErsP7NmFr1m+aMCFyeVbq3v8g+kbD+iYCB1LgDIpCci2U/mZWAS3gMTxfY+FT8r1uAJ/WBr7FAgrhZKFo9xkvBWsw/voUaPXvUwHGKriAWWBwYMkgXind9LYuFFYV3RHh0jlgZKXJCrNC3EafCYsRAeBiK3gjzdiTZjRBGprjOuJhHGYjHS4jO5JUIJziP2WKL5JQI6FSIGhUAMEaj2QGO8miO4KfLI1mMJ4cyJEjhqASKCIiKaLwKkKjGCjREiujGpchLxriLyIABECQHo5kMZKAEzMx0pohTcWxbvhwAHzhdBiNgySPOCKDMpZjHd7xzC0jGKPxMloj7yIUbYjiiJDhIo7xSo2AI4IIOILyLSL/MjPosaBU5SYGckW4Maq2IbVcnEvtarJYS/J44RU4cSHPoSxOYy07gBMnoySfB4v8rhNsr+/iwstG6WLKShER7w8IJHvSRHeaJQ0l5H3SZ/t1DVYej1Na2w0VQ0E+AKEQ5THQh082mb/96DhwJEPSD1iWUszJZFuiZbCQkEIaUCEQZTaN8yIEQEP2MRdVLbX88w3vcwCRzCY2TvJ8JQmRqTibGk3ezHCG54AAxKWVaADaCAWpqAJxpXR8dDyvz5O9qEUrzE/6zkA3EQYV6fFUkH4azX1Will+ye1QJrXohtg+wTLP5wrgJglGJxMoaVxCcV/W21/SYUt7M4ickxVN/7G1mQMuvsDisBK4XEEaJw3saGfVpk5bEKZh0qXv3EJmACapaGdheE9TU8stWIluGiVBjnXU5NNBZ0pc4yUftPVK8U1L+hvBlXW0VTRsShRhg5fpaJMFgZoYWWY46VFje5AhcHVKG/aYsRy1nE1hHuY4CAJN2VziMHVgbp9o/hqoUct0egFQH1AKDPW2INEV5qU1F+R7olF8dmdFG89j3WhFu5pLs5SyME6qnMdkx3Rv2siAnoB9mqck9fPOQNlx5418hrO1nWjMKU24IhqhqqrvXPfJ2VHoJEi6pOg1/yhiUwuHWjNFowDX/kt16WRyL0vPGCiPfrYIKLcvQQWNFP9SjP5xhpq1dmsLeFBVaGcLdVtzeUCoem9OSmeQTyuzDsMlQLQDNvRwR1fMn4guGgbFmuaLsYLpzb1aPV8nmBaNrboTsPSLl9pzMWTGC/ypQ2pHl+1paVvqQt3pr2qjSPDIjeTZWxcCpAZDaN64iE+0tYEqaxglj6ADj1fKXSsEmNIyqTor9Iy4LY1DqpW3j6MHemeKq3KzprBqAXhSC5AJjHaoj+Q4C71JKCCYJ8oZbqDKeDRQtjA5jac0mJ/jsK74HqBpj19RdRn4sVo5mX54rmoCH31CiKd0nLK4HLD2Y+iEMxfOyEYsT9XDmzjuiN0KuCbt0tqEG6xIzmbBvR7/BIXQBJriVTCMa8gG4GY02SC4QYFoetvCRXyuulRw0MRWgpCVurrGOsVyBa6L+rn+Osqmevq5ej0IQ7sq1sEaQvvZxLEnO7eOusjS1dK27dBaxbG7Ov05bdvSX09g5I4pg/xlq4xphcre+j0ErVQwO37EK7MTRq1Te7jD65GNK68ju2f3JrYj7Klfu61/uqxTbKjH7MkGwoskc/lKeIPBikNuuufml7M6AYTLgcDuAp+cwxxE+n6xbfRS/IIB5BE47/tY7/ltrhZ8/Mi7fOIOruZuOOVNsA7UPMUo2M07gf82Xclrgc5LjfDFF9BPQeZq7sS3nf0lb2LjgP25Adae/4Fc+i4K3G6VIMH0KkHwngCFKRfWSy8KZq9PK321+sAZNDwMeL3mnbAHXmDPPFUDW1ZfAXAAq0Pa45UkYAzcI7UKvy8uhBbv8LwI2uAKBH4KFEIKw0IGD4QS3q9ORRb9yiXXo0AKqoD8mgAEK1YBc2AwaRLli1YELzcEMiFpKV2tlP7vblUBAv4KEhh8iYLtFbAKHL5dR83oRx4Xu7I5cqM3drIYK4I5dg4EaBmiYFMZ9LIcnjUu/7dJemKu4OEr08Aql8cuw/IzhjcVA+NKJWIpWod1HIyD+Mgg+zt3jD8bl4cjg0mVmKMlC/MmT7Ii6UMsk3KABuNbiw0kQiIfEP9iHjQOCCgOoBxAEiwJABALIRxDkCAsKzzBswACw2OwHooFRHDz6Xg+RjFRaCkCDNtAAQk0UIkGgLYg+hIDQku562EHh8JgoVD4BgVItB7FDb4JhfhA8EZSRCdAZoaiwuKnggBBdtbF0uUGJ3djIGQAAZAJMPCWYFIZx+d3mZSqusra6voKGys7S1srMPWJ5BkQwMJg8GPTcKngNaArJDh3g+CwxwtQIATQ8JC7yQJhkFSCkLAgvQydu5x0zGL21ZuwXZdqJrBHnj7MsjBC4AXwS2JitmDiBIIDcgasYFcPwL0W+r5sM4fsRDtOCZBEA+irQDwW5zayi8aJwJ13HJH/bDyzUQQAB6gwCTBD8NPBhxorMow2rZoqYPDkHdNJLhXPciXOAIip7KOBFeN+BUPnsqe9gDVSjmCZZOO4dPQu3XvKoqaABvKinDsT0xNGgUl+OehSr+OetTW21rqLN6/evXxXqQgwI6iZccdOjoN21szZjQe+KXjWSwAEUILOlYiZ5MCCBQiOydHai9zJG4lZQAtEmeTJc+moUPZ3I4W7MwYpI1jawMGDcK5BwXZVGjUooyVLrja5R/geB5ND30gnF+pGT/yY9QlgBrfucG50MECSTjLlHtanSM1F2CILb+bLndYj+Lk64/LOsMderjYoBNOFVIdvl1G9sXFSd1QI/zBOcWfgsZB+A9hwQzEPLhCACdE5iECAfW3IYYceymKIab2cs0toTsmDGUYkJmPRRiKJ0wsC05BmEhnqsWDAANbEYQJoxY2mYGu9aMPKeayxgFUS6YCkGVQPBHQDAwsYQJAcScoHXERE3rBlP5MA4xNyAHTJTBVK/iiPkQvUx5E+6UhJZSkpFJeOjKwM4GZ+AjhA3lltSidPUekgZRE/vJkIpnx4AjoElPmtmYqPRqVzpXt97tlSaQo5wEAUT7KiWUEDbBPdp7GFtuSHqq7Kql6ZNNDYiAvk0AtgCO5RIAMHHNDpJ7PqEJRHDlSzhwwCGOBHDD2cBYkq31BDJGPH5P8oJjcLeCHkUXBZc+Zx+xwgQAEo7IkPNwQ8ZIaM4M6q0Ap1jDKuA+XeIIk5v/bSWAM62XqAA4Y0AJiey+SrE54N/CdgMQ+kWU4DMKQChwAv2OMuBCZsgeB3xCXb5A0RT3zcq7ze+DE8DMDaKwEHYBzUDrR+cUzAo/2jgMTZHYGAuhILcJLDN8II1bfhxuuvPBgf+G4OJFxrlAEEXKIzuzcUkE+7aAIQNYKotsp11163kiG4SMwQgEUBTBEQlVPLmwfZFh3wkNoFBODAQCwcEEAUADuwDdyLOHpDAw+FpvZReftd+NojhMbzerxAGFsnASGuRTR4t/FFEnabhqMDlWP//TZNl0fhXDip7Fo2M4/jUGEUBlSI4+TbFJ5hADbU/lDk0ci7eS+Fe6KK56+vFzoLAMewjXPU0J07kgEMXzjlyKcifGQJsI0O3g/5zbrZaMeue/Ws22CA5178PiMmPZqNY+UFjJ748X4X4LkN9C9+A9+YmB88+EfNnjb+NS5zXyugAQvop/nIIoEcAt4BH7ghgEHQQ0WZYF+ARBxYJIiCgLOgBz8IwhCqgns4+JkrSNihAYpwhaswQB5YWAvlwTAWieMciEy4IRnOcIc87KEPfwjEIApxiEQsohGP2BcEvLATzdtJE1mFQyTixQBP5MvPqChFVSiRhlVkFRbDlcUw/4pRjAncoCrMeLou1iJVr0AAec6IFzbNYlccQiNf2GjHJOgwFnuUhRvjGMVUQIOOe0HhKgYpxzEqcpEGzBkrjqW5zlgEGOMAxgspKUONQIiBYQGjSyKJpVgUAHLACKUPIOcK9QgAla7Aog9wqJElflJEOPqZIzu5xFVmxWmCfF4g2ThLHOQOmK+cGiRTMUpctkKTCmoFJplYwlkc00+WdMk4asbIbGqTVaCggQl2wIBRfSMwACCCEZDgDCrgawY1WMkMGKA8Ge2gbo/YwxWysAUaeIEGpxhCEY5AG33YJGBZeUYf/hAIcLyhFIYow2bs0QMzkEIORVFJBUUkLktkxf8JKoiCC2AAGBUkr1ahIFUoeoSC4Uw0Go7B4zfEYBdAKMM0B5XDUtaEr4ROzTFy8AZgvvmAcG4kn5KIjjwfMIKYkYdCSUgnPNWRUTkFlWxBexoVclbPo7DTBk4lHLe2Cdaw6mVFMIvCWjoFlGPMhhemq8ZalTenaAQlKbNjytbSCp6jWMNOPgCcpLgylUnwx0zA48c/qDKQgsxEj2VbgVxvcBJBecF0TWLrNJoUnXZuhC5uHEEGFfiLAAHTLmf1aKQcG4WPuAMwUfBIXUXzDPKY5VicGFPu3qqOEMmVtQoE7FEKgoS27qa2CXKsWI+LXFiUJj0lSY9hyjYZUMxKHhv/zBEQrGARTZ3BLsx9E7I6CFnIVJUjZNjPaAzGLcWU90Ha2U365rOGhrinF+GRB2hOspHo1FcmttEuLdGztc/2dq55TUV8W0AZ8S5jSYoRk3UfgN1+YAY+84HGgQ8T4P12JLpveC5pkgviEKeCrNekSvku5Q0R8XU9jkXj3KxxlrMYSgh24ROdTKOAXj1Swb41FYWpQYQ8+dgXU6pSLwNXWwoLCkc5kQMvgBcXMdlhGUN+QJ4Y64vXZfiMW6vgR4gJLdtieRkzhu3UdiAaG2muxbVyTgM4geHx/pYcK8Yamz8s4jwnt8PAGse/AiYyjV2PLL3gWA8GTU7n3UINTDuL/8v6vDWRATQdVHOzcQEUYF2tUtOzAhIDZpQuTiNBEe/q5S32dOkfoMy0HNHCQEfk6rGJKWILw5qoMeYAPMYMVxWZmNDGDI8uEFTTkK3ZW7SlL2v4+RkPeNnZiLWSshUhKM1KAqLbfOpj+7nXXFmZTYrgBUOfYFjkdIOezy1Wt0WzfVB63fToJzbjMW938Z7a5cIir/9BNnXFJKC7z+Gc/6xFff0mXOXKd3BHNUA9hOMf6O7WxMbtLZfXc0AelKe9dWdc39Ejd+c+h6DhZeXed3ueweU7QIO3+3PytrjjbNfvwiHIIvez2/tgp28vIdMB8ZY43VqrHu2hauP3a3k7eP+ecvCie+lh5CQRZ9WY02VKlkLEYATBtSimM5lVYI5FirUOdjEasoh4c3lmmsfKIdawgbwIZJ5V+KE+xqJuYa+73e+O97zr/Yha44Xf/+53t+998IQvvOF5CBjAKz7xEBT8hwyQ9rvzZ4dbFPwWfXj5w4/R8WPM45hVsQWDRH4vXW+F3F8hjdFH6m1KX70qEunDMLyRhUfKUtzbOPtVcM/pG4J9q+DOqtPnZexcT67nT8UKCB3gq62AZCkh27xjLWnyqtCIelJFfQ066pagGxzh4ubJ9UAIjZM8Juo9aX1Y8Izq0TA/KIOWBGbWMhWOjCUzYBn+R3qy9kmoZlCyL0z/nXAjumRMebAk8jc1pGRCMbZKkKMRVQSAPtBFOPR8zIBKz2d+/id+/9V8ahRMEmhKkHUjFQiCBagg6bdLxnRb+ScUx1R6i3R8HMgKZIEDwEQA3nE2YnBTgRFV6RAHa+JRL2AIKbACMqUGhMB+qWBc3SQKKzEFkvBpD4JINGAFJ7UP4YRKMMEFqBQdPxAEk0CEc7Z8c1YEVEAqWGA7KQU4V/AYR6FT6wFPSAUzIvUJoZAG0/CDdJAERLVPU2UtZjgPp7NV5JCHHoWD/bRSXrgAQmCER+VZAFJTmpNV0tWEPsUGBoaELaAD2rAFxrMCwVYGc/gRlPhNNbWJfTOIpHiF/w/SQuNkPaEYG5G4gzk1U1HlZC9lU67YBF/oCJCQCI51gwFAJJZ4MVxgDGISK+2kGALFeUUUgwrUClkncmcyYKW1EGeQEAtRNZ1kE11hD4+YfKhAVuvhDApkWcYDY2KCRssYFhCxDN7SfhXhCQ8ABQN3C7LyJSCxh8SALYIkW5S1LNXyE14BjkrBFHqoCvcYiFOTE+mYjfNCWojlLa0hWwU1YO5oZqqVZNRAkALSC/ywZE8BkGYWIOcIZCQpd6UFFsh3BqX1WbpFOoiikmESFPFYYNCgkRLRCStwIfpgWmNYZzAofNC4CqXgCtlCG9kVDxYxGOHkG0ZhIBrTGk55if+p5Byl0RhwoGBtx2EBCTSqwQB9sERdGCZRiQS/gFRksQ1/ERiJkWBj9h79NwDXhV/2JJAZ8xrUuF06xJYjUmA40JXoQZW/YRcYMpE4MpcQZpEaoiD69ZaxMZge+QXgUFvnUZcoGTRcOR6YeSdKaXWFqZQCdmGhcQwM6C3nYJaSqRzE0WDvGJYKwGq/cFGM9IyeZ5RH+V9m4GUGYGVQUSkCcilG8ZtWSSOdIAQvIimP817RsY6YIIfFuRHHEVeWARDIIgS6hRgWQSY3kCK/gUw7AGXApSfDmWU4QZRjQEv8Z2sjhikkMWBDdphnxnx/xZ5Xs51I0hKS+S7kcR7hyZn/QhKUzCl3u/mZXWZiAmY8cIYoBEqTABec2UImZRYdOCKHrZFjSRhGtdlHKsAzLWKDuTkGALMHuCZRRGMUR6MxmiYuZZNvr7CE9zJu0GYsWkYCzYZZyDgtZ1IC/6JHCoMrYYKiSOAwZmFTJxMrQUEwzCcNu5Iy1CNtyxJrZpYLK0ouetRskCYURooCCxkhNhqQVJpvSBlq68IzNKlpnrNoixlgEdJoyLgt8WeiSKkA58IorcYyApqZhealZjajVENxIloOwBaiwwYuxYZqMHMrg/qjxQFuQSqZSfoFV1orPtoPPEppBDCUSKShoPJ37QNHBcdu+yZyN4c5blY2lDNZ/6MDC9j0CW0XFnSzOXiDgnvTNwBUckvkO2i6c3VjAtGzDfLTDgExQGHTOCRUO6x0PxeHTCRnONtjq/pGqrI0c+umORVSrMkDevM2P6rKOOzTCfzjq52gBaQqFOtjQ4rDcQFxrMvaOgQ0rFDiO46ycYhjru5qEbSarreaEP2Hc2sHquK6cvI1cV/wPaEqORC3OyMArPb6chAyrQlrNwjnrfvggVm0qWK1FLOleRvLdFIDQc8YQhOmTRcrVvqScxyLsiKmel4DfDxEfIpEsikrszNLszWrQWSzeH6XaDY7QZnXfGDls9sUtOoXRK4URs0IVn2Xs4G3dJyxCi1rC6y3If90tHtR5BwvyAy5pzu14HscwnsI1DVOJ3dYG0Jm1LUF5LSfugpky7NZlHnHlCAaqDnm94AKZLTcZ39cRGDcF0rwkDtyGw0KaEoE+AqqtLI4cLgQwX0a6H95O38lKIAv1LLq4bjZR4JYYz/5N00WkX3Yd33n53jrtwp1i0zAl4FaEykm2H4/4358m4Kqqzl3oEKeG4Jtm02scYqrOBCpiIYsoU+2Nk9RWDt1qAIoBRhs4gnYUCK9aE9WyJ06FYxEIgNUuJiRaISJeAgPpRARFQ0LRVEmYFFt4L1jEIov8XrsZALT207JiAB8aApEkLvqq0Q8BZZfWKOKEFKjaIf2a1X/ZmIZSGiEgwCEATUJN/KLYmgNMVGG/HBPafhTShiGmiiM29BV9buIYKgIUnBVdehNkRpOs9gETxCEMHAOBxzAhUjAJ4C0tvtDtQcN0CBcvqI55WgT0RBnmWUDGOQWcOFkfnk1eikkMRxeF5kOnPUUhbUNhyVYSDETRmwm4vp6yCBceBAWBnmRJlkNMKkaQFoWIzmhtUcoD3miHQkTe/VeNjmP9QglCklX+li63YhRxCVDRkJzhlBghGKcZaUQAdEpkeUP+nAWYjHG34gWZszCiuTCbeYDgXkWWdmGqXLDYrJf3EAWbgQ72fnDfSsi4iFdaipnhlkf6AUVGNJe4QDK/6+QGJzcYWzCYFcMXZt5YN0SJglymV9cYPmFl085lXnpXbOZmmhJbmuZUj6MYKkxNTpyIB7pYbJcEqmpYUypQKZJXfRFI85sGpHZy613yESUyPMRoEzZWnvQJZG8DFOGQaFShyNFYIEKfwB6xpgmZ/BZH9VQDE4COHBiZPKMyshQZ3VWZiVpO+/8ZltcElfin7ZsFITym5SSnxaqY6YRnEUANzmGnvNxFvc5mTemDl9nRnQ8nXcsniXyN1/ix8ShVBq90Dj20NssRd08o+LGLMNSa/zCc9OCyZtVM7UWf1WTwRbWpuz8a9kibkMcIJqWNZ4GarZGplZTakddH346Yv8wCtOzUjaPpsiSaWjZdmkoUZYWozQzcKd32QLeJmtgOgIqGqdhgamp4KhD+glFCitb2shvGjgVkczZcm0EnQuOqjJ3CqPbBqiqxiusttd2naLgYtZQudYsHUZ+0623ujz6wz1zw6usgzmyeq0HexQeRz3+0zhFR69CUTmPHdnNozYp1z7nA64Kx3Afpw/Uxz0Idz5Qsq/ciTfqga+Gow8Pi9r9hq8Dq0eaPT/1U3LOKtxJPK/B2q6vk6rtGnBPtLDvs27EigTGujp7eKrYWkzwBnzxirALqzLP02r8pkKvI6wVp6zfnd3i2tylGiUVy9iFByvxIF9657FixbaxILL/i8RGXxspZ6sX+x3fKKtlK4xuiQuzHfKyGZpGsuCvUwvfAy7hE07hFW7hY5RMBpThkNVGGNohG35uBg4LRosDiwTirjC0v9cJCH7hHpK2rrcXA0RIMQ7gH4JBL/i1D34XVtcKM54VIu7js1Djs5DfstDRr6DjqSTitr3jQ04OL54XQ1miS97iefG23ucS7McfK6jO0LQKEdh8hfBCEeh+r1u6L6QRNChM03cjOcNAwLANPI659OeAniTnLZQ7t5QgpNtK4OfhWVFLVXS5FhhK7ue4JMi4qNstE+h7dOtJLka4gOvlrkt/YHTnFngOW4SA52eAWYFK0oeYVY5A4JG7/8Irv2+dBb4rCY4ovLzQidSwAij83vtgA04BBBcswHoYvU3Uv1aAhu47hCrVUouQieYEUNy5hWsALofw1m1IvE0Y7D9KxVT8MFimisJLjKj+uycAMOtEhcnLCQ4EFeyrR7hIvooRBwwDwoo4DRV86hWsJFNgJkI9GY6y67D+u8JbJvOkVdT7UajLhgwDXzywAvEw7VN2A8Yua47YAkKYLT8gwtc7vj0YISwu6nvRzTDckDLMDDRMc3EGkivTkRFyAN4ADtcJpGQsgwldEORhxZo1F55lBg+JV+bgk/hlJglRzzj8jnugEkki3taujqGRk8qQFjSWNxu/w/rS0J/gk/9jZuvCwI8tycca0dUY1ZC4RY0x8fCJhNevZUZxVQAxvI2uPvXZ8iLhTAJX0RI1f9JytY1dP9JFjFjXuCT9cvFhe5OKrMpeqS1amUFxJhtwFpncuRmS9BmzjM0r/8ztbBS4DBUDgjekOYCvafUURs4uAh/9QbGm58N/9ZaBbAcLoZmdLCGWDDgmI5ZjVhjTTEutmQvH8Vx9v8xYovnzYXVoLx9m9GD8EZhL0qnzkS3MERicjzDMNS2JaQOtjPuuDx3rJUnwhyB5zzUZHyPLCc7lnDtxtp9OyAo5siNFcRwpfZ6DIp6dHw7mvAe9eQaVYmM16ZxFQ2HdaWbq/yhne9P/CkYmfnIPIMAUQBAgDJCmx6IAw2CoKaEajzOXKWMIw8oFWBwANUURkPABXwJEIlU6zaDSwMwY1JKwvyx31wMUUDtwIfCgzmrXg5AYxqZOiO9r0VQ5FqmBgFNK2gPXHAAeEtdDUspDA42KAB1YpeUlZqbmJmen5ydoJ+DhAaCBwoMAi6CSQ8MDUADggUOpgMGZAoFMQUKAgEPOTIJfA4QMHmDvb/Bh20FDQuAoSeoDVouAAlA0cM0ysIMBQ8MBQ6AKkkBCgwHEE17ZgfnI6Fc2LGJTAwG6EqQOLPaA2DJwgN0rVgAMEBCyA5UqPwUIQFoQJcuRA+sASgEkS98gBvNE/2jZ+DFZoASufAGAuEplgwGUaECT9qIWS3dP2lypJuAagIJ8finw49KPmy7y6N08KLBBgx54+PlLMa7cOScOiCJVMQCnF3JMRT4hu0BANwdJz4Zq6/Yt3LhyQx2QQUcAugMBRjQIIC6oDDJ+ESSZdGCE3gJ46zQqoPdwlnZSrCapS+bxiLtVjegNbDnFJH+0CIMOgGsQ5oW/Plvdim4SAoMqCgQbAXhhZVdAZC9EERLMYsu8EwNAMOU2n8CLAfT9C0AYbx0LXWcJoCBAkui0Hdimgyt7ZV61zjQXr3EzdtNWsS+HLR3R618qiKPGrqI8CUmBttv+vti4eryNUwkuqv/IUJdj9uW33nmIqMTdepAYsBVAk5xGxkVzabghhx16+CGIcCUV4ofl/MBRCoqk0BeJH56xoSvRBNYijW6pyCEeodxYI489+vgjkJ3MFKRbuMhX3QwG2EZkW8ttOIl6TEqpwpAaRvcJAsJMuSWXXXr5JZhhijkmmWWaeSaaaaq5JpttulkmlCXIOaecm715J5556rknn31WJxOdgcrkJxgGIECohndgst+hi8KJ6CcGzAgppVy+eMmlM0QzQAKNtlmGp4vm1YioYOxh5gIP+HFJDTlaMqJcV1ayQKiVUAJroqvWyBomCPixXKZAVtniPJU42RZvvlbahSbB1rHiqWj/7GSVAEuCoSiB1W6oYB2e3hHYGZJSay0CjQaLjg+TXqKYbYrZCZy20qrbrQq4ulsvSFlga8i0g2hb7my3VNFojndYW9ySAmOEr8ILxZtFv2Q8PEMBtYI2KbsDS7zkvhf/8S4ah55Rgg+WACzJvPAlWVXDG0fi72YNKzZjyZekm4W49DLrb8rfBoxMExX7a23NOIMcprPVDTvDAnfBeoIaOZQSQKfRrBiFAkUNMAIBC/QzdacaZggD1UU4cB07ADDAwAAABiVT2DBYVMTabfPkVNheBfKFAAyo6psvFgXlwgGFwNFS02MMoAAEJvgyAKkvZE0QAQPoqkQAgpcUbdZ6/3BNhuVZI+K3RQvMXdzjRcidQBGMQ46K5nobcc0xMxxQOVK0Hwh3qAWE7kLff/+TAjtfqMG2AcQMGvwCvq2uRvMpas217ghAkMCpiiiQgzpA1G1cAqgI4ZXlrC+k/Ey9tOAC1am6kLweYQl/u+WYa06A7qjLUoQsFskwUFB8kbeerI5ubCtX6qrBtrNRDRJQw4HrNMINAUKCauL7k/8UGK0uJS0gmIBBoy5EpVUVoAwrKsQYkNCAOOSAImTwTULkgoDxjWJAdXBALOhQAhMypxAADFYNBgAQawEQJf6SxoAekIACyAE018kD8XgBAU0JQQGQwJXEbNKqU60wBQto4f8QktApI35hCWSYYhGbQIARHGwUbshUUt64FxgWQgVNHGMTZvE+FBhva2HkgWLyOI29CbKLQwAjs6gxHxdwSglM2NkZYAXAJpIENBfJDB16QMlAfswQWQyEHB15Rh6uAoBCHIQHf0gHMxZgirLgGA6VgA5OgsSMydvZiEjph1eOqYNUWpoNfEOgAfjtDhCAQf0y10oSsA0GRXCDAI4pt7lMQnZaOEgLcniFaCLTD6oEQ6sYED4iEjJfyhjANbLSAxzERAYWkYVA0FE5ZHqQWbDyXTpBmS8pNBNyWuAUMu8gSJDMEwaC4FsTHHDMIbmxJzx5WQm4OU2vYA+EKGklE3P/YDw6UAMQRgSgEwLQz2cScDPJa4ADHmDCjTpUkuXsaFVcV0GO/gAdHh2oG/ApUn3aE5mAaMIXiihOBVhrB980gk93hs1teBIPX4gjLmfgVG32Epi/zMREsKoGNswGAqs428KKI0wNVbOTA1ojSEZmgrEelKoPXQgOZpDGj2Wuk0WpiwL4eBGjoqN2YDjcH2FVV0FscQZg5QkjpDrQL/i1kwitAgNC1dCd4Quia7VEYiUx0C+ShKUtEeMjBQFSQBy2snwFAwMWYBDReTaSWQCgiswYGVdm8hSgNeIbVzXZHTTWhl0EKVy1lMhynqGxuBwBY2c0VbXxwgx0GJFv2WfV/yn50qFgUIeqQAMr1xSlJalYRUt2gSFmINK7ERGbV84CFJjkoyAP+a43yykUfKkjbVSyYj5Q0o2dMgeti+tNOVhCjYNApY4hGcnnNCUN/hZ2Nr4IhxZOoJGzkJEgCPFhOXWCACFGZVK7HRJZDnEUyE4YLwNliBA8axIgfLScTgBHM0JZFBQNIQqtLMIX3Pvc15ZzxVJVADCiIItJsJgdJxkoWfablVASOCEy6QYJ8AuE+qLotDk2RZMLcQb2xmIW4niHQH0CFNfKNQBQrq6U0Jy0CZnZBkNKUCPwU5zGpGYmcpYLkP8Q0UEMpjJ7WQ5+hOPnok7nSLMJBmmGI4O+GP/oMqBBh3EaxBoA1Yo/k4nMauyCmyzAOTOtabOiN12c4wi6NOUiWRYsoxmctXnVzPGLutgsofCkwDmycdJ3KLOCA8kg1J1e0GK2o6+89HrQwEp1sRkEhuZk5jqNyLWohdNmRqv60XU4TlCitJ1EU0eqgSh1tkdAaZUJxgGkQQR2kGsC3oTG2guyXZSOBSY1TxdPyavH0Zal732LCc383je9lwUV5Py74AbvkrwPXvCAK7zhDn84xCO+LUAFak6DkjiZOjYbixk8Z21BwMH0BPJhSyxllRi5mYQm1TGhfE1xqvic8o1xKaXqcnfZoMkuZ4PIbUJZRAKWVWWFHEVmAuf/7/aE0TNRLE2MglZDUNU4zJx0uQZiWLzKeYhYHC0sAqlYnyH6zPWEl5BDbGJSDVXRiuMPxTSK7caaEa6gubWH+eBgKncYaE4VMUuofGaa2LslbqazepLMHz4g2AZherKSAydgthmRxi3hD8AHXjnvKtcoRh5KREiC44SthCLTvnEbvGZSi89YHeIleEKiPimUP/ui0C5zG/zPpk/wfNjXVBSRSgoF7ugN4nivQd+tjwThe0AVp/dAczMgaklCX1BwNx/cMc83YAuV8Y7vgggSn7XY69qqTPcFKOyPuWo7VA+6D7zv/1WAh1ocU2fwPQsiHxHXyG4EVWA97L2gfEUg/78/8UT1RV/9dI4fdU3XXITVfMPvfFZLcA+p7BAxiM4MIN8CvIMT0E/zHNA3TCCQDdQsSJ/+XU+XZZBiGZ/45A/ZmE80NJB3CQ7eHEqrQIDpLJEWqB/fNaB9sQMO0t/48IAMRBZzTQEJ9t/p5F6eaAMW9IADIMT4KCEJ+NEduY0WGNIXDVYakBDTJAFJxF3efQwPxdAXuhYeTGHfHIoNSQUQsNIUIQEULIAJmaEQmsoQGZIVEd6OUUuDUZ1jraEULQxurQgLGQFApBBJTeHhNJJsbdMlaUodjcKHRULT+AsI8pQPCMwo6BJ8EFcentaA2FIUoFU9DNHmpMghihHHIf/iHv2RElAhrLghMZjQabUVEt7JOw2KFbVN0xTBLWLBGQAUCLmWSCFTXRDTGhiAMUqW7XnSy6CERNWPZkVVMlRU2+QIhxXCUyUVC9AKIDASNYaZsQxVGujQTKhVJEDBdeyhNQFQQW2dOfHUMDqTISjTFP3TN55USvHQVclUPUEiPO6YIrUYF0DJIOXLRnkBVYUSNdQAVCnU8ohjKdrTC3wj6H0jRn3RRAYUmc2H6WyYNgxXH9aim6xDT7AAI8UASTLLGWRWSz3HD/JZHRHCDMSWDHjhO3IVxCRkvrDkPr3CHSZXkqBTSygCT7pKoeAAYDWRQ7nWKUUkH9KicQkgTtX/2ksmxY2tSg3wpNqoFhy85IsYg2HpVkFuXlY2gkBiUQ3B0Et6lkIGwoCMgT7agVXEVYMpQllmglZy1gjw5EZahVBmDf/EU0iKJJtchVOQgQsJjmGyxBlImACchWvBWDBwBXddjo8xo9qcx0CNWDS6loY5JoWdytp8YZYRTzHUDmiaGGJaC5UtRSWtgCm4VjZ4zUKA2UwuACQAUGlKZSeRhWR6ki4ERg2kZo2dUeREFJA1YZKIRVZEYkmQQwPAITnw1yiE2G3mppnZxAmSmVGply9aw1N0GJU9J1Z8DnHaVx2YhVs2RHqWWF+aJnPUzkPgJi0SJptE2nJARxLg594Y/x6FkBsddBqcXQa3uFkjVAkutAOtvZpz6NqxoRsa/ueVNAC67Ce2Sca7ydqmGZINdJulpdqfoQMdbMWFuMehSU2yjZoJIEmoJSiBQsZMnNuCaKja7VrZMejBFIhlVBuArsdfhMaO9lqbUUwzZNu83JqIWhugTN6RAEivdRsWTEhtXJqG6mOHDulz0Mx/PqimgIu1CRu42aeY5h5bjKm+gR2IsIiZrimb1gjutameXB2IKAmc1qmd3ime5qmelonHFQnGvGmhAOqeDiqhFiqPTJ2t1FuzzMT46RzfaaehRqqkTmomAAzq3YvkOV5xeIvCBAvqGc3KnIFixAQZeEraNf8MMlKqqq6qpD6P8NhPFBxECZlPOKkKMZwOA6XNpfRNUdggAhJZBuGQSHnB42gdCtaf+uhCOggqqzars4rkaM3SOgRCC5hOJFSY/sXSrjaBXUKCLi0Ts4TNY8mmMCQFLTwruqarmEarTmWFEuxBg+nmBLpVvuyA3OUdHtjrF7IlK7ieoqorwAbsvkXrYGVeAuRNvJYTWnnWFzqgG0SXFTALBCCXsbrWI7wMugmsxm6swUWrklVLZPXN52Arl1HW6JSnITyZTcDEoGQDU/Hrfq3F7HEszdasm4CbZVCbAQwcc1RQtCVbGpgbjrHMg3QHvAUGbTRIUAjtpj2oheRUhtj/rNROrZ0apYdkyWOuyo5QLdd2LWEKXYfQhoJkideWrdmeLdqmrdquLdu2rdu+LdzGrdzOLd3Wrd3eLd7mrd7uLd/2rd/+LeAGruAOLuEWruEeLuImruIuLuM2ruM+LuRGruROLuVWruVeLuZmruZuLo/gBV4YiufixaGE7n44ydhhmqGtzOfqn+c2CoBAxgqg2qOdrtqJbu2e7unOjLuErm3Q7h2Ebrm07iBsBYRIDLqYXcAk3L4tHVw4nf6RHScgqqZAI9O8nyfMLBpMil5gr1WYXCi0HCdwL1xI76F2gs99CQGkLwHIgvqmLxC0b6uk76HcTj9IVfvSGAm0rx8N/4D6ThkBfB8Q9ELlQAABJAH85mb/vkD7ghL+IML6CgD81i8/dM0fwC8MJLD1HBMBQMDopm8OBED9hmPmjAEY+JuHoGlYVQLX1dP4VoXzdgJUbcI4lJCp8FT0gsIPUIJ1TGsnMC8mJM0ZvPANWy2HYBERe0gMb8IRTwn/BsId6AKQyWA/LAYEs2cCpG9VlIxabBAIY8EWS8H6OvAlcQ8B5EAZiFf6EiAYc1QZn6764sX6ugsWa4suEIBvPHFD7EQX8wABHAoC2LEDb3Aa1K9e5KQXeQEsEFX/qYcsKHIVwMIHWxtezINBVBMCwAJASN0ePdFsbANRQbB96MEpgfL/Yf9ydUwOyOmwtYhyJqPT+wUCSt2GJlvFNqQuKRPif5FBLVdH893CNiTBZJWCAvAaIoxu1eGGLAjDT1yDusCTCpgReEnCA6TCCmBtsO1yULzCA/yPTPhAItdDN1vGMueFNjczM8lHTKwBMkPOJW8zc8AAQGjEXy1ODZyCK58zLN+zJUgdHG5DXixOsSWzA9sHReRyJaQBOu3GNqxBGlAJ9JJIE1NJGNPA+toHBDNAP9hxCKcae1bHRGO0yIQxQ/wvfQIAAduG17RQDaiFQ0w0/17HcyUABJDDRBuBVeLPA7jQGks0FvxxhlzxHVQO/oDwNMAKHiRWbLjkUFbLJJJqMIH/HCLtQADQoEZAADMvge+AUhEwQi84QFXEVQPERj8cirf2AEM8QfIoCdGpQcVMkU2k5H280IQUAgLkJlpwMGFtdRHYBCdbxVhzBgAklk1M4nwg0TkUQGI1VOEohnNJzuf1DchKClZD6lU146mMQ+/9Ty/vwGALBByCVdZUS1KDNpBlNWZjdh7QRlUG0C28QgHMMGSXwV6czQm8NjAPiWszxEL4MQocRGur1Ay/ylZvMxUsdt+MTmSftQzqtSVMYinstljJkoMESUTvNEW770BDgFVXN8UwQO3wbxrvsQJX3URHhfq6QBrvdPvaYP6ysfrSAOQI9a2YawHfzviId3s7//AeNDEo60JEF7JUHVNqDa8SUVXjlMCI9MFDSfXN1RqgDEpbZgEqYKjr6QEGuoGwOnNl65EDSpWFqwLrNMpXzOGHRSwcmdZalUD8feGGgQaGaQE1v4BAnUIU1GPCKrhCVPZAnspWSEEOUMMUNJ91AMFR0UaB7wxp6dCPuxjDNAHylcA5VJg7eDUmXCwXwAH/7iRMuys4tWSMV+NUWpYlTGy+YHkNHM7WHupG43d6a1fmFPRGpyde325+q4147XF/0K8S9LEjuFD6ek0liTd3I5UC13SbX/HBpm931DSeb7AKnDQotxIWS14s1JFKcFIkhS4LH8IZ5CuQrW6Epxrj8P9UNLxyGHx6y/xiIHBwPd5H3OxN8wiEONnGh+XrkMRwREmD7UbjcjUUTJm0K+CmGr2jqpcwJdTjT+AhK+S68B7VpXuWR5BjfTb5H3j12GErLvCfJSzkEAxzRH6F50IvWbLCTXUSri/NvbZATaYAqwfJOpQxuBh6RXtBHBc1yxAwTJdwHue0H8xQQ9wBA3j1F/ODkf0vRSswXUPx+zUEqlVOIM93HVROCfCvMIi3vyvAoXiNNVAwKOdv/Wb5CQY2FqDVcxesMGDfHZv0CDxRpwNVJckgAdEYOkwiWtVVL4AScr28B4HrsFaHREjDyJEqadngh2HUENz6411BK7luyJP/uV98noLzUD6Q37UWUhNQtnVdLEbq30XYDZDvxZybuvFgJWLEglhGrNcz+bXuVUyG1kCIS1YFxWZMYladkm6npBoMwoHUyrhHPR/hVNIzy4RkgU0IvYS8UfNJwUMjsfrqkLy/d8dXcFWAcPvqe/omfqFXzg0QMAQ4cjRssCOnsTsUMHg7fOnXr8OHF8QPgU4TvHWXfhOIlB07TSZ9vFEHDeuYw+LsBvaAnBIlgIFJAfYUggOwzZg1+ApgT9qE0qboQEVlRiwOv020TwBxSpWxjX0xhN1JP1oov6krwBJF4kHAwpBQfyhBAacw6j4crCI3VAGAv30dlrsmbI3l1WYQ/xPb1MHzV8fBgkAAAIMwBiKSDIlYAsIAGCtyMIMi0wPyBonW6BUbGQnDwQGwWCUMRZIpxkssSSIjoDAYBJAI3AJJUjKdBgAkrSWjRsiCItiAyaQA4ALgFjkUWgAqDzqCYmQGBAWGgY2Oj5CRkpOUlZaXmJmam5ydnp+NB4CgjosAClekqo+mDGyrsLGylwgPs40PCJmiIw4Ot8DBwsPExcZarrdzCXvHnThWztLTjw0mw82YyXmm1N7f4OHi4+Tl5ufo6err7O3u7/Dx8vP0WzoH2epyPUYLupwIuj26M+nauwOp6ilcyLDhOQW/GhBUB3GLkRec/PGBRGaSjCiZOv82EqnqzSqSDlOqXBmoQBZueXIsEvBAJgwBCBvV8nLCJk2bO7McyJHGwIEAA345MsBAQYAiLr2YGqqg6AEBL40YRap0QZc6eSQu2HdNYq5ABu7NaJo16YMHbKim2adgUQCxIw5AIRBgidcBYFEaMVtHRAAGTx3E/aeFbgEBfP1+hRFZUE2wjv6CvZtjRNouWS0nnaE2zwgBJraOhtw3j4G7VwwoZUm7trsEUxIwESFRUJo/eSAsSDgCQsBfC3jLQPAbkPECvw48eMwABgMBBba1TOAAtQyneQBJpw4DwoPQ1rEnq5M9DYElbw2EAdBgOlOB1ws8OFCAu0ESYwE3ngD/1T0QkS4E1GGgFIkIoAt7yQhGXwIFGLXRAbgZkNwWEAg0woINMEeAg/Rt4UqDzD3BxX9aQOgefEvgdkpWTB0HQH77bZSHCASqZwCKfHiBQId55GPbkUiOwwsqaqDwxRYOPLDCjo8wsAB2TaIQR5RTWonlA9f0EAVGjRAhAwRGoAnmEAiAFMiYU3gFgQl9wAEAIShcZ4QPp9lC5hBTyLAmCQgo8EADbJBRxAsdCSAnnY8c2oYdnlXHSyOGImrnaY/q6IAXSKHH6QBz6oiCCidk5UA2fMJgS51w6igrk9olaeut0xiHJh+ooQYAd4/JYFIj0D3Q4Yi9/upAsFAauyKg/7E6YqasSGBUgptawNlAArowmqqdSfXaTRSLsjittSaIUqqiMng7YbeQSvsfEiDtx+0j6sa7LbymKtDrKy3e6y4KUQxL5Wl3FAHrHe7KGkZ9uEYscTGHZTGaIHwsMhSVsr05Am4XI6jxRx8LsKqJlOLRsRbTSkoTACdnl3IAAsEZwB79xWsSEgHYsgXARAbwy594FBFzdddsSMYCQ9NpF84yknEAY+GNgCAMup2GQ15UJy2CIkVuEfVMDJiiy9Ra3Cy2zjQTuaERBFqthl2/EAlerGDLSoKeOE3s99+qJGKKfkHYckMOwvoxihFSMrNF44bjUEjjOC9TR6zAsRyoIP9d8CMHHZTOly3D2K0gJdubNsECwNsmUBcemlP6eQKFrTDAIgSw8PoPzPQ3wOk6rtHYHDyR0cUVDIAlvBFAdGFX76bLqAcAGLJQx/Ij+A58nRi+FVrztrT+ugM4nJcy73uIhGFPgLfv/i6LW3JWMfN/4gs9Ek5SSyZMWe3zKvtjB5PeR8ACTqJWlTCSMBTICZrhbxPWyMQAIwgLCqqjfwbMoAY3yMEOevCDIAyhCEdIwhKa8IQoTKEKV8jCFrrwhTCMoQxnSMMa2vCGOMyhDnfIwx768IdADKIQh0jEIhrxiEhMohKXyMQmOvGJUIyiFKdIxSrSECtOyqIWn2LFLnr/sYOh2qIWeXIk+RiDRUgy4xfXOA2DPcKNRuACC6gWj+zQ8RG+oh5x8IjG/IFiKK57hIbi2IV7aUEjorpEztjISGPAsRGPhNkeICYJAbwCCmj5D4mE0Zo9MaZNbDDJjzyDJU9+KxCCsaRW0KiTUmbPbrPpBwQIcjJK7gl3WmjTm4piECiwwQATaaQwZxHJtCVyULuCzEjOIzykNCENQDAUILiwAAXEbxZZKwMQlvAHINSBAThAwBuGAoRuDaAJSwAnP44gCAgsgQDMhOY5n9A/A6Cpf4ZqwugQ5oh6XWNXF8FJ7vZgTa/g7jyIkSb1WmBIBdxxmBAFRTGZl0iMIAI9/32QGfX2sDMmXMGQsyhUQNeyp08dDAUahdi04KgIBlwho9XZ6I1kQ7sGAAJsArEjzJaDGlOAxKKBcJdNR8A0U2WhWmCZSiwjylRPTPSUZbqGH/tArsSBy3brnAVWRnohZhTCJASbZRf2sFKMCmFTBEvYdySCgORwc5ah+ckCDIcCNvxUqkHVGQ6OZ1Q7Ech1Pk1kUwdriacerBHDmUE2HdEHDA61ozkaxlYBRVKwFQGsARDdSC+L0Rv8o7ExHSo+ANGFV4ThoQN8E0ESS4O8euqadZKVARYEA8ES9raRMGwkBYAb8FBmJN/ywrZM0NEwXOVKwcjmOWkiAu7URwZDsf/kGwyFE7JuLroAQ0IDjNNX4cqoAAk6wxAa0IBatQkIjkCAA3Azk96G5gUuLV1ifhFbJKCCt2BBLm73WwndChYrqXgNJE9zjaPY9RpZkM1dhOGvIRAse0KzQV5olscGCC0NepnBFY4ikCw04BdZyKOBjaAUCwmirm9asCOOguLa7jHDr2HPUfhjmpucYAYO4KLY+MvjSfi3jBSCnQxT2+MiB+LHRyIv9QD2QvUa+clHti1UoUzlKpMijGJ0EhmtzOUuZwKLWc4iK71M5jKb+cxoTrOa18zmNrtZFl8ggJznTOc5S/nNeB4mkm+RRwIbQ8kU84Yub+GAh+aZkXsmFtH/LMFZYxaDBh7C1xUMq0fg3qJzA0BJDhaAQDAwkBaLPbQwE51LUhnkMY2Qbh1GXABdmOQovh1Gg31zPxx30prYGSX1dMwcXywC1wIhAwJ0Id1UsPof/zABdHSc6mAWLK4LVeVrljWDrVSok68JQCj3KOo1ktq1p0EJAa7kugOYtNHnicGdVaFcMClgklcBD2iyPaMY1OF3NnWBF7JLPe6Om7cm8C520IQARaDKuf8LhIwaAwGaEY1niHEQYNa3zfWS25LJw0f2gtltb995omRCNSpPSa/EYZDSoHDUSAuwK/V+NQt1vY7J2rU5lp4WrdrO2lC5VU2E7AECmAnFHVic/4YFqM5DJR+BU1CDm47u6OZaCHXHv/jt2EWivpRK65SBMVnY2fdQJsUsgZy0hLKOpOHs3FFVPTqAtCzgcsbi+I2u0SbsXCpz7ByTU+rq9HFm+iVyn7oVq87VLfSR5FnXdkxR/om2jhRV7DqptolkEbOjkgYvTRXL8zLJB5D1dhb5FYs21ojM2dKvd4i1S46q+ex1JPCCpyLhX9OUKyhz5AdL+nQ9v2VhKNcLtDsF7z+CGHGK4AYBsGbRiJ/ZSQ3pnd9y5hPgoIv1jsBKTfCQnojlusPQMQ4Nb0B/nMKtvmcWMYTwTMJj30XCPwY1/xB5tjxj1y3oQtfM0fUwOgkYV/86qNWkVG3Zs0kBYX8BOH8zMAX0d4ByY4B+1hJjZjWsdA2PYTZYomvXMEqPwRizxn5eRHgOoVOLdkKk54Ef+HHrphBmVIAs5EomOHgo+IIyCEVxVmc2yBczmIM6uIM82IM++INAGIRMBWZh9mBCeIQ3hGVh1ntI2IQwRHiFck6R5gl+hEecEA2TgIERqAX6l3azMBRj5QjPNWAA2Anv5oRIRHghwgTX9AlVyFibcBT9FWJbSFGWRkyClXwFEGk8AnuW0HZoaEQgyE+cUyZeATIM8AuzAxbEIzVB0AyA0QNOsAcHMFAL5TiTEGRMMFcMcDZOoAvqZANLoALOs4kDoCf/oTgp+lF2XlE2EwJYafE4soghU+Joj0B5ZXIKs+QXQbAE+HCKv+iKTYAYp9GGgfhDgzgjVsNxBFB004QmOYYyJ7MRrcIk/7aHH3M1hXgK3MaF/2MGvBV6EINZN6IxpLUE44hRJDAKzcgEv+CKQjM3nvUyYENHSLECTEYgncNkSQczWeAKybcF7cg04YgxH3OMRDSI63N1iIcuQHUYXUCMHYEUpmYqe0WMkdB1QLUTUyJ2YjUlltcGyodzawcm+4ECvyAlzBYIUcIEXdAmd4B3qDcEtjMn5pcd5/EKfoiQOQSCGDKFk5J7dwIWPfCQRkIGLYkHbvBp/QR4yoYm3NVo/2oXaiF5BHNgCn2AKq7ij34yP+qFPfuUS1mDLf0IGLYYW44SUyTAk0JEeD9ZapbWUQNSHS2pTExhAghQB0hpCz2iBgZQIXqSl5KgHxexBAH5HF4BM9P0BtyhYcunmKFnJ0CAS1SCI0tgT0swByewh52oBYqhH0v1KwqyVGBQHQWwLWkQIuYnYUNyEWwZRIT3F12wjLlYaWtJPUTRE70hCDrgULfpkjfzIDwRhb4pCYBIAjXhQD6wH5XTdjlRAF4hKRrhePsAMHdgdLeZE5+RCtMBA83wKWbZIjURmvZwMSyjm/RRE2ORE9nJH9H5D3L4msgYg7bxMkKmQv0BlPKZhP/0aRuJpREslFj76UPJOKAG+jdKmGVMeKAM2j5EWIR12KASOqEUWqEWeqEYmqHIeIM3mIIa+qHvAIK+tBCARgweSg99Zg4uoZ8gSg6EFyXbVA+QRgnsSWnsGZQr4XiHtQmFsE83GofG2KLl4H6EKH9wIzRTwUVqhGrLVn9YchQRegmz1msllmNXAGy6BqVWIxvUBmxBOWww8BrGpm0OmGxQspK0Rm21hUaqtmu/1EkwAAMag6YYIl19Qab00WLF5ggU2RK64KVamqZrehpIOgRMJqRD2p/9JCm/FTAm8wtLBxiiMx5KgJpB0gORGnSe0G4CcIYNEG/6pm3T9RRmiW//8rZvk3IA/nZxWDBcm1dwraYbCBdUhwIePcNcqERuqHButIMUcPCSmZo2EVdx1ykA5YU7rKoFooAti7JvwWqq53Gsw1VrFoao6TCIyXcFRgozcFEpqGFSMlIC0oEa4NGOdzlzpKBylLV5gvAHVrUj52pSVUl9nWlUrUUfgMBzqKBxQCcvlOKKGpV2HaUAYDF95ipzJgU3d+B0p3kYqLMnusGsVhWvNHc+JtOthGSt6JCM7FoKQAB0Y4cCvlgV1YFl8RKycOoJGolXmRJ2MPcUiCGyj8lSaEeSasV2bgd3s+RaCuOFOAcuYXKyMZuyz2YnYdAdUTNl55R8LrVPb4Cy/2W3OVLgEgnQr0OgsedApDOwK9tqChJhT4NTHEVVgpQJttlDCjqKB5DHT5hltpVXcxiFeTjHrhpXH5+3CKawcJRVBPdyrwLLekVVjjritjWzsKxnEgOTFXW3Xl0zsZS3CNMytSOwm4SJtYnqY8fkFE3bqCQGfL6YUKOwAJSnAz1DX0aAfCMJCr/nTcL3F9aRWeMEuo85dlQDBu7UV9KXKNWXNdiniXsrA9vCukHZUTTgFayXF7IbR+FXXOinJ7GlWtBLu6hLWlJbAp8So9RDnpbrDSDYJt2wrQn4ChsYR1QzonEaR5t0ZVfQf+MSEP+ASbo2voKAt+/LIhmogAKYgP+5lD2MkaJWQ78DGGkZWH+n8Qr/Ib+NkWsEDAWtNhMLSCx0VIaYZHjIBsDzG75G4LvbGw4FqhAiGKWNFGsbzMGKShsryKLDBL4jzL0lvMIuzL0caoMn+sI0XMM2fMM4nMM6vMM83MM+/MNAHMRCPMREXMRGfMRInMRKvMRM3MRO/MRQHMVSPMVUXMVWfMVYbIIsKEJdmEtTuMWZUIafAIBd3E+GNg2Y9ouY9nmdwzmgB0xZNSFy1p0toQAQQAAQIB5mUAbZowByljx50TmSAoaYFgiyOVY+0DmUKMhgQRWTO5uHdDHO5MZh6Mj0Acly8MeNzMhuPBPntCeYNmylCMf/uiCbY8E4ZJTIL6nKF2PJEsEwhZzIGNYDhNzG6dU52uu/xZBhkGBijeDLkDCCmQCgklVgvsgGxAwLkTSCwkwJ2MIJUgkJzBBLlNNGDEAA/tKKBCAGfJA7swkZ73EKcvYfyXcYBBCaCXDOJoMmX3BUZJDODrAt4fUF53THRsECeAzJ/XCK27xc+fzJ9Cy67RhnaXDNJJFp1ZEIuUMZYsVRclbQcvYx5yzPhTFQ9kwCOJhpvRRn2gbOmTnOGG0oCy0IcrYrryFnHb3N5myYD30jEd3NbQzOwjIigPTPeCQDXHAFoARVDGzGmTBoAUxZmZQGIAEFyTYR6RtQYPpldDcu/+LrgqWgSquULf8gSmmAESy41HBzqO+3S6sER6J8v6bwAl0NCen7GLtp1ozxGL+0SdG81YS4v6KHxiPCPDgIByIBzmVzx3WNWOGMSu8xF3lw1xHdAPBkNQSgG+2M0dcAGbC32JQxEYut0YONzeB80HJ2FHL2ESN9AnLmL3NGH4dN0oqd0XWt0A6AzSOhKH/MciBN2S/tx5mWCi/t2INtGJ992XidLXicIF/Q2J3d2YT4Bt0UfKFITiAlNtXkL6Szjg3XM1tTULdDIJ5XHUNSi3nBUIWyi8zlebqoBNSUukmwTSyHt7jYUf2x3EoZT1jTpyxjx5nVAmagB+kX3oAQiv+nAgEgGXDWdAfwFABg+Ss3kzX/LTzXi5GM826lgtz80gL6FJ7sdU7Kx1vufRHwbd+GULrdvQdvXbw8Ycd7zIWuKA2U7dkvQWec7ccKgAN93QYjzWIiMAZ/zNJ1dttHwDMDldhwM9LZpmOQfdk4GNA6Pth2TAgvfRHYfIqyTRl2RuTm4cc4fuI4fk5DXtm4eOPhpuIsHnAjUnAxpd+G/T+1rdIQ0EzY/OQvjeKUwWnC0de2/atvghs3YFouizLpeUhZwCx48MkxsQhD5Y6xQjThqeek1I8CmtwvgE+/IJMdVZCQizr3gi18Pn2bZxKucOjGF1xB++cE21cQmLQ7wq7/BkNJJZBSfkKBACcdjIDpkR5MfM7qFFjoiXdIyEPoynpWJN7ikN3NMssaf1fi2fIFeyCbnJLOBCBOuaMlSJDazQBe7LzNcta/I63Kk3bXkBGzxAXtx+7Z2zUiRz4E3g50C33tD/YF3Q7OMDNurvfsBr3W18xtY44UfEHZmVbSq2bZLd3N4Vbm58ztd4zuvN4arGHY/x5ufjh2WIgh1WRVAiBWfC7UFgs7YLVXShDo9ssAgBUFKuAUZYlVVANU/VMrTgfi94Y6kWd13jybiBsDHk+O6EKOz7sFv+OwRlW0digFDa/IUzvzqJgWZefxJ89VLNA5BSeWHD/rQu8dkEBk/8YA7Lv+7QPfdsBOH78h3Jsp0cjuzjOwzYuQ2oDQzn6cTW/Op9Yu3GA/5L/dM/rOMkiQbuNu9iOi9hGdCK7o9bcd9mzPSvH+tfSuzmNdZ1of2ZVo5ljxKmQA9abt5p2dsqHTmZZlVZoVCJEV8RhhEjJp8UthIGMSGCkz+a6FQecUTE43uWiSuHOTMlwFlpY+Wwnh8kF7KYkV82qjlKmilQYzjSUQ+VIw+z+w4ovg+UQi6dcA/DrJ+W89QE/wzP0ww6RAKold7VIe2qyB5P9R73KmqTCdzl9P2FKDx+kcZO2cHWX/2GU/ZzNNM9eM2wbx7Ri945xt/oO9/t2v34ltF/98If6A1+LLuNltAgJEAJADIQAmShrEQyIEg5jEgAg28OjBSQIIBJKwCMiNYr+jjjgAkgRPQCNRSDgaj+dhIDAoHoLDAipgNBqLAjrAQHlJgRHgGhA4HNISSrFoQCkcCCQ0GEAIICwoCCwMHSYiMAwurJRUPtA1LAERNg4JMDokpKAMAcwBLApsQZWSHBRqoXoFPElSjnkZpPoBerEdHDAUBMnRkVQJuJkeA2A1DCADGKAN94mRlSoz14nATDY2MipMAcUB4IrbjjmsOh49pXYW2sa7ho4xGLj2+/8D/Ddnzopllgam4mXpQAB+QAw4mOPQlQGGARBEueOMRURAGVH/IJhTjNcBgAZZICx5MmSAAssmzgPC8GGAkrwGqmwIJCbEAB6PaGRZDADDiSgHGlAoU2dRICEPXkSYtGadOTh0bkQ4QilRrCR3loRSEUiaAgEcIAjLsFiDs0apuQU6ht8BhwIsFWB4oMBYovwK5BEbseBFABF5ZcTY8ycshpaq+Suq6WyxuqiirDiQxRysiSwxBlBAlaNPWC3v1glsGbCDoXRQQ2k79/IRFIAHWUI5m0pcy7ItA9j3sCMstGFlTlycca/hhltV5oYbtm/suAGvY8+ufTv37t6/gw8vfjz58ubPo0+PXdD5BoMGML4eUz397wcU1M+vfz///v7/Axig/4ADgjcNeTdFdx1sBPYHHIMPQhihhBNSWKGFF2KYoYYbVojAUP/ggBGHACYFXoIZFiDigfx4aF6JD76oHg4jStgijTeeh84/0hwXUF+KZEcdeQueo14qwkT2FhCn9Cdkd3uUl4qO483XzwAJDDBAjwEBuV2VnYm3wAOVnFgeZ1AYaN4CKmrnYEBT+mNOlzhq+AWINBSU4JkGPJZIFFOkSIJLRvH55511CPBhP7B9iVei6bBZ6BHJPcrCMlvZVamOMxLB3aBi5eanpSJCCYVL0dkpqADRBPSpqg7h4JCUZS6qpKXzEMlHQHZKGqilD6W602ua9qloP6cuuRGitgKBrP8ZSjo6FJPp0OoKp53A+mGwLhn7CqKOighnP0xCyadn1dKJnnAzBJdUAgtIcwSWQzzgByJXLIIfFOYE8G69R2QyJgAKQKDlHggkYEtJ/YaBH8Fa7jvAAgmPycA9peCrAH4MMHADFKAwMOa7Ey+cQMOZQECXNAlg5IA0DIzQywJuGIAABFgO7McAxQwBHwkJ5DYAwRclDHG/YuJXgMQaAxyAwA/3mPDERKDMDyG2nCk0BEQrnA7MD+QhWiGojDDluhjtY8C78RJigmEvt/Qu0/vq4Y8LboT27x4M/xtLv2zKTLPNOHfxdwpDQyE1KQfYsADHNyDctdbTKE51ACm7AnL/xUQ1njO8PDsyNRWkaPx5EFW/cjfmV2cJxeBPVC6J0w5gbPI/5HKRMMue75zufoIgvIbFC4RFzBkYzVIKIYK6wi8dwlGTw8V7JPAXBGR3Wuo5KEDpRfd3kVIH9plfHMfedJwiksVUPFDA9djHFErZKDSg7wK0D3HAC5I0X8Yz1o9vH8T7mYj4BIozqQpoxsDe7rSXAv9Vrw7XU6D40uEy7E0JeO9igyqK5xJ2ue8Yy6ugsBRADPKN74ApTIFHFBU/0byCg+x7oD9cosD00SGCIZRYDT2xwCqpMHXJsB/+PCIcQdSPBPf74fyY+AyMOFBHNlyG/4rhhX/drhNP8Fkd/5KoCtr5Lj9kWJMX8IMO701hHnF4WHycxweEiSaIe7BBluSBvovti3tTQKOu2Di+j5VPjyskmwAKlqVKpDFmI5iYLZrohjqW5BT7YE8enVDH8XnhSnVEABx9gEdBDSATb3DiKaK4Ajq2blqxWIQdvQWLBZAxFN7i48V6UbD4AGFmKJyHCnl5BAaYzIWLLFoTC1nHMsBJaaJsRgrruMXoKLMbOCTf937YsSxFcidruN4jsenEOEyzlFmzTSiZYYABhAwjmgwI7n4ZzG5CLIz1OecLNFYSSlYPSu7QVTLeV6SN7IOLcnwC5oSVPQSab493UShZuJmmICZ0kFZZHwzCl/8Kgli0iQ7QV7JQYUJjoaOgADXAA3ok0E+iwn/gdAYEimFKEogUACIlgEtbOSV65uyeYcnnFBCmrAb40xVLBOQKz9cpFoANTXfI6Cv4V0k0qZSZ84gpnAIQVScCspqn2CgKJagNrhJ1Vk5sKUrjYFV+muUFK9sSFMhKlBcgNWzy7M+7qLC6ejyhXNZ4Qz5G0byd1OIJ73gEInCQuzS8wJeQYFNEMdYGvopicbvIKkON6sQwjKEM0IiXRKyRsIH9wQ54wJ+gvtG8zMgisYH1Wi4GS43CkgVo0nTGKspxWliklhbtgEYrxJq4MgDVanjF42bvENnmuQd6HfWlZYcgCEL/MKaz7vmsLwaWDWRGhxujPEUXvhALxLoyGbLdrrIOqqtwiDYw01IAAf6SsNF+U6qLZEQrAvEH7eLBuNg9xMLO5LRVKfC5hUgvGOeqHkPIgSbTOY5CfEOZv8pBNMc5zGsu8iOr1CbBQGGTZfpiGYM4uDWmcSE11MKPsTAKM8mIy21Qg5qQ4CY1tMtLTYqBDOUixykYDs1oqEGc5iBmw9WZzbCKkxZXOOgzyymAWYyTYTdRQVYKZsFxWky/B7vOOmhS8WVQvIKtDAYfIKkJalizYgfQRUm/4Qcy1pIODEOZN0Tm8k5KDCZeAILGzJnGkQWlFxur2DJFJspmXGHmNesZ/0whcQlbL+WQnqxAz90y8Ia8AJo0UZpB9+nOlzLt6U8LyD1SwCWoS40evWTY1ASKs4LQpepXw/o7CIo1rWtt61vjOte61nWM5sqnSZ/HVwBxFa5dTZ+avQpCvU6Psa8j7CiU+tm7vtCRmMUdJ3knV9ipQmHkgKXelceBFIEZqRm0Jv1MKyDIQGB32KAYckOo0+ZJN0CwbSiiYsfeFhJ3ds49bRmlyrfRA7akokcqzohKzM0KODK0DantWUuJmPZHwQ29qimYyxUx4aSzE36sYCU84RlHlIhstCg2AQvYzlrgxy1BLmyZqlKpRlNYNo5yf3icIh7n1sOBtZFfcylY0f+LubQ6cXMtAuvgPGd5zs2AcKPwnOOqAjaowIODmm6HUzaSOmao/m+AbLRfgLDKzbiwMnUOjW/4YYXTygA1peXLVHLDT+Qg9jhCxH1fGrtF2Y81pU3rjyj4scXE+DE51uXOcEB4HA32XgLEgWN2TpQd2DKmALgzzW8sozztvABLJa5haRyFxdmrIN5nWDV8Q/Al6qfGOB4+Ym0jOMPmLO+K8AWnY423bRAcgRfR58xrOAhYGWg/MVgmoGRIw17hduePsI/taHpjgB+sYAzMjz4QBRsE8Y8AAeTzrA7A9wfU1Aav2Yfs+CQbndjl5TYC+J7w1YPMIaixvngFQmT3OAD/IsjqPkWFwdTEQb0sACKAFs0cztZ8XXYgwAWJlQzNAg8NUvQE0QA9ET0wjw45lLwwD1noiwL8QoLQQPuIhcU8gBUQjwxpgwQ20Ba1kFJRwQf+gv9oE/NMEwUVgC7VgQWyDBeZRRWVAmS0Cw+qCAS+wBGFxRQZA+shyg0liwUaj0KNkKIgAEelgheBYBDEBxE+w3cBC0QJ0jzsg/okA1yBiAM+D59MAXsMARcuCmcY0MWwYQcREM5NARS6RGXBzomRwvEQQZ6tjzbswyikgb4MQuYUQ03ZDEYoAO2AVTIAyjbAlY7IDw0t4HWskm2JlTEdkrf4UidB1Ld5DBD4ESq1/9LA3BIMYlCZbBoU7APYRIMaGgo6iJM7XR4MzoPAsQA6PQBGhNNTpYAo4gAwXd45pdMrwEcECmMnGBIPWVUIRRN5+VI0MpMxnNFC9VEqdgIyXBQdpAK9aVKWYEQBmBYoBtI9qNGlcKIE9kMmniItfWMwbpIdVlQc1dII9MwyviE/0VJEMUkQLRCU7AEI3sDMsBUQOEDBoJ8B2l+7qCIfpKMqEFN4XaLdYJ1YORXErdBJQUlJBQRQyZRRzAdIyoT9lIS4QKIr+EFdmFBDxqC3kFWpkFSBMZ9JUqSgOM1YTYRHkgBPikVSVYVa0U+9AIJPug5FCQoEaMNZCZEvMeVKdf8KPsmiK5FkRhhUKw4QvRklUVyJFXkEGKJjGk4UdtBUWJLAPkDJHG7lPrKQeQ1MNq0lPqzhTk1lRAkHB5XKKQhhEpGBGQ2AtYHDMI7CUEjMmTxiKeyT8jAVSlYkEPBWK1UXZq3gl92Ray2WOlRCJxzXd81Cd90HHuBeHUzCMFhRdCTj2MRGWQpNCfiEAqFDbT2BgEXXCAQDaVLkYPhBCjiA3+iWZpxBGqxJOFSCbOImdp3l+mBmbkim/7AXP+CXMXgCPDxnOEDncH1PX4XmMxhUbZ4QvSWnJKSVKjACPFTT3qxWL1zX6NxeFvTWav2mbQ5Bcj4DYyyWa71nd7KWOMz/p1gUFnTZQ3nKgxhkAh4xiTQogzcAguioAg2WQBqgpWBZ3yZAk1KyQhBaAyJUw3Q10ec1pqGdxZGVWWDwBpr5BZfRAYUlho+VRnWI2Jt121q0RYs2Sx4MBZQpmaGFxYI0RYkamU2EmRlEGo2CiamgmnTAxjIwBy+QqHJAWh0UKXA0wGP8GIvCynGsGW1IxorNBp7RxlfYWYnGqLEwApexhmtQHHGgBQmkKYp62IktjIRxWYzygwU2y4e+6WgQgpB2KXHIkBkUBpvmQYvSgXL06TYqxmi06ZeexJfShmlMBBhRRwRlmU70RRa4pKFFBEZ02B3EAYyhhmVIaoeK6qga/5jaeB1/yFvznOp88Fs/tMWBTdyDKI13UFK/jUF2Ghq7kequ8uqGpMGDOFw/HJ3CPcRB9oMBnKqsJauA8IV3xGpkYNk/NGuvUmu1Wuu1Yiu2VsqpLGu2euu3guu36iqxIgkmYhw7hGu6quu6aqtJUCYLPNq2BsuYykGzseu94mu+mprbfI/tMd6R6A4nFc10mKFG6OvBImzCghoYTuH4iIRbXQEA/cxO2KvCWuzFYiyDgKUf5SKnfowz/RMqVGzGkmzJmix6gGU/OexFIGVMlQDFnmzMyuzMoqxotgVkgSZXfoGUVMIdcCZczWq9MgHNEm3RGi1AlJLPOieWrQVsMP+ER9xoj2lEkB1t1VrtyeIBUp6HTyEKvV7t14Ltxe5oeqQpXGBF2KJt2qrt2rJt27rt28Jt3Mrt3NJt3drt3eJt3urt3vJt3/rt3wJu4Aru4BJu4Rru4SJu4iru4jJu4zru40Ju5Eru5FJu5Vru5WJu5mpuhVyKVniuwW5u6EZuI30uQuBfrCGbsLpUf4zsfphcd7yueLQIuqBA6oquyaaqQdVQljhfGLlbnFSjt2VJt2YHveXHs/KTdzCm8gav3dQBBd0uyeZueUHBPiXPrlCKzpnBsKZHj90FYTaviOggdixdrZyCS3AvDKAKpQzFyk3LtUAKnPAJm5QvJy0vtbj/jiV8r66QC5t8gV6Oa/Qe7PT+kSuIAUxFAb2pDptJTASpnfjlnX7gnh8gIFTmam7Q3/VABrdF3wN0TMbE59fQZNs4l87wjGiwS/NhROW8ntuZ8A7YS6h0n/GtDwEyZBTMC+8UQwCSzswIx0ph3/MuApMoQPoKML4SsLzRIkqMyzGoYBn4khvWRxXiAwxZsFOEkrEMoizgRwSpDS0Uw1CtHhB2Art40RJx1+WtT/Io4SmcMXsm7xcGUvJMiR++MauQUCWuFBGKsUzQ5BEnbBJP3BIjrQhNQXPJozjqxzLk0kReMRS0IilGgyJQxT9i0ilRAy/6bxpdE8SI0zqG3jJZ/xMkRaRTmIwnfU8p3xs8WQQUMFK8rFQ43gAhAwUgX6wg/8MAfXEhk81eDt4dxSV9MDIHriLLuQIey8QipMBfOiQHzcMDfGWdmuHFHOYC3UdGphT/qunoJeaUcKRCdXOoTMFhPuIIiRW99Ag0H1Ut27LC4jLOAQ0MDe0ulU1rosAnCmfrdkf4ZChvPvJpxgc5JqhFCagiiRceDEFxOp2gvJd6HcCBLud0DgKB9fMo5dJ4gmFFizND3wGNUugD9PNnrVRyKoMDMElmtnMgI28B40OPUW2dpdqOppiKlht60KunooCgWQuG9QOkHseiLshL0GaRFmuz/FkQjK2cytmm5v/ZUTfYW7CpicHFblCZUddYahQGTpfooP6YUDN0SrvzShNwqVrfXBnvv9UqWOvrO8far87VSt9aA6q1SmPHWM/1XbMt6ZbuHJwuXvu13HbuXhPEXxN2YRv2YSN2Yis2sAo2QujzYkP2AEtDY/d1ZFv2ybK1PyCYrC3MNNi1eSQf8Boz+1R2ekgbW36HjcD1EfjdAPzxZbQqDBAv8462msoErl72q2W2WBTgY4/FfHw2ecyEaKebZQClMAcwSnEHOqw2vSVmP8xeAN/veDxyKExLj+U2rO32wkEvDVgJvAANOtEOkKRC28DMf5T1xAyvEJHflhBPSSnNlWiqmEyCEiX/QGjHgnyjopbE9+6c0zrtiC1Yn3rvzOukgH2HdhWe4Au0sCvqHpbU1YHvQSzgjFP0XRUEk+vMTO5EOIW/AIGX5mjHYbPgdnaD2nYDo3dnzpwmzfUYFVkFt3iQVLMoUec1bzokwDSXwC4cMGSEhgQBRhoOxSx0ZO2aICDEdntl81As0RJHxFnyifXtDr3Nw1BM+T2UJcqhwwmdhRlAgB6oOPCc0DjWOHt3VU8CpokbGIprJC8zlx1BSYyHxzBTQZac9yPnkoHQYh2tHh1k0rcV1hbgDJSg0hDUYhbdQzSgUxNZI6Bjo5nrLtYYoAqdIOjqikAiHCfb+UDExqZDekfB/6yaqxqbx7HzFhWcJ5J/DDN4FvNZv1QQCBMBcRFMQVFeTUFZdlSSlyGr+1bPMIZWQfcIOMAkNgOUNCBVgUT4VCjSZXMNgoONNZHxppuli/qnkborqXhY3dGLe8iA9kcBwBV4nlO0axyTebtGLgKT0c6Pn8HoOOci5uAtWEwOXh5g7MC632F0tBe4H4C4xwt8G0MVvHs1pUysD/svFbs8MBm7AAHAvwG/L7T9gYQhYA5aEMO4f/o69+RsVzuNsDkNdGI6IFRjvCyQIAkC1Mtu/gczc2UjlsS5GWaWvLa/vY1r04LQOIQWSEyKhJI20AIguIzNF0AY+LxbLUk5qIXQqP88yqtVGe58l5xbNExDuZ4fzKdDGQR9fDA9NSC9tdBgFQoNFG0B7XSBy6uCOiEZJO1ix5vatWfasu+HnGuHLJ05th4w25+4WK/2XNGpGBnrkChJcpOqz+O9tet94SN+uOr1Xpd24jt+rwa2YD/241N+5Vv+5WN+5ocRn9xF53u+56e55ou+dneyM5n+eY9+6uPax5fDGqTHWe9KeIS2lTSvzu/9d5y2XIaHas99a792dHMJxy937Y89eGT989a06p8HmzcARihzzXYH7GPiIDevcb/2ecT2vX0Hc2uHczPolmX/dIvHI9eF0vx9QLTG716B8sf94e9KTyEUeEsBA8z/mALct0fYv9sQxX2rFAg0A5IMyQIcxIAeyQnE8iwnRbyUwz0IAEGTKQ60xeFxKAxMiNTiwSACcgmiiwlQQAbJZaJp8A6CskHAdMstCwhICTCevogIxSPxSK1QMgZjVAIDByAw5vIm0/bW8KJwk7hwlvLCd5intgPnA0QWEEDDmOA4dSRFw2AQE2BK1ur6ChsrO0tba3uLm6u7y9sb5BkL/KrwCYAQN0OQuqAAUAAB4PBZwBDNB3QcM/SzIFDw+PUTk53FSmaQF/O44KApTkOSPrMkgO5jUB3Q/FwgHYP6qEGeQjEe3Kv2oAEhZEGUAQiAYl27HjGA+AOASoANAOE4/80QBq4JEIIEbjSZ5wPjjQDtZAiA4EAAuSEIGJh0hmPiplYMUvZZObFHqhkHGLQ01syX0qVMmzp9CjWqUmGvqJJxAYuTMCAUNXUFEuDPAAafPJ4ZAGHnQ7FkYQkoBkDE2E8UPRaBG+PrkgFgi/UwsSQtggeAF1bcC4QTwVaKx8ht+xWOjrSL6/4qdjatOIJ3AvjM62Px4hiLwy4ha/UxXbU0FPBxGYdg1yBKfDKUiju37t28e/uy2go40Y2vtBYDkjDvsZRgX1eM4SCd5YfO3RaruXL1uyCjQVd8pKrYlwEKZUBoQnBxyWSkb7OP+wD7Q+3iyM+ozFoGsOjeR8ZB4P8ABEN5RwJp8hhG3UevyQfMdDMokNQMBRKSx2yXleFbhhpuyGGHSwl34VXEjeOecc8dUYAA1fAnABD4+ICAQpyw2BMAAhbwojHluVJAOtiFoZ1dD33zAF7uTOFIPw81o2JcCaTSQBsIFLDAGDU5w8w37TzQjiRTfPaDAT0e8KMZACBxAxCMQIkAfjaK+dEnNO5EUADfMHBSQUlg5A0S98WRY4wGCBhNmUG2FuEpfRJhoTFE5GhMdR5OSmmllu4GIg2ZVrkXiUHEcYAUoA6gwFBniDCOAqQ2gUyVEDUhwid1rBrLAEMdQKoDRCzAKg0OLHGUDLzK8OsAXS5RagwCscD/xgBI8HFqNMA6Y8cBfEAAXkWqSoGrAroa80CFyhK2ABt8DBsrUVK4OqyVKBS74zjhAmDAtvAsqKoC6BHWTrfftkvDXizQUC8XOOSpTpXJaQPmpQ4/DHHEsmQap8S+CHBgVBTzIkCiz1kMsi3khExyySb7tnF4J+NiRG6hQlXPpyvPLEOPCNOMc846w5LyfDv/DHTQQg9N9M/6CIB00kojTUzRTj8NddRST80LrgJfLbA5VG/Ndddefw122GKPTXbZZp+Ndtpqr802LAYsDXfSA7ZNd9123y2xaVhf3Rbefv8NeOBS9ZxpAQessnPLtRgwt8iEBcH4FDdHPPnMw85g/7PgmhdNuJHExuRazhjPIszLwXiOZ7YxvNzon711N06VP7c+8ua279w5LALFYIDnZ8RHrZkISGFAO4PZ91DvYqrq+S62ri7QAzdgTCoPZrztQwHMQx9uKksEMGCLq1A/CtLu/I5wWJ6lQGrjZMb0UPWENKDqSSIAXzDw6n92gKpkYGwQVShPBgY4HBcG84BUFOAMdqLXAd4CLuTpZ3U3OICYGHiDAkIQgDWSS3kU0LDbidBkuXNFAIBHCCHxJ0Yc8UEkBgWdUj2pNj+4XgJc2DxcKKEM78oDAlLhgGZAyBvAuOEU6FKuIGYBhOAxAAFk8sNoNKNBAlhhvFxQDxQ1af8eZBFAJOIyhjOwARoCwZFNDNCEK2GxcbCjFyrwkYoVgM8lPaGGnZTYNH0QAgJFMsAMLdSDZxABCHlkEh/BN8Mb/kgKXhyhI1dWwlZ4UVIycAGZjIEa//kJFb/yhJk4URNP+O9icIlMP+4QRswEIJT6GANF6uQ5TpzyDVS05M0WE0A4IKwrEPBEAPoCmgcQIyw+6B9fEESDNl6EJduBjXcIAo0YQGMxnWRgnA4XnzFE00YIcgAfhAKTz7jnkeSEWCRdIaRkLqCLN0QaekYQRhAiLY6kaadMlAJB74gjAQ5IUSrDo5GksSo0/6QBJ/jpT5+9cp14cdOR9PnEpPnMKzH/QRqVkuWf/7lHGMBIp5tIIoOMLklu9wmXEg63HZEKgyK9Q8QgygnTiJ3zPqSpBr2MNCUwPuMkJ/kDEVT0CJGo4zzjUEq9yuCD3a0HVwmaz06L+sowSooTS/1nD3KKKpckADoRsSlS89KSJgDjGQ9JB47s40RCbJU77pnQCJrZnmeOITmjE41NijoDUUTDiHQdSByyesPIFYATR42pYS81U/0E4iQtAsVijRGIYjjAq1dIgIwSEdmlEAcwby0KqcbgxxEAgwQm0A5BQoswTnjWf1RkBBbmwQXtvSBeR+rRC/JgGsviIBBo/MMCOLEEVuRgCzcLwAuOw1a5GmMv76xk/yBo66e0LncJzd2tAgIbCCkg7rDcnVRih4bSh0KtZ2QrwFq7i94NfXdoVRDv08grNvPSNr301c1664vf/Oq3N0eLm9Katt8AC3jAT7Ha3q6mNQIreMEMbrCDHwzhCEt4whSusIUvjOEMa3jDHO6whz8M4hCLeMQkLrGJT4ziFKt4xSxusYtfDOMYy3jGNK6xjW+M4xzreMc87rGPfwzkIAt5yEQuspGPfDbs5SJF3tjcW0LYGwv+BjdShtrhGkeLt2FZF1W+BZPNd44Ee4gAZCbAGcpM5jGgeSRkTkWLnhgEB5CZDGguCwGI8AwzP6TMUZDBAwiwzTr/oMzheHOaU/9IZgiMYh6ELg9fDq0END8QzYYuM15+W+ZBlll64yDzUfgShxW4AjDtJcM4dYMAStIioJXrTetwIaR08qJRsg7C5VqR6t7kWlMgZOor3BMd44q5krVOgaigHAsV+VKSBdXUJ26dG40QwAEFPLMZNL3sN3/iz3CWUJn/l4Bpx1HUctbzLxXQAAg4ZLBkLo+0qT1oLxJgIARAzU8JcMNfnjcv02YEARRSBwLoCw4C11I/30zEsAh8fdCZtzMc0A4yd0zgOCDzeR89SNA2GSX0imYDPJEKJ96zd/0MwuEAfgM2OGNKoSHE9Lb7Q4hXMLASKt5RDpeSKf1wiAYPKhsYV23/HMHcEzm3+SPesieSq448EHeGTzbujMOVPAXbBSV6Vv5kdUAc6qtDnMqNwYMGNJ0QKenHHB++SvPC7y1TXx3Ne6c1nbt5u4w73COUHnWWzDxm6uCnN8DAuCYc7lFPRNjRT92eYvOc6VPHOxuy7jpJepJet/JMyMXk95ueHSp88ckv4SLxe7YIAgICdLdrwO1WdL4i6q6Juj/xeYL7QM4KcDi/maMmh7eonW4W9ZnuzGgY1VsVenaiV5Nhl9XPQM5dDCmb4+CGcJ+ELwzAlqh/CSaKkPVLDbCJ+MhEHqw8CITdiCohGPCGFYzgCJOEQ0Ly2PwyGCR0xCiEQgBjtVVG/6EoPCjB4argACcQUNHQAAPoLPTzCVgEccfQAOInfx2DAqjgRhISE7+CJF60EwdAVCNBFt33DVXQfZ/BDBjoJs4CgXvmDFywJmonEPhADIxQRcGyPxrxcbeBf+y3AChgXGK3VQyIFQBSRWEUf25Uf2FECSPYDd/HHQtDBscwWKN2PQfYND64VcrmgfdBFloTHV70T0VSCLAHPgxADPjQgKqmFMq3Z6BXZmPQIr/1Amj4ENbHCZwSB8q3Ai9AAL8FewKXbtjCEdCgbo9ghytAeughaC0SB7FXBt02Z2mYQmPAKVLQiLdHA5GWaCLxRLX3CQ0wbXL2TU8kcKKGKzdDKv/Cpg4fVyOcUH8DyDvHZ34a8QgOgREF2Fiv6B7aJyA9EYRwoF0JeC6M0osfIwxvYSbmJ4Ha4Bms6B1kBRFHRDCHgxwNVBE1cRIi1QP9o08FIY0lmD3RBATs1zGrkCgUER1YthjoFgNPMg9SwAC0CEwcUQfJaETVJlIcVydJUSTgUWv6IGbmRU/B4RcElQXyiDR1+BkGUIDzMgMSCEv4oDJUhEmtxhRoqIjxJnpmVnu4cno/8AeHdjgrxYhcsHDmxmcAV28K1xKDCGqkgW/z9IgVFyyrN1jRFHvGxz56NmjB14S/ImpoNgp/BiGAxm+/53um5gDpZhJGMYDANUyb1x3/thhSIeVLpsWGt8gcyuYJjJISwMBR9LEV4WFe3dA05pd8TTk3poQtfuhck0YvCuAHcdRLUYkfK3WQbpkRBnkkVBU/vvQWeKF9xgUB8eJQgMQcUzlRf2GWltRYbWR+wlAvbwlXmLNNmlIkFelsylWKIOdQDWFQcUV0iQiGR6KROXSGp1eRoRcaZoYAdgKHvkRmzWOHO7BKsWeZtYcYNjWI1KBnu+dOL/kSanl72oOTisgX5aKIkyh7vjJHtJeTBFRvpwF8x+REovhWHIcVdPkOAIYTvKOWNJQeyOARNYITUBkwMPIk3XkkwLA7WXB/W4lc81EaVMkn6qCd2UIRE5Iv/+X5HOtQFn4kiQhyjUlhIfzJjZB1IshgOHHAA9mjLAyxGOzwD/aZEuKZHdKkPXBBQ5thlYYBEjhQFrTBneMwN9jTItkDJthJEPW5mdvpkAvpZqnUolypHY/whFAhaI5YEWiWQqW0kc5HZ5ZWQ/pBkngBAV7FAASAAII2Z2/WJmjGhmiGJwGDZp8IaY9GZpNWZikBh3qwhmliF3LGLQ53THsWRj3aFRASSlDgA7liXsQQDvphBut3AkuATB5REzm4Veb3DAEQL9+jW0WhD83QFSsFIXg5UcYRltcln4ygD/0kCsa1S2agW8Ygi851QshBDFGKDRAwSADqDSewAJrhZ/+Z2gQM8AQ14qfloYpmwCVw4Kbxww6Sygp72gB+5Cr6iUl4uhbW1KaQ6gKX6gy91KcCKQzCFBas4i0zYKx9hhGtploZo2zLYRi9+gUr2knMaqmPAwx2kAOheQa8QhbCFBVKMxRa5hJK43QD0iaqQxohRK6EkCfmaq7qcE/jUA/vCmZtwnIC5XS9GQRtYlGJwK+8A2ZftnHr+j98R3YSsnFMZgxlN3JcB3YugSN/d3RDgbAEc7A6t3IukUw5l3InkSL2WYDgkSI8dXfqmic5RXmkwTsKVA+Rk1NflyLqKrE/BHVt9LCEYK9HR7A8+3Us+6k3k7Ejm1M4q48EpLBtkgj/YKCwNbNxTzsO2QJmRDc3Gcu0EJstMwt4AgseUpuxfuQKKYGOGjuxX/ewITu1Gsuu9MKxkWMMBgChcIsATXCySEY0r7YyeusLCRCouxAdiMdfpLkhpvNrluIaVdK2ePs0LKszyOYLbyORs8C0lAK3tuOwjKu5m7sykOcUhAsLXfaxunC3siC6SnG6rwBmvZC6P9O6OgO6NXMRRFNAS1G79MVqNqoLFrJr8PWvfiuurXA5fCsLbZB9kHuZvkC8zhOVu7BrrzC8yKsL0GZqT1Fs3mEs8wW91TgL1KsbOusKhoshyCQV17s1PNcPUyd3OTe1xUN3gXdTKkAw0kA81TYU/+lrRM5VD1l5dmanQG3CcDXTvLSReYx3dO97ZbSBftkndi3hvqaAdAs0Dd7AvmD3wC+LRg8XgKGhd6TBrhFMCAz3eOsjclc3wtmDsl0HJmsUv5VYwA18wFqzvxCMOBnsdGq3wjVceGj3v28xOZB3ws9xsFeLIzvsEr1THqu5PjjMszdVckHMxLJLwkPhEyfXde62XSFMw14yePO7XTznnDJRCJ6Lc5UIwHbLcioct7xzdS3csk3cO5snNN9TE6FyV/gXDoFpIwXQgOH4EJRAAg0oJH2cRwA4BuZ1ACH4EV0kbBZ4UmtihXd1LznkgnTxfgloEDn4xwdggZgDT9k3f/8oQMgJeEMQ5wltCo82ohDYMsp/fAKIHIIwOHY9qoDSYBBFcn586n1m1qmRnFDuUITxMoOW5SWtOJaXnAKZXB15OIA4WC66VQWVPANIiDS8/MhPoiJHeYyqcMuf4MvisA0YcZbVnMU/4Bm6dZQBJc3YEH5V2IFnJIZ4wU+785VLhIFD1A3OnMztt4WyQ80z0MrfEz68/M3BjIXa/DboNwbBrERZEHFqVYOH6kZlyDm+iAPAmBP0I0PjEETxpA3/CQ8dLdHYKF7xeSIGEY4rujqarHpaKpDtWM0SraztqZ/bByD+s82ilBTsoNFiawwirUcpIKBVlED3oTrbfFfU4Kn/KeWp+PEiu+hM7JmO46xcMN1Y7wEMVo0NYjjUNJCPzQuORZgTC5ly1eAmI7FVWfVV6cQJ60mM9EFIBFmgM6DHKiMOLTqBfeCOsxjTDDlX0hjSrBVLcaUJT93JhM0OsOhGSPMr/EANaSLVHBHHz0GN7xWaCpUSPU0eKGAHYldQkfEgCWGBX4mdUU3aZkB0Kl0DrdYVZGmY9VxPniCGVA3Ooq1mH0F6AQEhYdAAnG3bE0WXC5QAdU1n76Gh/SGXBokfWFnOgylOLm0YZrZsWF0WhhmHXzUDjymBWoHayQiaxm2NanFDTIjcnbkQYenHkZGZ4DPXLvEAWyDRo9Ed0t1R/4bZGG0JmULw28Jx35rA3KwQn3blS0QwBCTNFS5dz6NZ0fChDTTtDHgwBclx38IQzrHmmchF0hZi0uLga05nqOrQB2BAitBNEBQq0/SKNAjFcQVy3xQKES6QchD+BJfFocWQ4RuXVVG0kGUXDmJ71skNGk6NnlENoSrBce5Q4mVn3lmt5Hfa1Zjjoe/Q4b9M3j1ehXipWmPxKfnxMd5k0pGhonjZKODQl88xKEHVnSau5i+6nV/UvLDEmZ565iAe1QmxGHOOE6TFvUVuE19Jo+ZLM4Q6SrNhLJR6A9xKp8IQSr/VGg/AKRIdluv0GbRaz8zDJdYap0mRrB8xMOZ3p/85cOK4WgaSqhCI7hh+6y3buhGFnqSH7uiJXgyR3hOdVGpRCtCofpR+q1slmKzhjRGnWkxkASGSyae2aiacjgKebqqgTt25mgPm5QPt9a3KSqqu2g6WHhMQwAy3wai7juXmoTUOElKukUjM4LewKg7U2iZ4Oe19gKc40kt/pgpxupr0/uk9uOxb9auPs6wIY+q5vEve4iaAOuwuoe3+MxoEnxQu5SJz+gmDAqxp6jFAc7l1mwhN5LOk8bYDkiJNfB8b77Ie7Lj0iiNUrLT/u7bZrbCSLCFppLbt+rIh/6+qg7QuwbHp+sYxAyceLxMqd7kul1Pz6tOVyHcjqw4pTAj/btaxZ2ux9Do5Rp/0TejyS7+wyRTzMG/DHW8MRJuz5RozhWDxtNGwKVx2LH/xHh9SbwO1QDcObZy2S8+yYX+uSuvxb3N3OfsZq4tGQSux8Pp1ap9MYoL0pQsbYY+2Thev4XPEdA+xkwtihSU24vtI4FsLvvsxtkP5nKv5POL4xbu4YytCh7/5o0/6pW/6p4/6qb+5QAzAZScNW6b6sT9gJ4Qx3vzO36CC6ij7u09gSW3WBhnWscv7w29YHhHeDER0xK/8+GXlnjrla7z80W9Y3a4QboLtcCD80q/9gAP1QXv3GAv72y/+40/+5W/+54/+6a/+68/+7e/+7w//8S////NP//Vv//eP//mv//vP/yAAiCNZmieaqivbui8cyzNd2zee6zvf+z8wKBwSi8YjMqlcMpvOJzQqnVKr1is2q91yu94vOCwek8vmMzqtXrPb7jc8Lp/T6/Y7HiwI8Pt+v0Ce4CBhoWFSwMDfYmLA4SNkpORkCR+LJUqiQoFZwkGLgYGIQCBLqM9AqUsBgkmqDAJnyQDtQKsOAQ5CwqsPpozAAIqDKEnuy+9NLgJDMeUzQHKm48nBA4CDQtkB9SU1aYt0Tq9LsKvqC/nIcQ97zUNDkHi5sIkCBDqAuzfuqDb0s3mVupVQEK8AAxEI6pEYsGAAA04NEiTYBODAQwYORP8soPhpSAJZCxY8YNDqAK8ErRgwsHXg0y5anEZCDMTSFgmUCa51lAmAJoN8DnjhAzCxoiyFKT/dG/BRxCudC0SknFqAFoMGCCDwKrFvBEaIGxFM/dkKqIAHO0UQeBgSQMwBM629pMgQLle5CijGI5uowcY9AARXhdrAlgBeDAgCKAzAIUROBmh1LXFAgTp9bmfykgs3pQFL1go84KRA1GmUA1RezDZ17wB2A5wBjCSQhMBexxaaICBqwcaI0TYG0FYAAjZqzYQYuAb1U2IAshpcw2RJ+OXHn6hHY8yMUyuRG50ada4Uqk1OATaOkHV88F30vAEo+CRLZYCyrTIDaKn/sZJxyJnzWCDkTcQJawSoNxV22tAigAEKwjVLIA44gtBgEDggwC70JTCcdFS10pYAx6nH2H0j/rYRPPCVwF1mEuYX4k8bQRBeaAEIcCMA8BjwH3LTVZcVAg6UxY4DT9UGyW0j5FbKV8aIwMeA5mCSy2q0FBWEYOixBdcDWXY3pY4QUCbMK1YylsxhEDmS5l2YpFLlXQVgFpuLFAbQkpvRaEkKAwo4wAl/IiB0C5lfDvgKnF4eE8yOZxIoglo6UjgpgQMCgJxDwbSSyABFPVqPNKCKmuioJExGaD6ptrmYptGUdIuFSaZyDQJhdiUnlCN0uSSTjJ0gkEHSJZTCMXx0/zhYddRgGU8Rv77yHo9qkhldQ4FYi1tZcAlnSaNOUpPKsmmR8AB7ucSK3owjOODctNQ5mE+2uDmbJ6Pa1vPKMdRhOwI5RUJA2ystPoaApg+sR1ZC7zo6CqkEOTxpso6kOsJCWrK2jgjUfdfdv9F4pNAA1yhsYyvb6uarsMAS0mSi1VyTDcm9JRoUaZ9caVQComglBGkA66zNjQU8hI1xliSwkQGfNEpzUgYMjM13k72pLwlVB9VfiQ8oie5FyySUFIE/BoIAYNcIEFQDFZp8ANkIQIecvV/+WMDaBWJNsQE5N8a006UEUMCh9Y62dp4XTV0yNmpvzU7RCpPgcN76JP8KdiIoxNi311Ur0l88HPJx3EcVXWTSprEcjQnlSELr8iEwj5nJABbBFd9jIrwEgAGYfbR77uU5RPYPs0EV5uC3e20VZk3b91CLC7RClnTNk5DWABsdUHuSZsHVbceKSM+77yWQNsBhU6JPwvgIYKbAWeIj4H7t4D1gnnQPwW/ZR/U4IL/3qOe92pEnfyWLx/iwQYvXceQW2zvN90bQOxF07ycAZEiuBKUkC+ZnP7qzjwKWh4IEAqx8F+HeJ3o3vN0t5FOBuArJRAg8P6WPKsSD3SBkJzszmAtTOPzhGSwEREPosGVsWMAnSDjEJX4hVzdkYh2KCMUpUrGKVmwEI/z/8DkrcrGLXoTGHrL4B3p9sYxmPCMa06jGNbKxjW58IxyXFAAC0LGOdrSjEeOoxz3ykQdSFAI4fEXGIDSAgVw4AG1ogEgdkIIUT6RBHmHAjUQycpDS4ZAJAumCSMIAHA5AVB/j8McTXMWSK9hWzIpggLewAHg7nOEOCpUCAdYrBkpkSx8oWYMoxaA4EPqBQHYRgAf8Q1ww4KUMLLGsUIqSk7MzwUK2dMlMhiYek5TOp6jBDQU4cwcKKAUCDOAA9ogzAB9RwDcLcIqLWAou4hwUfdJJggJYaHpUUsg7iUfPoZTimvPkBjxR8kuAvdBCxWgAH4qxh0EVYGmtQkEorskK/4WA552DaadvAvA6boCTFX2zEDoauiHemdNQsYCQKNSJTaMkdBSD4cQ2jZiUffCBG5woAEBlERpiWA4u4UxpSluB0AAo9KXs5OaUNshMNozyBOQQwFdIVJED/M9FllBYMLqpgw8dTwAKmEoDDuDVNykiR/TR0foOiFRaELU9S+OOA9qWgALBA6luPUADtqaIiaCjSAKo6p7aiZ6r4LVnPxFAXgvA13H+yK7rWA/xAuCJqi6Krg0IoUaFQwAdJSAe3AxGPLKEkrjir7GcRagw1sYLuH7ISIdNrD5okSu0RtIvlejsUOCyoaoyI6xTycUBbsRabExlAYjVrGyxukUYLv/1DU09R3voVTFFCSOhx9phDgTQrWnRrUiYmZ11SVHVRkkjO9drxKRiZd5UrLJjxRRB0+aYOIJagxRIVeye/voAZ/BHrHsi284qm959BaJf+w3KX9H0EQgY0kvFaowBEnNTTu23WPh9nCh+lMpqjGQgIuIdN3JRH2MwIzwU7t1BEIph3l23G1xtbhueeykVTNdyahoQdnEgrV6FEDDVpQaVFlPTAT8zlQ017lr3FrM51UO9noDqfNmlCCoxY0NzLYBkGexD6BrTxgQmMsUgtrY+BG4UDzDTpXrB5BHMtT4oYYVGElNgiG0YBRtbsgBQIlYsoYMAEHCxV+sCZyvPOU//v8AdjNEg41pO0ysxU9ePNVxkIdDyFR1KlXWICgH3ELm89cBbxMCsu3+k4j0XAd/K1kWg7bWHV9NBUz6SspwuQ9pL4eIXBRcgNU734j7oeAVwRBARTZGkAaT5EK96KmlMlGieI0Bdlze9Mrtywjee4Ag8jj07XLM4lYhOtBkWTdJAfQTKjp5drS0RwodoNQcvZmtn6fOAh6R2MQgQzWLQSeQxg7J2kj3yXq423yMvYGuJ6AhtUDLMXBxHo/XCzDA/uZiSJFiyOnNI1hZTOw/3lAEk0eve+PVVwx4g3/MS9khY6aVVsjtxO6LUVJgxzMeNYN2fk1oJ/qeJSmjcEQp//0AuWL4AbSwDAnODubdmXmh5t5x3+AO3op0pELyR4hZ4yyR8izrRdf5Ul0Ao6WPalhQOTZR3gVgn3m4Ri5WaHZqlwFsoRLH2sl+PFTolI8IGY6hmY+zuxYiw3c3ujPmZb6CqKuolAz93tXMCQiHFJFzGTq+1j6IYdJ8Q7/5eorX3Ne6nNkGEKRkKw+ddFZAvRYQVknX4br7xWfM8fUwJ9TCIWw2Fk+XsqQBBL7A692movRoMML1H+p6JfC9+uKXebuQzv/k4nOMdo0/H5Tu/+ta/Pvazr/3tc7/73j+vGAHx/fGTfw5YDP8Wy6/+9UedHyeg3wKITwNkpkD2Kri2Kf8Uav/Mo2L/cnNqLYCSMugCL+wfMHybD1wex6XA/6zPubkA7nWSMKAE+/mR8qHAzwxdO8gA/akAN2zSN+xfjqWD/TEDonXg/OGAwfyAqgFBC9aZCTAUtHEMCWYXqShVBULSBarAgMxHQ7hFMPyHnfCFCMDGMUiFYdhCYRwAAWAcErIAK43ErFxESqxES8gNTHTGTGSETVxhTlAET2jhT3BhzhFFIByF7bRH9pwgCriPWuBKWYwPWrwhW2zGZ/gEEnmNTtzFVvDCEMabX6BPYDiCYPSEZ+QhIknKCFGEIzgGZAgHWlQPETaFkiRGn2QMTpzArK2DHTqGTlwDsOmacVz/Q9AY4lx4zWSIiXS8WA7aAPCdVc14xW8ESHIYC3F9yXyMGIkQzoftRj2MmAo0h9AMxocICXg5QoNoR3lM2seEB0eMx3bgz7K8wrewB5shDKL5hzWOwluohIAZSDeOyIL0B0w5CHtJiAC+ghBhyI5sSIfsBYiIx2OwV4u84MQ4Y2OoSI0oI1xdSEKo2qaNyQNoy9OdzjayxTimSDMSyL9tCk6ZhLnI44M0R+gwxH614g0AHwXS2KNhSiqszJ5ghcU4yZ/0VEj2CQ92w8rkiphkWqSICXmtCUG8isDFCq/QCftAx77QwjzNIL6QwpfdWqFBipnAZClUSj7kC3poCqcY/xdO0CSmXAyXqU+oFBq4YI2aAWUJ4NhIfokJlNK5WcmfJEPtsNJAeg0fbARUrkziCBZGzkDtvdkK1FguGIwtgCT49NTEcFu7tMCOSQdyVMuPXQsrdtqadMvHXOV88Uq54A+9JQAE5CWj/eQ3hlyh+UthBowDTA1B9Qi0IIZFLkzBecuJRCWdOdXr7KVV1qQw2CU2bmWoBeSmTMO5UYdq9uVjTGFygOIDzM+3CFxPaYpbvmUv7aAJyCXG4A5dXkRpIE7rsNjZxMMxUM7WDIw6bQ3arEDQPEc0EI3qCAPUKA3gEBnUSNDUSJw6fU64KEREmA3X+E0m4c7/vdz1ENjdVP+OUOoD53zC0oAYpgxO4XTm4fwjQwSXKDCO5wAn5tSDceWEXOAUda4mkQ2ot9CICESOIyBVcWRNCm2NMexnhEqNKIwHKfCI1DDFhyQopizoCJQGceqg+5kAvfHk7bjCB0GF7tROMfxFPdDP/jAEu43PYTiCjwqgUxVDySgCeJQMRlTPbOyO0RxQADGP8fhKmGgPCk3piwCQCuFgBJmP/gigAI2Pzsnh9MThfphQlEYPrSxQCSTQA8ldt0wQNvxOliaQnYiQQ1qGlAapB11EEp1pju7eX2QNMXUPlinpPEFPgxHQR/gps2SP94xGjzReWTxQ9+BpCDUp7yDgi67AK57/QQ9FIPl51RQN5KfCpXHCARJ5z1sa3hBxaqoWZ4zOqq3e6tdNGfpRH672qq/WX/iJ368OK7EWq7EeK7Imq7JeAfRJ3x3x6rJG6/rVXuidQSGBwSJtQbbOQLXuQNPgQGh4KQ4gEpbJn7RCgbi9i8WVwSqZ641OGgrAkg6QahMkEL0Og8Lgnw3eAEK0DRBExXudaxWImywMyNVtJWTpjqUI395Jh0G5VLNxFA98Ez6NE3xZyDml0zpJrDuNk2nIU3vUE1zcU8fC0zyN01wpbCKxwh6ogj+1B8IEQCx47Ci0U9y1wk6RjUgVCGDAUzl9RES1lbNFWTjR7DqVAoQ43DVB/4rMGsrD2t3ZtRRYzJUotGzWCd/a9U3m4VTCQq3D8hNUeJ3APgHwpQW0mNsILNZGfBb6MIPulIZTTIQoNKEtsG2D1cC7DeRXGYVYrVVZqRtahVZdkZXQriJpYYNcWZZjrSJe6ZVGpayvLAZs7RXkjoLketxlOcIwpYXmUoT0oM9GwlegvMng8u1YiQxVIZrZzkLp7oxmJEZ9UJbR5VXfxG3PqNZsZIWsRgOsbK7kSFYCjASLTAU8+BVlMYAfekJelQJCja0VAF9xfMTBustFQmeCNYbe1Nfp+ob1VlV2bdcLdVc2DGZ3mM31xqRlBOweqKeSXQSpQQhXXVZ9okd7Gf/FewmYOQgHhmzoWZFC5Xrk3ngX+UZJ9F7KthzDcg4IcGjvZ71FicWnsN1UQvAvdWibcMSXurzFer2dpzrvEryiqZFSlrWNkJXUZWjY+Q1lCYtrDPyl5fQYYAGZjqywYS7gkZ3uem6bVs5XZeGkr3yZObBDLsgJN0mtlxAZDA8wCoSwlxywVwZYxKSwpmzPZs1vT1kOJiDES8DPh+gZlHHlEQePB0sBwcIX3UyvoYTPrqXxpgRb74XIMayxhd5ApZ3Nh2CaDMsxq1gVY/QeqCVKDm+wqe1uZQ0y+OCvMLBGe2GCY5FNVroIHntle5ixASuxSd7LgMDDG/8xjRSAOwz/iCIjm4uVBnVMRarVwwYbSkGOcROIGzHtSbntg85dW8kVxz8sgGxCHNiwQy3r21YBjCLEm83Vm8zimy3vm701BDeFRPAGnKit4kgYnEMY1g97ycFR82k2ykRIVjxkcUVIFigdHBLPG0+6botyEwNsUKNIzcI9MSZH5nfRhyKgSw9O3P3WwzbH2y8M04VaUwK0s8EGb8H100GyciuvagkgTFKgMes5Q9rBrKoM1OMZqSv2j9j5SizcQuqhHeQtHuu53d55nkdvZeC1nfkw3kefNEWxHd7oFG0oNDQNH9uRHc4iXtYcX9+xXeoh7erpHSsQngT9Et099DwhSkv3tHQU/wPllR7bjUJJq5xBO0GomsHtGWBUx8DiXjUTTLUZMCzlabUOMDRYKwFXj7VZJ1qzOmsdQetZt7VbvzVcx7VczzVd17Vd3zVe57Ve7zVf97Vf/zVgB7ZgDzZhF7ZhHzZiJ7ZiLzZjN7ZjPzZkR7ZkTzZlV7ZlXzZmZ7ZmbzZnd3YUNBKEIAxopwxoX5Lp4XSENZLoNRKiiLYjwUUjJQVMEzVLNS3VVZ1pQ94JvLZCqHZv4zZMj4JquzZo8x1vD0ZxFwM3FG5QW50mRRiigHbVNhvc3XZsC7d7gLY6dTTekZ5EhwdrQ1StZJhEn11pE3dqS3fhnbZ0FzdKqTfCKBRpt/+3b5MU2Jmd2sleOLHAV1dDComtJHnpLX0lRbsALa3AOuVAgsNAB1MBHsWGHQnDHQ0GHZ0EHaFDWgtLWnMVhF/4Y9hRWcSGtjThKtoRKUQ4hdeRT3YMHW2XHY1HHaEJAajCg98RLVQxVN1F9A1OAjQhBBDABs0R3SgAHbEZHckCHukDAajNZkHVHZ1hi4+CiUPffnyFJxPAuxEAcqU4Ha04E7bEj0dDFSu5mNfRh6/1jr8pHUHLju94hn/4lrf5WocN8mK5elT4h68Amq3AgNeNvA4LJz3JChy4XzZZg7/rAr7An7cAClKBiMM2kX/TiMw4ODi5NvT4jOMGAXwTrE7/yWY1VKbHxoY0m4jbSRU/eo7Tx6YTzidB1VxhUqrviGzWXJcDzIw3AImL+bhkuq2fjVdtOocggJ9NBgGAkv8SwIb0DrIbC/c6CR3BjZnzTh09xaMrOaV/+olTumnU+jokCx3J+HHWEZJOX2xReGpBwKwruSxo7pgXublDBbKTQmr3eLKXAAPQ0T8ce7Lre9IC+y9BuMWkVmLE+4FmeoQIhwNsepmDezQo1WXMGkv2sSho1MaRD1sht5PGH/ZYBFv1DcTB150wRlpQXDQIN3K/xLciFmYg7f0wd2ABZSKwB0saEjjg1f0caFn5iUWQwkvw1EWItpM6wrdiw5R4xfbE/xzQFjQUVLuud/uQQdW9Qz2ve3pLJE8lfPq9F3wRw/vZ+dmHj7gw/DjZQP09pbqqb6Mn3w8BfOamnxm0zNGu/9rUw/0ILICWt4VT8brYc8SyOzvyOsC9H4PdM2GWQwlkZsWYk7mhLDnQvY67z5Go40kJQGbCh3gTFjuJmz2Rb+O9k9udT5m7m31sFPG40wuub6aEcH1D8Drkt1RsxIawMwTTP3rlLz5yQD6yS36un0sDBFvq0NOlAHmP8GcgaGgjbsf8jKg2oFOJpOwCNGLxE8Qq9U3KTlcARKZYVddsuO30NxQ6CFSE4UwzdL86gEv80QzzG40jpM/1I5GgXKhZOf//SDbAwKxLpqOLiUSDZC793IMAEQAkYRIDIIgQ9AyEQJLHEjDEAsAmEJyEA4nX28VKBKNslSrOVqcRk/QbzQ5BrGJISCRQVBFXNoORfWJSAUJgFGZwM3JWhf8cBAg+CWAw+gQGYyUDWDBWAE5YB1ozRT8CDBBfcAAGBAqXf0aXMClTaIgACEQJBT9AfKBER0qVAAqBsUKDZa2oJjIwnWC1rnVzkJKUPrQza6MJJAwLAm9xMnwBAQjKPiPT1XAFDg8JKdOjDNMKA9rXcA46O9FU2FYC4FZJ6kNnKin49g4D0/12IwYskUcCwrQf6MQBOLAl27gA5dgpCODAgahEJOL/wRLCQNCrjyBDihzpC1giPhlFLCDQQM6rKQgEyESjgI0DX640uZqCg0yBAqBS5psF54sXE2/kyAHmsmSaMBdtkfmCgMQDlnZifCnQo0GeAWzWuQTDA5ETo18IPHsUAwpKEisZ8GhgBA0YUESPASjQoCewIqtaSa3EFQUOa64Gh4qTBFW+xK68PiCBoAsamSdCHoAwYNfebhCe2cN4TSO6aaZJJHAAlKCABDIFxMwXjo4VgaTD1dZYu/Hte6ZNC4QY26M7dvp6x5ZRm90D5gFex65KcUCBBwrukdaIgEGDySTDixf/moADjyZNHFQhAihkANhvPKUjAkpVGBMDCILh/6DBF7o/PHfVCFhAsMACDGD2kBArwPYDYqOg4I95RvTHhgEIxKLAfZhMY0B550GVVVS1eJVAAw9WAgmGJ8EnwjR5qPBFiHep5wgflfUTAH9A5XLKETxUAsFDsUwGw15sfNKFACnCYaAADbTw4zxJGIAHbO9liUd+OFT1nks/6KhLEmv0khiIgnwRgH9YQWIEH2ZaRRcAC9w01T24SRPAGm/YcM0aghRwyRsHgKPDGl4iwCedorSkmgyhwfJORgRh5CgAWD5hjXAyuUEZQMjxJtZNoyS00ACbTIPop9Xc5M0rfNQ5RILj1WorrFGIiERmKyDSlA9sGPhRHSuZwsqYJv+cOMMCwa4DgAM4EPDAh0AoaQIECohGJ1YAmPhmG3QRkcKxQFhh0mIfNcUmttpediNXiP1XbiJDPVXESnOa6FYMbl7yllfrFFbAkQvVeG22lSgQ7QPUpdEDLkn8muVWcOWAE5jzEmyIYvMWUFMXc/ZbRJzIUKaMNwk4O5qeCyXwwAOT+teZAQfIFZEB3yBQzQAJEOgyzJUskIACWEI7ANC7VRrr0LTGUQinLfM853G4aYSzOdd5MVlzAEBASzg791yQIIXCyjPCLd+q9tpst+3223DHLffcdNdt991456333oQtYxzfgM+ggDGBF2744YgnrvjijDfuuN1yJUD443L/G7AJ5ZhnrvnmnHfu+eeghy766KSXbvrpqKeu+uqOK4o4AjoY8Lfcj81de9y311q7ypnfzsjn2oUnwBaAux447IXLvjbyrJeOG51eGq7R77VyDdJbcmMPt/bjodQA74CnFhL21j+OUu7XLzu5SM8/T9LzC0TPt/h310b9SNbT3/zepwywAINksILH/uGDoyHAchNZiCAE8LIAtoR4CHjBRQ7wnWlRYQBo2xHC+vcCFciAgi/zSKES6DT9GKAc6wuC/9RQjovQjEmjeEHIWrIOlmAwIwJgBAMx+IYIErAlDKMBBrG3Q4RBqRxkGCFKMrGXHe3Jg/eDohCAWBWa7YgW/1S0RDmCeIPodMuAQoyFihRQDi9l8YsPaMAJwTgTH5CgJQMIGQ9VREO4dIYuvRKCFbJoxQHYSQRCSIEPJ9iZESBQPwxIoA9neMNDKlAFDaTCAysxEwPQhWZ0uqMkb9jEo9FmjjJhxADR9goQPuANRUxKPz4kgwGaa5I7WOUTUtC/J46yhzLcSzlIuT/xJLBsvXkUo7oxigYUYDW6EIDlZNeRRAjhAUKAgKJIVYYFcGMLfnJUNlPgJ2AGxJoO2MJ3BIU9MjojQdeZ3BEecBMs+ekJLtBPAgwwsGjQhZ3OhI8eDXSAAz5rC9LkRrdOaTm+EBR7/gxnATH0h3FeQg3WSP8gRID1Pzvw06FuiISiGIAAjAqqKt1pmTI96lDynRIBEBiooNzgH0EdgEUhDWZ3XMqoL1YCK/ikSwE6cgnZWIqgGUUnT2MQvYBSMyNvgOYxHeAMZOKMnnl65gGWmsxlLjOf0ISDRoSGDp02Mwj6rGnZtknRA+RUfnHQATETugVznmIE7hwBWLPq1llKygdbOOtT63nWXtYqUryZhzjIUQjJeal9ArAIFW7CMmY4oxJVS4FBYNS1gyQBsASJLHzmRL4RkCIj4HEEpbpDWK3mgx/+kCulcjOpz3gjBY5NKpcYyFnCdOMbCUlCGktAA1qktCCmso1VZmuaacTnBh8sRxL/THPcBO2WNMJ1zmyfSwPl5tYSeiDDZBECB1V8YgFgaQdvmyuTfOSpErGthAF2NA7kIAe1TmStewWiWB8w9jjd3cGGnqMC8EJAvOHAbGUpWxsFpHF20OAtN16bEIeUlmX5k+wMUmpgNT5LR/2oMIL9KhLvXlc6MqmKABAUEDIMx1yqRceCI1WGgSRiOS+OzXYy6+LndVYfOBYtPkDsU7vitTgzlm9tVtMa14bGj7GpJ2+LwprA8tbGqlmLaMtXGyTLpMjXsLIzFsDE5ZqXqVeGMqjYoWUlw6XL17VEAHDbljbqOB7+uY94MVJmqGFvxaKxHIBKPBriyEQQLENsbcLB/7I41KAB0OpWAuQsXw+3GTpXqEnwRoMRIju5NLAJsZAvohGU8IEh//WzMhciaQ6LB0uOqsdDVzUK1zkqjvY4hznke6cEa8SPn8J1qVBNY334iSsqWkekKHJTuLBGmp/ycSSeUZVY3fc08yDUJx4VAPAI6tfYU8uprottLc5gtwwMLn6rrYYP5WPR5N6LAWD90NdQwdoG6DaokJFuQU10FOymR+yqFKiIkQqtzg7AobCkbYzU29wr01atMxLRgMwJ1sv+VKAfLhtrzLrQM3DAomPpg4EDGK4yePW/E0IGP0EJsiGfjLaBuQ5VIbtUEOadRsA9mZJHx1OjsLmpw1ONl//RUi4rMRnP1vSNjcsMOWsWm3xRxjvNZs1le0HZZHoekXA4vTNBh8PVOuoFXtJraD0suihSc4Ci0wUFYN80DWyWAqbDpehQ7Qf2aoZBpe2lkI2ZGik6Q52oNEdoPPsQZ5QO+Hl2x3986IwQCh937tIhcnNivMe+QQ2gk8nylii6EJ4eWkKA/ZhHw9KadbC0wENt9N/2Au+IdrQRHP3oZZeafI+Om6QLVtwhvSvovfHxZGCHllJv8DesE9Y4DL8qdL9ZzsAmdvlu3a57n/WaO0Mos0+f+DsnD/qa9wzLKY57mYPQ2/TXS/Bnv3GXa/H590f+5h1+44kz/+P4Mrf2N0///utHnJVe4b78+///ABiAAjiABFiABniACJiACriAdcM8cTNp4qE8JBE/o9AueOOAcIFWDagtFKg2EBgSyCOBjrN9JIGBItGBaqCBdUOCDNiCiFM+I2F/49E+4tF/C7E+6SIDKKh+1UMipoVyuDNpO2iDI3E+tjI9OBh/ayODCTYDJjgeTKhjLjiFi1NIrMQIaxREaNQAGnEKKugDdXQq/+BIewRGfXQTjvQEIadJWvUytPJSBcQwjtRPTFUoBDRA1mSFBbRBO9JBcVBtJ0UL+wcHI7RAAWQJiYQNYASHDPQAtOJKhLFLPRIAemQJB3BFEWRBcIhJGuFmYSQILyQK/7X0E4jwRBpEKAjAVEHDhiq0DnCkU06ESjl0AK9xRZSRS5DkiPfAiQ2ARJVghxfRRcq0RVVxS6TRH1SYjIXjVgHATzDVUKbwQikwNONzT3aSVFOFTD+1UkAhVPSkjbYxU5g0A3uFJfQ1dcakjagSHY+VVZLTLRmSHQVAVt10O//QDYsicIR4SpFwXVS1VuGiTPN0TDIQV3CgV0SFEZFwTnuiUJp1aTTAj38gAPEEBxK1BRylEGS1jtrhVYAmA+wkjkJwkWUVCfTEUXslEOUIHOAwAAxFSdhIiLAhOyD1B32VBEJjgcq4k3UzaIjAEEdCXfFARh22Wuu1ju6lW8RlXv/JpCL6kV2VUA/IIRBl10+U9jxHOQ7ngF/bdVmoZI9kkASD0wd/w187gADBhBxVeViJJRayQSS1o2FLppBMqQ8PWSlWYWKz8Qq/1TX/tBEDhhDww3f9FV4zZgBQ6ZfAlTTuAF/9IJX9d2nYk5Vj9xhAKZYHVgJlp5M82Zlx45NnBmjuxR4MkIRLFg96hg5QVmd1aYPhsF64FV24UTUkNl8ykJqoUTvKIWMe1oRJ0B3fAYTskJbPM2LtdWL2wGNoBWpz5mWjcWsuBpG2qT+ethdu4CmPNpozEGfI4WGw2QRTBg+0QQ7FUWUsmWYkgJuVGZqkwZyJkEieGZ892XK3cUn/jQFB8bBTtGCV+UUnTNVwO1BbBwc1sAYQygNs23luyeRq40JxMkICEwEo6qaPOzByvAaEwbkDTZNxh/IHqpZ4dMGg7HApsMFq8qNzBeecodJ2dFE20lkPO5Vj34ZH4LFLQzByRKiPBEkadXKgukWjJHduMYFzHaWgP5iWDAehY2dx9qkCcKFa2EEFGyafVBqBy2cFhxd0k9cP3OE1XTM7aIcwrAc0R1d68wQ1R2cbV/OOcCA0RJNMMmN0uPU8Y+p6wyc7OcN5vhcRxkeYaROJXuBViPdG3xCnjOamWBI2onB9b4B6KvqQbJccokg0yqI/0ZcogaAGwUeEu0dwZyMo/5qHb4S5G4NnBbGnLIh6nkgKod8ANE7TT5jHqBhxTFsgGFV6q8fTeXPJk2OJq776q8DqNlwIK57pfcF6rMiarMq6rMzarM76rNAardI6rdRardZ6rdiardq6rdzard76reAaruI6ruRaruZ6ruiaruq6ruzaru76rvAar/I6r/Rar/Z6r/iar/q6r/zar/bKJAcRsALrRf5asAZLOk40sAJLQAfbsA6rOTDolCFxiqrDpngzMLpmCejhg+/zgRfrJZ4YEgXwheExji8BEiZLN0TYn1dANl4gguJhPMZTgs8Ah41zXqUkfvIasWNWSpOhUKhziXsjldHFsyOxsnoTHP8e62Nqk7Isq16m6TZIu6uPNGwcCxKIVYNJNKWGg7OvQIn2arT49QoK4FWUkTv+gypv4B9pVwOoQipCY7F4YwpwAV6PSKkhamBQ1zIpUwmX2gdyET1+YA7V9rY0oHpBM3xJ4YYg1RlY8xjWgbHwV1GEuACOKARhM5KcwQiYq7h0YrcyUBOFkFY8Ew8McBOZOwo64LanWzD+k7rIw7o3gbHeAQewq7fgoXGG6YTf8FV22ycIYAgIErhlF5vLorgolTOTkALFKxa/m7zcRB1ecBu/C1nVy7YI8z/QlCHeMDioooOee14bAhetpLPwKrbixoM4kjuZKiueQmwThQz11Uz/eGMAoTW6walYMfoab7BonwWY37YEWxOM5rIFyPC/vaoGxhagD8pf4QZrjsJfxkq5dGDAofEMyFBcI+ApDLEDU1Rz7CsIXIYke6EGKcUbFrxkGHzC4JDCFCo/Kywj/aszFocnOgVoInwTONsbPdQ3/mmb+AahQtC+OmxismFezZbDN6XE76vDKsm/mPLBJfzD56VQiPltXMuu6BuxYpY+pZEPkrkDw/dfeQNDzzkuRswpN9AZ7SWFviGx17XGSJmgSAll1WlWm0UvnWF+5jlAR6LBFNkZcxqd7ItfZFIOf2x3pOHHzhlMkaAArLENiPyoAEtpJAAtlBtovQcfPdOR/2zMZ0gnF0ipyfYAmhi3ZLm5WsVZlxoBR8fZDjv1VnSwtOq6xT5YttZZlNdwDuEWTAW6N2a8onl8lmoMPgXxDCllPaBpcMY8U6rZSinFYr/FUZtQcCIxZBFEKiqKGuJ3l8R6XfhEl2nGB+HcyLdnUMRjFdqMY8ipnZb4jqSMcakIAcbhzFZnxB1XbM+8Dy33bNajJ7xsJGQANfFgz3zGB5BMvz5Ay+lqyyCBx0D7v/0ZDuiUVcHkH4LQACQLN9ehftMjkeysTLTSURaJDQ1xEQolyxhhOTJA0pThBusWEHrUViZNBW3MZT9BKgdwVHilAjZ5E1igELK8GpYozCGlLf+FpltAbc5LRs/XsdSSylvDSkzfBtWcIo4b+iyCgE/xfMkGvCc7FT3i+A9KpU8r1dJndxxlrZI89VVji8ob7AxZtcpnPNYHnZ6YcJCc2a4ODRIUG8SQ1VtaNLo3OARv9ALWpDcumYGq+4mNDT2jsEswHIuFLckuST35kCEYJD8j5ACL10JvMIrpiX0Xpmuu2RlMdB1x9EkN8DvzeDR0QYHMsyNTswOCbduq7SixSwv50BJ7IkOCtLq8HdlzdAzA/dgU6Ns7+B0ElA+/Q4H5MEBWwoZXgEGeHUNT9zLEPb7OjbnaTYGNaGK3XQaCvUa00IHMI9ura92Ldx8zkJGjHbb/V/vWphZuB5h+9P2wiSM+ZkmvfX1+FDyAH1JKUavfgEOwC2HM5zvf6WvgDv7gepOwCnsQDAvhFn7hdAOwEx6wDI3hHv7hIB7iIj7iJF7iJn7iKN48EJMKqcDgKf7iB/vfH0FPazOylT3efBPgy7LRi9Ph/Nc2t7ODO+njIQGzkF04LCgSRl4rQh4SRE4SPh5Bex2AMr4NffHkTqgDXIO+cmPf/IflwgPGSc6yY+7Fa4M9UxuATFjmI/E7WVsr+EcScf7QBf7llny0Zq47tVJfCFjl5Ihcf/61NDRAt6lHhoTILo47IlRIQwCIoR2Lp0AHjVrc6UmMPjAOTILpaFRF/5eIa3nkRqfCRGdoRwVKRL04a6HEIJHkTCuEHIu0Sdbki4OkXihEB5u9hzFxiAuRisCx6mvCSXg46V4X3lKqH48XHYwoYszxRrAdQ79MBTRAKKzkSH4UQp30RG0kBYCkVafO6TBE7O2JQaDY6aSyRl40E6YUKDsS4NTeDRa0h+1iSOTOHmD76j6wXq2dnjdRhkGU7B4UZQno503IHrDyTNMSUk6GJSTEP4/RjoE0AsREkhkZUmRFjjUpUjQzkx61kDslOwmZBGbVjT59ThltnaJpB9aBUmVlVV8FkkWcktFg8C9pVOgl159dTCPcUcSp6enZ1oAmVVEMjxXf88wEaP+ydLjKZHVbcF4tRTMwDw1rMMR/oo7gRNM9HUw9JT87MrInHE8sL5oh348c30wKPyn+c01iVTtUtQNVX1OXIlpj7/Gy8fQSQpFevY0FpfTutSYBz+BGm+byJc7ZYA1cDjfBTJlJqZh+qVBj2ZW/aF3BkQ/kZWeiZZbmQND+NWf41c71RWweRl8YlmLBlF5OCMaTwWJdIxrEqR2d78/UACGOn3Hm8mw/iA8npAy/9aMZF/oAcYkM02vC3JfJfHvaY56m0foYYfl7yQ7noBt8phEC1oSaFftwX5d84JgpFlZuPfkuSTSKH8wGKPA8OD6GLKkaHD5WoJ6JX52xjJ0wtiz/aBb5N5pklP9kacyU3Om1m1/JDQYCAUAAgDAAgxAogmuMZSDGhfNARWmifLyTdrNSULWT0YbB2elIcLmOQ4DyWGqWII7GotEjGWWt11HweBQGB9EwbGwGY9NgXEhTYadVt6uH7w21CfgEYe3wEUINOvmkDC6NCcDEnSB8pThA6Whxee2sWIWKjpKWmp6ipk6VroqGARjQMFLRkDTNFOQALMim+oYaKFwllCiIGDU8ADw0mCgDKAwIY5YgHA00G9gSm3AHPBcYYBkR6MQ4LAAUMDSqBKQXJDxaDeXSVnMPWActODgKMDC3DwkREyXkHdEVwJ+aag0BIEAHq8iiHQjy/w2klQtGuAH+IB65WELfjzLclqG4WIvKNAQABVpJIMwBwjbNHPlg5gyARG1EzNlRB6GRyBQDJa5rJyCXDl733qBA6OnaTajUQDIa90jHy2olATB4SOJbiXAoISaQdeDAr7Zu38Kl12tUq5ADICRIZ6JOwXsxbok4kODM3LioEphTkGDAg2OLSVoaQBIiARjqHiQYHDLsgiINJbNdsDiBOD+DAuStoThBM63xGCPkGyAsa79UMtcaIFOHEcG6my1ZiTn1kQaZFeiIjE15g3UDOo+sKAR33yHGJRsoMPzZ9LR9rYDmOY3BIhIFFA8IPPrmjgdsfd67jrOJcmvOod/WK/+Dduset72rlll/0QEg2APpPTUIfYMdaIV8VmmXGXcFaZVfget95QA7fYmmGwwOjFfRAJYZVqKJJtYlSoonsnjiGi3CGCMpK8pYo4034lgijYYlxhYp5hwwTY44CiDkkEfCtWNQSDIZk49NQjljYVFSWaWVrExZ4mr6jXJAWAMAdWVcCDBAophXKknQmWuy2aabb8IZp5xz0hlKmrbVmaeee/LZp59/ApokAYMSWmihWQaaqKKLMtqoo49CGqmkk1JaqaWXYpqpppty2qmnn4IaqqijklqqqaeimqqqNQZgqKuEIrqqrLPSWqucd+4oTpgsxipjA+wdcYCZjfZqylz/wu5pQ7EwRgFls5Aa8OSc0Y6Ka5Y3zAbsiXyh4l9bBiDminQtIqBXub74x20q6vrC1yt1etTAWkjeKYohqZyLJ5aizNtWvakY0cO9qPT71r9lePuptaOYM1UB45oQSzNrWBbLkxYHoaxlChbQwAwwaCOAfQ4EMOwoLVTDxEgNOPCRCQEM8vAnXAUgrTprOKCDYJLsDPJCOhTgEswTiWwQLDWXJfQiHpf8XQkGRBuADlAbMHLOREhMoMZXZE2xOiRD7PUVNdN8QDgbVxO0mTZcHTICCrRQ9tNRm/xJ1hCp/fIiU4iNgAEtm7NCA/ZZA7XYbC8VrDyx1Nz0147vADVE/39fDXfiK/iIgNqJTy55gUMH7ZXRc6vDkTWau33CChWJvYjkloe5wtWfL6K53563TrqyCoJZEeeaLlzKAc8IwC0BCwgg0wEOoJC8xymxdoB5ahg3iWTlCtBAQMWTTT1pp5y0RfKDMFZkOt+YIQIEIA81vAALcBmRAMxTwQDMs8FsibzEABSA9g8TAGnbeJ4J7Pe/XWQvIF+5DcuIgZq8rGMtCgyg8xyRhgNUbwTIUx79ErCFCaXAfwjZWctISLKVpGAxT4qglwBYM8mUzH3wu83yEuYEmNVGN2pAX2OeIkLyMcMYPHnA+5qHAtTUUB0JwCB5pGC/FSyRfhfMYFAY0/8AIcIwWkScoQ6H5yMGIGAIxjhBc4aCgHIUpQTJ4AkxJIKHAB6gfwdMj3Hm8ZT0kKiOLYMGzLCRwh0e44c/GIIH19iEMsFiQ5sKHsPAWBaIBacgCrgJaRTgIxK4r0giqExZPNbEIGRSiKV4XxkCgCAj2EOBSXHKEBjQABfwJWq2EFgPxji+CsWBBJM8SGm05kk7LikBYZzGAfSyALYEYY0qCOUm1UQCCGgLFty4IlhIhEhnjsRmxSzBMQdJA1fC0i/s+oEyvwg0dnxsmsKwCiKbAJiCBIlAnwDESpgphWPwzi/gLF4KfOQJwBiAPPOLSrksuc0d2IMxwWgGOa5gGnD/qVEYkazLDSomUPo9JJ0R9SYAoDlPKqTDKZxiZCjiYbNQRDIGfAjDWNKjsiCQKROxkYFLhzZKGsQDeVgsT0lIENBqjmAGrRBMHGfp0JEY42O4BAJO/mGamI5vgVNwRxKq+oMmuKOmdpyDMyDgLSzAYRbYbOqSqiBOobIBhaIoBApYylQm0HI+KGCrD7g6VenkYSWmFKp0BFHXWqCVrGWyJC36N4PQHGBECuhCTIq0lnA1VClgnStB6lIA1EDTsEgLA1yPGkkzeNUHTNHFSItFI5MeQWZWSCkJ+lGCgBA2BolFKEdxAkr/7CoU+corTkQiTGmW4AELeEYT1XENnk62/xiyeJhperqLj2zPNHeVKg1yMIU1QgM4JXCjAGZbltqa5yAVsUeB0lHcdSzisih8FwCwu8uUnlec1RhWELh7kMI5UGpDKa9cgerOI9ZzGu/irWxxe8/+TiG+rwDRhj5GWh0kIx2S2dVwm4MZAtHVgvvd5kTn0rARPbipuNhwOiJpDnlgIRpGAp5ps4QZoV7BeNgE1wIQRKZ3BCEa3/AHTO33gCZKwx86foDLSMGNnCrmGOmpjXFQc5MGPKEaDIDfSS70DfNAwH+50LJMUOOS5gY5BjRGkFZu/GNg7mevtpFGNIiw2O8ZYcg8xuaURRMmU4oGBk1WwBbSwmcDZPkBFP8JBZsvUcAAIIBMVJYvWKzhhDfDIAxNrk0gngPnfArGlEaUb04XAAHpbJlpfZHzga3Sv0TXmRivKEAACeIlFkyDANagSSgEsF/hEijIFcLz9xTwgCQf2tE8WTJbXg03EbPB0jDwNbBTzdxqcLJTJA2JIh5Za9KNThIIVVDktD06XWmOa0/ztrF89DCqTe53D4udFZ5lEW6rI3Hrroa8HR3uiGXbMqHDGyyWEu5xMaFiZkq03Spyb3GgDRYJd3e3U+vtc4/baPe2AsGv0PAruA5tEF2tOCwClHkrPOJpU4ejq7bG0HnOd/EQ9iPPZvFxD0ty4d53xzE+co9j+2HCdvT/vimO7XtLYt8Hxyu6+20FhG/b3ubwXM25lvL0OnpgLD7FwQC1DpaXVlYFY2qMQORlU/h5xbaKEnunbqxlKapqoPLc2EfHrN+RQhxYb7uzQDVtuuM973rfu6Be5Sq0V4rhbPoV3wtv+MNHKhCAH8UCHF12U5AgX/GoG+Irb/nLt2kNQpQc40AGtdu9XBL+U2Im+C36J62B3BbvmQnEjvnXwz72OWrMCdIaUHmdLzO8QCEFWRPQnWowqrRHECPwt4gqyz75yl8+XH56jxmQSdgsGGsylYGI4Di/LkbdAfKY7/3vg99e9LxHYlutB94f9fpIIDBT72XT8MM//rLPflrN/8Fqv3D1B/a1LRLov9pGcNPcyd8AEiDf+VqNpZWZCcMUANqVuVmeUcFz8N89HCCAMFWoHUQBauAG7t3teF68lRyJdFx5NB1EnA5X/JwBuFYZtNzncOALwqDyjRMpLFaN5RbFKVAM6uAOIh7EnMLD+KBuUR4PEmERGuERImESKuESMmGmtIrfGcriNeEUUmHWnV3cqR6gEF4oIAukSCE9WEEXlooUfqGYiGFbCF5clOH33d12NcYSJQq43ODjmUi+5Eu3cJ1bzOApuEsQKsodnkK6tAUdlMhu2VCL0CHV9UIiMp6j7aFYgcdbPCKptKFxNYJqldLspB4s8FzMkAzaJP/OJrYIykCEyqQAy7jM6sTbzLyMzRQAzujM4rBeLFxN0Kii2xiNxSSNKrbXxziNwq3B1Hze18xOZYweTmxNxIye1+wOF0IO5pSNy0lc3iAUyTha31AO0IDNhQQdLJLcLT7BQHCO34gCxrzcGvgIx2TcNyIaN2ZH4dDN09TMuPwN0rBjerUMQiCU0GgO4MACyfhIPfgbV+ji2AxOannQIxRkK16bLQ4NLiajglSczLjOz/BbdoSc3bXYKOnEXjiIPOzRGC3HhgzPFH0PAVyPSEZTXITPKyFE+SwWFRBRD60PLLTPFsVPJtCP8Rmf/gjGof0P9yBTNxCQHCkQ8hyQbLD/Bq090AKw0AThEEMthfdMwgZZUgd9EHgIkgmZUP51EUIVkvUJkhUJUVjWT/7oZPMY0PbAUQzE1jWFRPQQ4gK0QPehpD58FgNsQZkY3y1EEfTIC1/IiyYBZUCYlPbg1Vp2gRANphDhgkzY1gYNwg0U0RH83iZJZoHg5P8ZpQuZDVWOAGiQpDJEHjb8pGvhWkcqzEbOSGxhohtalAt0EPl0FxERJicFlGwe4luQ0ieoGSoNhSqxAyuJwD7F0hpsX4rBzC01Vy5lFy9VSMfMBpr5hTBNH3/twlC2l/XVpgsIEWt1VDRtHDXBJVx6pTYJyXiuUz551FE9DXIqhXMlT3sd/2JsEWJjAEW0fVYP9ENycZV96haIbJojxBNZxScWRESbzcCxTWArwcDAuNU9GCdnNmcJ2FO0veQ82JI8JEOEgMUNmt2+lAJ5icJlJUBm2c9hFYgC/NRevdQVpKg9mggoKJFO4VNBOOdPIVIAwdgOEBU/JVcKJFXJLFVB8EGZ6WVUycYdrIBV3QNdZRVfgVdXfVVc1UEdeCXAyUJymRoODOiPbl9k/YA8qOZx9YVPKQAD7CjXDUFe+edKROgO+BrLDChVyZN7WsWc7iQEkFZkmRWE8tSTBlZWVGgESmkcBInzgcGQZgcDrIUCpNFqKiLDPM1+vaYlegGg2V8WuJZ3Gf9XEGjqd52IIRKEEfgWfgXXcL1WepnpX8QVH21bocbACkZXdEzXkmaBeqnRM7zXdklYdxkYeJ7YeJEYWKTXeWVpGPZAAZDXNkGIeFWIq2IY1yXWhpCjnF5SQZiDUzjnPWABM7ypJGXrLPxXdBTogDVXWNXVMUHWVhXngyZMhLYSqxLqtBZIsCbECurScgHAYHQMroVKJf7abKQjXzAPEhWI/TCopyVGehBZSRib68HFkeUFsMEQk6VFbbRXlEFEqimOA4ZayHaZMFVImPlUXpDZU/nYJ9GD/SDIKhTaA14aNDjsnMmXs0mBsrWXn/UZCzhAAwranR6CMTiQzrITlTH/a5btjwOWLJ+VBAR8EcvdGH6QwMA6Uhwwm3fYGl2iQKi9UwzcmALwxQFKhlJ0WnHhaT6RLYBBA2L4qXpoGj1IYCQpmmhQaK45LanVAcNq68haA1mEp6hUIkSoG8Qg3SMJW8/1W8IhLozY47nJnK5sG7uVAcS4hNHMG8i5BNAonbj5jr51Lrih4D15G9uZYMHh3OK+XMrZHDCA2sOVLrxNHLVdHL/t27PM2+XGTOfi27FODfKt4iLUDucQneRUQuIuBcol3LrtVxnYDsnd3ECmVufe7vOmXNWMLtMhAHaFhDWsY+uyoNAFTsV4G6gJm8FxjlnwW8CyJqVcnUa+Ht+c/9SM7iYppM9DyInX/dYUDq6jqN2nmG7lza6MKC6+ZGGcuACIImH/VmEDO7ATQmEUjgrDUcxCmkIaxskZnmE1FNkDezATKh5LiAw4MSJBNJ5ucQkplLBh+NUh+GBsfXAMH6HmiQDUxEMm9MzMWWMuwsBjlp7iaBsvUhxBLmPTOCTP+ePLtI0vSg427BEyfmJZAK8MU/ELDp/tMUBSPZEK3PAaddhltuz9zGRhkINVJhFA7GWjSlDHgOTPutI2tQERxSQXgyYCVfEdv6D/+ZVWFGh1pBVOMA5bYIFwvszQvC2F8KcDHNQxVZSUSd+NJlR3EmYv4nElFyBv7bF09UKHIeWjC3ivoYkZGRyytNLC+ZmoR5XfH7tVlJoijVryK4efHt8oHy8rR7UwwtwXcIGHuyJycP0KrzaHGoFJWYzFjYrEMhlYe3UwLDOz8pGtKucTTkgDakDDr3lHpaVwqE1aNI2yLUAA1yJVmx3sEingHTkZTpAaNAhgM7Pz63lgyM0c716u033g6VpB5sIdzn0v71RcNQjb4eoc6fjNOC5d6dZvOyN0QrvnkMSDHyr0QzdzAd/I/0J0RVv0RWN0Rmv0RnN0R3v0R4N0SIv0SJN0SZv0SaN0Sqv0SrN0S7v0S8N0TMv08oUAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Breitbart, W, Rosenfield, B, Roth, A, Smith, M, Cohen, K, Passik, S. The memorial delirium assessment scale. J Pain Symptom Manage 1997; 13:128. Copyright &copy;1997 The US Cancer Pain Relief Committee.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_328=[""].join("\n");
var outline_f0_20_328=null;
var title_f0_20_329="Surgical management of esophageal perforation";
var content_f0_20_329=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of esophageal perforation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/329/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/329/contributors\">",
"     Daniel P Raymond, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/329/contributors\">",
"     Carolyn Jones, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/329/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/329/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/329/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/329/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/20/329/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H359219675\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal perforation is a diagnostic and therapeutic challenge because of the rarity of the condition and the variability in presentation. Surgical management is primarily based upon small retrospective studies and expert opinion. The following basic principles are applied to the management of a patient with an esophageal perforation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rapid diagnosis",
"     </li>",
"     <li>",
"      Appropriate hemodynamic monitoring and support",
"     </li>",
"     <li>",
"      Antibiotic therapy",
"     </li>",
"     <li>",
"      Restoration of luminal integrity",
"     </li>",
"     <li>",
"      Control of extraluminal contamination",
"     </li>",
"     <li>",
"      Restoration of enteral alimentation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The etiology and surgical management of a perforation to the cervical, thoracic, and abdominal esophagus will be reviewed here. The risk factors, clinical presentation, diagnosis, and nonoperative management of an esophageal perforation are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link\">",
"     \"Complications of endoscopic esophageal stricture dilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link\">",
"     \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359219173\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The esophagus has three anatomical points of narrowing, the cricopharyngeus muscle, the broncho-aortic constriction, and the esophagogastric junction (",
"    <a class=\"graphic graphic_figure graphicRef54206 \" href=\"UTD.htm?15/16/15620\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/1\">",
"     1",
"    </a>",
"    ]. Perforation may occur anywhere along the esophagus, but there is a predilection for rupture at these key anatomic areas. As an example, iatrogenic injuries to the cervical esophagus can occur during endoscopy at Killian&rsquo;s triangle (",
"    <a class=\"graphic graphic_figure graphicRef75732 \" href=\"UTD.htm?35/53/36689\">",
"     figure 2",
"    </a>",
"    ), an area lacking a posterior esophageal muscularis and bordered by the horizontal cricopharyngeus muscle inferiorly and the oblique inferior constrictor muscles superiorly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3822727\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased intraluminal pressure at the anatomic sites of narrowing, as well as sites narrowed by a malignancy, foreign body, or physiologic dysfunction, can lead to rupture of the esophagus (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71821 \" href=\"UTD.htm?32/2/32814\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82026 \" href=\"UTD.htm?14/2/14383\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    More than one half of all esophageal perforations are iatrogenic and most of these occur during endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. The rate of esophageal perforation during diagnostic and therapeutic esophageal endoscopy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/9/12442?source=see_link&amp;anchor=H61432898#H61432898\">",
"     \"Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)\", section on 'Perforation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link&amp;anchor=H2#H2\">",
"     \"Complications of endoscopic esophageal stricture dilation\", section on 'Esophageal perforation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of esophageal perforation include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spontaneous perforation (Boerhaave&rsquo;s Syndrome): 15 percent (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link&amp;anchor=H2#H2\">",
"       \"Boerhaave's syndrome: Effort rupture of the esophagus\", section on 'Clinical manifestations'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Foreign body ingestion: 12 percent (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/54/21353?source=see_link\">",
"       \"Ingested foreign bodies and food impactions in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=see_link\">",
"       \"Foreign bodies of the esophagus and gastrointestinal tract in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Trauma: 9 percent (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=see_link&amp;anchor=H9#H9\">",
"       \"Penetrating neck injuries\", section on 'Pharyngoesophageal injuries'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=see_link&amp;anchor=H28#H28\">",
"       \"Initial evaluation and management of blunt thoracic trauma in adults\", section on 'Esophageal rupture'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Intra-operative injury: 2 percent",
"     </li>",
"     <li>",
"      Malignancy: 1 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359219180\">",
"    <span class=\"h1\">",
"     PRIMARY MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major principles of the primary and immediate management of an esophageal perforation include prompt diagnosis, stabilization of the patient, and assessment for operative or nonoperative management. (See",
"    <a class=\"local\" href=\"#H359219748\">",
"     'Primary surgical repair'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H3823773\">",
"     'Alternatives to primary surgical repair'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Regardless of etiology, an esophageal perforation is a surgical emergency [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Leakage of esophageal and gastric contents into the mediastinum creates a necrotizing inflammatory process that can lead to sepsis, multiorgan failure, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The near doubling of overall mortality from 14 to 27 percent with a delay in diagnosis greater than 24 hours after perforation emphasizes the importance of a prompt diagnosis and treatment (",
"    <a class=\"graphic graphic_figure graphicRef82453 \" href=\"UTD.htm?28/44/29390\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/2\">",
"     2",
"    </a>",
"    ]. The diagnostic studies performed to confirm the clinical suspicion of esophageal perforation are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=see_link&amp;anchor=H3#H3\">",
"     \"Boerhaave's syndrome: Effort rupture of the esophagus\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link&amp;anchor=H5#H5\">",
"     \"Complications of endoscopic esophageal stricture dilation\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rarity of the diagnosis and the variability in clinical presentation often lead to diagnostic treatment delays. This is especially true of spontaneous perforation, in contrast to iatrogenic perforation, where the clinical suspicion is low, which often leads to the evaluation of more common medical conditions such as myocardial infarction, pneumonia, and peptic ulcer disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=see_link\">",
"     \"Chest pain of esophageal origin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20090?source=see_link\">",
"     \"Evaluation of chest pain in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359220294\">",
"    <span class=\"h2\">",
"     Initial management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis is suspected, treatment is started immediately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patient is made NPO (nothing per oral).",
"     </li>",
"     <li>",
"      A large bore intravenous line is started and fluid resuscitation is performed with isotonic saline solution or lactated ringers solution.",
"     </li>",
"     <li>",
"      Broad spectrum intravenous antibiotics that provide coverage for aerobes and anaerobes are administered intravenously, such as",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"        ampicillin",
"       </a>",
"       /sulbactam",
"      </span>",
"      (3 grams every six hours), or",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?34/13/35030?source=see_link\">",
"        piperacillin",
"       </a>",
"       /tazobactam",
"      </span>",
"      (3.375 grams every six hours), or a carbapenem. In the setting of beta lactam hypersensitivity, use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (900 mg every eight hours) plus a fluoroquinolone, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (400 mg every 12 hours) is acceptable.",
"     </li>",
"     <li>",
"      Antifungal coverage (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"       fluconazole",
"      </a>",
"      400 mg once a day) is warranted in selected cases. These include patients who have been hospitalized or received broad-spectrum antimicrobial agents prior to perforation, patients on long term antacid therapy, patients who have received steroids or other immunosuppressive therapy prior to perforation, patients with HIV infection,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      patients who fail to improve after several days of appropriate antibacterial therapy. &nbsp;",
"     </li>",
"     <li>",
"      The patient can be transferred to an intensive care unit for hemodynamic monitoring, stabilization, and volume resuscitation. Insertion of a central venous catheter, arterial catheter, and urinary catheter should be considered. Delay in surgical management should be avoided.",
"     </li>",
"     <li>",
"      The patient should be prepared for operative management including laboratory evaluation (eg, CBC, coagulation studies, type and screen) and a chest radiograph (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef60957 \" href=\"UTD.htm?40/43/41651\">",
"       image 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823140\">",
"    <span class=\"h2\">",
"     Selection of operative candidates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following confirmation of the diagnosis and stabilization of the patient, the clinician must decide if the patient should undergo operative or nonoperative management. While operative management is required for most patients to minimize morbidity and mortality, there are specific clinical settings (eg, minimal extraluminal contamination) where nonoperative management is an acceptable alternative. (See",
"    <a class=\"local\" href=\"#H359219748\">",
"     'Primary surgical repair'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H359219188\">",
"     'Nonoperative management'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823291\">",
"    <span class=\"h1\">",
"     PRINCIPLES OF SURGICAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary repair of the perforation site is the optimal procedure, even if the diagnosis is delayed greater than 24 hours. The exceptions to performing a primary repair include a cervical perforation that cannot be accessed but can be drained, diffuse mediastinal necrosis, a perforation too large for the esophagus to be re-approximated, an esophageal malignancy, pre-existing end-stage benign esophageal disease (eg, achalasia), or the patient is clinically unstable [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. Surgical alternatives to primary repair in these settings are discussed below (see",
"    <a class=\"local\" href=\"#H3823773\">",
"     'Alternatives to primary surgical repair'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359219748\">",
"    <span class=\"h2\">",
"     Primary surgical repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;A primary suture or pedicle repair is performed when, in the judgement of an experienced surgeon, the closure can heal and not re-perforate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527634957\">",
"    <span class=\"h3\">",
"     General principles for esophageal repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following general principles are used to perform a repair of a perforation of the cervical, thoracic, or abdominal esophagus (",
"    <a class=\"graphic graphic_figure graphicRef61590 \" href=\"UTD.htm?37/60/38849\">",
"     figure 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First, devitalized tissue is debrided from the perforation site.",
"     </li>",
"     <li>",
"      Second, the muscular layer is incised longitudinally along the muscle fibers superior and inferior to the perforation to expose the entire extent of the mucosal injury. Failure to visualize the proximal and distal extent of the mucosal disruption is the most common reason for a persistent leak.",
"     </li>",
"     <li>",
"      Third, the mucosa is closed with absorbable",
"      <strong>",
"       interrupted",
"      </strong>",
"      sutures and the muscularis layer is closed with interrupted nonabsorbable sutures. Narrowing of the esophageal lumen should be avoided using precise reapproximation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When there has been a delay in diagnosis greater than 24 hours,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    substantial extraluminal contamination from the leakage of fluid and debris has occurred, the integrity of the repair can be enhanced with the use of a vascularized pedicle flap. The most common flap used is the intercostal muscle flap (",
"    <a class=\"graphic graphic_figure graphicRef54219 \" href=\"UTD.htm?13/44/14018\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef80384 \" href=\"UTD.htm?18/7/18545\">",
"     figure 6",
"    </a>",
"    ). Other options for a flap include serratus muscle, latissimus dorsi muscle, diaphragm, parietal pleura, omentum, and gastric fundus.",
"   </p>",
"   <p>",
"    If the gastric fundus is used to buttress a lower esophageal repair, the gastroesophageal junction should be placed in the normal intra-abdominal location to avoid severe and debilitating gastroesophageal reflux. A Dor fundoplication (partial anterior wrap) is an excellent alternative for an intra-abdominal perforation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359219755\">",
"    <span class=\"h3\">",
"     Cervical perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical perforations are typically more easily treated than perforations of the thoracic or intra-abdominal esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/2\">",
"     2",
"    </a>",
"    ]. A primary repair of a cervical perforation is performed if the perforation can be clearly visualized and there is no distal obstruction. Otherwise, drainage of the perforation is adequate to control the leak since the anatomic structures of the neck typically confine extraluminal contamination to a limited space and thereby enhance spontaneous healing (",
"    <a class=\"graphic graphic_figure graphicRef67045 \" href=\"UTD.htm?9/2/9253\">",
"     figure 7",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H3823780\">",
"     'Drainage only'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The surgical approach to control a perforation in the cervical esophagus begins with an incision in the left neck along the lower third of the sternocleidomastoid (SCM) muscle (",
"    <a class=\"graphic graphic_figure graphicRef55814 \" href=\"UTD.htm?24/62/25583\">",
"     figure 8",
"    </a>",
"    ), unless the perforation is documented or visualized from the right neck [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/15\">",
"     15",
"    </a>",
"    ]. The surgical dissection proceeds with identification of the anatomic structures such as the recurrent laryngeal nerve, which should be preserved. Soft retractors, including the fingers of the surgeon and first assistant, are used to retract the esophagus and trachea.",
"   </p>",
"   <p>",
"    The following surgical techniques are used to expose and manage the perforated cervical esophagus (",
"    <a class=\"graphic graphic_figure graphicRef68608 \" href=\"UTD.htm?31/14/31968\">",
"     figure 9",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/1,15\">",
"     1,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The SCM muscle and carotid sheath are retracted laterally.",
"     </li>",
"     <li>",
"      The middle thyroid vein and the omohyoid muscle are divided.",
"     </li>",
"     <li>",
"      The trachea and esophagus are bluntly retracted medially.",
"     </li>",
"     <li>",
"      The esophagus is carefully and bluntly dissected posteriorly along the retropharyngeal plane.",
"     </li>",
"     <li>",
"      All devitalized tissue is debrided.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Blunt dissection should be carried into the mediastinum posterior to the esophagus and anterior to the prevertebral fascia to assure adequate drainage of the infection. The perforation should be primarily repaired when clearly visualized, as described above. However, if the perforation is not clearly visualized, then the perforation site is drained. (See",
"    <a class=\"local\" href=\"#H527634957\">",
"     'General principles for esophageal repair'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The wound is irrigated, widely drained with Jackson-Pratt drains, and loosely closed in layers with interrupted absorbable sutures. Alternatively, when heavy contamination is present, the wound may be left open and packed with wet to dry dressings or a wound vac. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=see_link\">",
"     \"Negative pressure wound therapy\"",
"    </a>",
"    .) The authors do not routinely use a nasogastric tube. A feeding tube is only considered in patients presenting with significant malnutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359219762\">",
"    <span class=\"h3\">",
"     Thoracic perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough knowledge of the relationship of the esophagus to the adjacent vital structures is necessary when planning the surgical approach to a thoracic perforation (",
"    <a class=\"graphic graphic_figure graphicRef54206 \" href=\"UTD.htm?15/16/15620\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef61563 \" href=\"UTD.htm?30/60/31684\">",
"     figure 10",
"    </a>",
"    ). The level of the perforation of the thoracic esophagus determines the surgical approach to controlling the leak and repairing the perforation. As an example, a mid-esophageal perforation is approached through a right thoracotomy at the sixth or seventh intercostal space while a distal esophageal perforation is approached through a left thoracotomy at the seventh or eighth intercostal space (",
"    <a class=\"graphic graphic_figure graphicRef68858 \" href=\"UTD.htm?33/19/34111\">",
"     figure 11",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The following surgical techniques are used to expose the thoracic esophagus (",
"    <a class=\"graphic graphic_figure graphicRef78253 \" href=\"UTD.htm?15/37/15953\">",
"     figure 12",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior to entering the thoracic cavity, a posteriorly based intercostal muscle flap is harvested as a potential buttress of a primary repair (",
"      <a class=\"graphic graphic_figure graphicRef54219 \" href=\"UTD.htm?13/44/14018\">",
"       figure 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The thoracotomy is performed, the lung is retracted anteriorly, which can be facilitated by the mobilization of the pleural reflection and inferior pulmonary ligament (",
"      <a class=\"graphic graphic_figure graphicRef78253 \" href=\"UTD.htm?15/37/15953\">",
"       figure 12",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The pleural space is evacuated of debris and the devitalized tissue in the mediastinum is debrided.",
"     </li>",
"     <li>",
"      The esophagus is encircled with a Penrose drain proximal to the perforation to facilitate dissection (",
"      <a class=\"graphic graphic_figure graphicRef56059 \" href=\"UTD.htm?7/39/7807\">",
"       figure 13",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The perforation is localized and the repair is planned based on the size of the perforation and fragility of the esophagus.",
"     </li>",
"     <li>",
"      The repair is then buttressed with a pedicled flap (eg, intercostal muscle flap) utilizing interrupted absorbable sutures. An alternative to the intercostal muscle flap is the parietal pleura flap if the intercostal muscle is not available or the intercostal bundle has been compromised (",
"      <a class=\"graphic graphic_figure graphicRef66998 \" href=\"UTD.htm?34/62/35823\">",
"       figure 14",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The wound is copiously irrigated and drained utilizing two 28 to 32 French chest tubes. One chest tube is positioned in proximity to the site of injury to ensure adequate drainage if the repair breaks down and the second posterior to the repair.",
"     </li>",
"     <li>",
"      Pulmonary decortication is performed if exudate and debris are present to facilitate adequate lung expansion.",
"     </li>",
"     <li>",
"      A nasogastric tube is guided past the site of repair and into the stomach, taking care to avoid damaging the repair site.",
"     </li>",
"     <li>",
"      A jejunostomy feeding tube can be inserted by a mini-laparotomy procedure at the time of the esophageal repair. The authors prefer to place feeding tubes on clinically stable patients with significant extraluminal contamination when a prolonged intensive care unit admission is anticipated or on patients who present with significant malnutrition.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527634015\">",
"    <span class=\"h3\">",
"     Abdominal perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general principles for the management of an intra-abdominal esophageal perforation are the same as those described for perforations of the cervical and thoracic esophagus (",
"    <a class=\"graphic graphic_figure graphicRef55061 \" href=\"UTD.htm?25/63/26610\">",
"     figure 15",
"    </a>",
"    ). These surgical principles include a careful dissection to isolate the esophagus without damaging vital structures, evacuation of debris and devitalized tissues, and debridement of the area of perforation.",
"   </p>",
"   <p>",
"    A laparotomy is the preferred approach to repair a perforation of an intra-abdominal esophagus. The left triangular ligament (peritoneal attachment of the liver to the diaphragm [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/16\">",
"     16",
"    </a>",
"    ]) of the liver is divided and the liver is retracted laterally (",
"    <a class=\"graphic graphic_figure graphicRef63869 \" href=\"UTD.htm?37/27/38324\">",
"     figure 16",
"    </a>",
"    ). This maneuver provides access to the esophageal hiatus, which is proximal to the perforation. Division of the short gastric vessels will help mobilize the gastroesophageal junction for improved exposure and access to the perforation (",
"    <a class=\"graphic graphic_figure graphicRef56689 \" href=\"UTD.htm?40/59/41907\">",
"     figure 17",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Following the primary suture repair, a Dor (partial 180&deg; anterior wrap) or a Nissen (complete 360&deg; posterior wrap) fundoplication is used to buttress the site of repair depending on the site of perforation and patients&rsquo; preoperative history of swallowing dysfunction. The peritoneum is then copiously irrigated with isotonic saline, Jackson-Pratt drains are placed near the site of repair, and a feeding jejunostomy tube is placed for postoperative alimentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H527633838\">",
"    <span class=\"h3\">",
"     Postoperative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;This approach is used to manage patients with an esophageal perforation at any site:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nutritional support is necessary until oral feedings can be initiated and effectively sustained. The patient remains NPO for approximately seven days. Jejunal tube feedings are started on postoperative day two or three in stable patients without evidence of an ileus.",
"     </li>",
"     <li>",
"      If a jejunostomy feeding tube was not inserted at the time of the repair of the perforation, a central line can be inserted for administration of parental nutrition when a prolonged period of delay of enteral feedings is anticipated. Generally, this is not indicated in previously well-nourished patients with iatrogenic injuries and minimal contamination.",
"     </li>",
"     <li>",
"      The patient is maintained on intravenous broad spectrum antibiotics typically for 7 to 10 days, depending on the clinical status.",
"     </li>",
"     <li>",
"      A contrast esophagram is obtained on postoperative day seven if the patient is clinically stable. If there is no evidence of an esophageal leak or postoperative ileus, the nasogastric tube is removed and oral feedings are initiated.",
"     </li>",
"     <li>",
"      Drains remain in place until patients are tolerating oral feedings and without clinical evidence of a leak.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823773\">",
"    <span class=\"h2\">",
"     Alternatives to primary surgical repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several approaches have been described for cases when a primary repair is technically not feasible, the patient is hemodynamically unstable, or the perforation is diagnosed immediately after the event. As an example, severe mediastinitis associated with extra-esophageal tissue friability and necrosis from a delay in diagnosis can preclude a primary repair [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/2\">",
"     2",
"    </a>",
"    ]. Options in these circumstances include drainage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diversion procedures.",
"   </p>",
"   <p>",
"    Endoscopic covered stent placement has been described as an alternative procedure to primary repair, however, there are no patient selection guidelines. For patients with a distal malignancy or achalasia, an esophagectomy may be warranted. Nonoperative management may be an option for highly select cases in which the patient is diagnosed early, and has evidence of a contained perforation and limited extraluminal soilage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823780\">",
"    <span class=\"h3\">",
"     Drainage only",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical drainage as the sole operative management is reserved for perforations of the cervical esophagus when the perforation site cannot be completely visualized and when there is no distal obstruction. Drainage alone is contraindicated in the management of a perforation of the thoracic or intra-abdominal esophagus because of uncontrolled leakage and contamination of adjacent tissues (ie, pleura, peritoneum).",
"   </p>",
"   <p>",
"    For patients with clinical evidence of mediastinal sepsis, significant comorbid illness, and large thoracic esophageal perforations, the authors utilize a hybrid technique that includes aggressive debridement, drainage, muscle flap coverage of the defect, and endoscopic stent placement. (See",
"    <a class=\"local\" href=\"#H3823794\">",
"     'Endoscopic stent placement'",
"    </a>",
"    below.) The goal of this approach is to reconstruct the esophageal lumen and control the leakage and septic contamination of adjacent tissues in patients unlikely to tolerate a second operative procedure to re-establish continuity of the esophagus. Alternatively, a T-tube may be inserted into the perforation to create a controlled fistula when a patient cannot tolerate more extensive surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/17-19\">",
"     17-19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823787\">",
"    <span class=\"h3\">",
"     Diversion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A procedure to divert the esophageal contents rather than perform a primary repair of a perforation is indicated when:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The patient is unstable",
"     </li>",
"     <li>",
"      The defect is large due to tissue destruction from contamination",
"     </li>",
"     <li>",
"      Pre-existing esophageal disease is present",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The goals of a diversion procedure include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Control and drain extraluminal contamination",
"     </li>",
"     <li>",
"      Divert the esophagus proximally with a cervical esophagostomy",
"     </li>",
"     <li>",
"      Resection of the remaining esophagus",
"     </li>",
"     <li>",
"      Obtain gastric diversion with a gastrostomy tube and feeding tube access with a jejunostomy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33592?source=see_link\">",
"       \"Enteral feeding: Gastric versus post-pyloric\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Close the diaphragmatic hiatus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A thoracotomy is typically performed to mobilize and resect the esophagus, and debride and drain the mediastinum. Alternatively, for an intra-abdominal perforation the thoracic esophagus may be bluntly dissected. A laparotomy is performed to insert a gastrostomy tube, a jejunostomy feeding tube, and to suture close the diaphragmatic hiatus to prevent subsequent hiatal hernia formation.",
"   </p>",
"   <p>",
"    For the patient who is hemodynamically unstable and critically ill, a diversion without an esophageal resection is performed. The perforation site must be adequately drained to control esophageal contamination. A cervical esophagostomy is constructed and the distal esophagus divided at the diaphragmatic hiatus to exclude the site of perforation (",
"    <a class=\"graphic graphic_figure graphicRef66616 \" href=\"UTD.htm?9/45/9938\">",
"     figure 18",
"    </a>",
"    ). A gastric feeding tube is inserted at this time. Once the patient is stabilized, definitive operative management can proceed.",
"   </p>",
"   <p>",
"    The fundamental technical components of a cervical esophagostomy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cervical esophagus is approached by a left neck incision, as described in a previous section. (See",
"      <a class=\"local\" href=\"#H359219755\">",
"       'Cervical perforation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Proximal length of the esophagus should be as long as possible to facilitate esophagostomy construction and ostomy appliance on the anterior chest wall (",
"      <a class=\"graphic graphic_figure graphicRef64619 \" href=\"UTD.htm?28/18/28975\">",
"       figure 19",
"      </a>",
"      ). This point cannot be overemphasized.",
"     </li>",
"     <li>",
"      A blind cervical stump should never be left in place, except in dire circumstances, as the stump will invariably rupture and lead to uncontrolled mediastinal contamination within days of its construction.",
"     </li>",
"     <li>",
"      A subcutaneous tunnel is bluntly fashioned over the sternocleidomastoid muscle, clavicle and pectoralis muscle and exits on the anterior chest wall (",
"      <a class=\"graphic graphic_figure graphicRef75797 \" href=\"UTD.htm?30/44/31439\">",
"       figure 20",
"      </a>",
"      ). The site of the esophagostomy must allow for uncomplicated application of the ostomy appliance. The esophagostomy should be as placed in a lateral position that will not interfere with a tracheostomy should one be necessary.",
"     </li>",
"     <li>",
"      A 1 to 2 cm disc of skin is excised at the distal point of the tunnel to prevent stricture formation. The proximal end of the esophagus is drawn through the tunnel and secured full thickness to the skin with interrupted absorbable sutures (",
"      <a class=\"graphic graphic_figure graphicRef54813 \" href=\"UTD.htm?26/18/26926\">",
"       figure 21",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The neck incision is irrigated with isotonic saline and closed. A drain is placed from the neck into the superior mediastinum to assist in drainage of mediastinal contamination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postoperative management unique to this population includes flexible fiberoptic laryngoscopy for evaluation of the vocal cord function, digital dilation of the esophagostomy to prevent stricture formation and reduce the risk of aspiration pneumonia, and aggressive nutritional support [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34073?source=see_link\">",
"     \"Nutrition support in critically ill patients: Enteral nutrition\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reconstruction of the esophagus is typically performed six months to one year following the perforation, pending full recovery. Restoration of alimentary tract continuity often requires a retrosternal colon interposition [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/17,18,21\">",
"     17,18,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823794\">",
"    <span class=\"h3\">",
"     Endoscopic stent placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal endoscopic covered stent can be used for the management of an esophageal perforation in selected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. While no guidelines exist, stents may be appropriate for patients with extensive comorbidities, advanced mediastinal sepsis, or large esophageal defects and the patient&rsquo;s inability to tolerate more extensive surgery. Stents should be placed only by an experienced clinician.",
"   </p>",
"   <p>",
"    Precise stent placement can restore luminal integrity and prevent further extraluminal soilage. However, control and drainage of the extraluminal contamination must be achieved for this approach to effectively manage the esophageal perforation. &nbsp;",
"   </p>",
"   <p>",
"    Complications of this procedure include stent malpositioning and migration, especially when used in close proximity to the gastroesophageal junction, and stent obstruction. The types of esophageal stents are described in another topic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6809?source=see_link&amp;anchor=H2#H2\">",
"     \"Expandable stents in the treatment of esophageal obstruction\", section on 'Types of stents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The authors perform endoscopic stent placement for an esophageal perforation in the operating room with fluoroscopic guidance. The fundamental technical components include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diagnostic endoscopy is performed first to localize the perforation and measure the length of the injury.",
"     </li>",
"     <li>",
"      A covered stent at least 4 cm longer than the size of the injury is used so that there is at least 2 cm of overlap proximal and distal to the perforation.",
"     </li>",
"     <li>",
"      If a percutaneous endoscopic gastrostomy tube (PEG) placement is considered in conjunction with stent placement for enteral access, it should be placed with minimal insufflation prior to stenting the perforation. Otherwise, stent migration can occur as the PEG tube is drawn through the stent lumen.",
"     </li>",
"     <li>",
"      Stent positioning in the distal esophagus can be challenging as the distal flare of the covered stent is placed in the lumen of the stomach. This gastric position decreases the ability of the stent to anchor by radial tension and results in frequent migration. However, it is critical that the distal end of the stent be placed in this location to completely cover and control the distal esophageal perforation.",
"     </li>",
"     <li>",
"      Debridement and drainage of extraluminal contamination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postoperative management includes a contrast esophagography to assess placement of the stent and to identify potential leakage from the perforation. Oral intake is initiated if the clinical status allows and the perforation is controlled. Stent positioning can be monitored with plain radiographs, particularly when placed in the distal esophagus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3823801\">",
"    <span class=\"h3\">",
"     Esophagectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A primary repair alone of an esophageal perforation proximal to untreated achalasia, an undilatable stricture, or a malignancy should not be performed. An esophagectomy at the time of perforation may be performed if the patient is clinically stable and there is minimal contamination.",
"   </p>",
"   <p>",
"    A perforation of the distal esophagus following dilatation in patients with achalasia requires special mention. The degree of preoperative dysfunction dictates treatment strategies as illustrated in the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who have maintained an adequate nutritional status and do not have a dilated, tortuous thoracic esophagus (sigmoid esophagus), primary repair of the perforation site and a myotomy on the contralateral site of the esophagus with a fundoplication can be performed. Many surgeons perform a partial fundoplication procedure to prevent reflux as well as to buttress the repair. The edges of the fundoplication are sewn to the edge of the myotomy and the stomach covers the repair. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19001?source=see_link\">",
"       \"Operative management of achalasia: Laparoscopic and open Heller myotomy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with end stage achalasia, generally an esophagectomy is indicated. If there is minimal contamination and the patient is stable, such as following an iatrogenic injury, the surgeon may choose to proceed with esophagectomy and reconstruction with a gastric tube. If the diagnosis is delayed, an esophageal resection and cervical esophagostomy is indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The same principles can be applied to patients with perforated cancers or undilatable strictures as these patients are not candidates for a primary repair of the esophageal perforation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359220268\">",
"    <span class=\"h1\">",
"     OUTCOMES FOLLOWING OPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal variables associated with mortality from an esophageal perforation include delay in diagnosis, type of repair, location of perforation, and etiology of the perforation (",
"    <a class=\"graphic graphic_table graphicRef54174 \" href=\"UTD.htm?34/40/35467\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef82453 \" href=\"UTD.htm?28/44/29390\">",
"     figure 3",
"    </a>",
"    ). The most common cause of death is sepsis leading to multiorgan failure [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following two retrospective reviews from two different eras report similar findings and illustrate the variables associated with mortality:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first review in the era of nutritional support and antibiotics included 450 patients with an esophageal perforation diagnosed between 1980 and 1990 [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/26\">",
"       26",
"      </a>",
"      ]. The mortality rates were dependent upon etiology and location of the perforation.",
"      <br/>",
"      <br/>",
"      The mortality rates by etiology were:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Spontaneous (39 percent)",
"     </li>",
"     <li>",
"      Iatrogenic (19 percent)",
"     </li>",
"     <li>",
"      Traumatic (9 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lower mortality rate associated with a traumatic rupture may be due to an earlier diagnosis while the diagnosis of a spontaneous rupture is frequently delayed.",
"   </p>",
"   <p>",
"    Mortality rates by location of the perforation were:",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Cervical (6 percent)",
"     </li>",
"     <li>",
"      Thoracic (34 percent)",
"     </li>",
"     <li>",
"      Intra-abdominal (29 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lower mortality rate associated with a cervical perforation may be related to the anatomic tissue planes of the neck that limit the spread of contamination and infection (",
"    <a class=\"graphic graphic_figure graphicRef75732 \" href=\"UTD.htm?35/53/36689\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest retrospective review included 726 patients diagnosed with an esophageal perforation between 1990 and 2003 [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/2\">",
"       2",
"      </a>",
"      ]. The overall mortality rate was 18 percent. Other pertinent results from this review include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The overall mortality rate for a diagnosis within 24 hours was significantly lower compared with a greater than 24 hour delay (14 versus 27 percent).",
"     </li>",
"     <li>",
"      Primary repair, with or without reinforcement with a flap, offered the highest probability of survival regardless of the interval between perforation and repair. The mortality rate was significantly lower when either a primary or a primary reinforced repair was performed within 24 hours of perforation compared with a repair after 24 hours (4 versus 14 percent).",
"     </li>",
"     <li>",
"      A perforation of the thoracic esophagus was associated with the highest mortality rate compared with a perforation of the cervical and intra-abdominal esophagus (27 versus 6 versus 21 percent).",
"     </li>",
"     <li>",
"      The mortality rate was higher with a spontaneous rupture of the esophagus compared with an iatrogenic and traumatic rupture (36 versus 19 versus 7 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no reports from large series detailing the frequency and type of postoperative complications. Based upon small series of patients, the most frequently reported complications include persistent leak, fistula formation, mediastinitis, empyema, esophageal stricture, pneumonia, abscess, and sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/12,13,27-29\">",
"     12,13,27-29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359219188\">",
"    <span class=\"h1\">",
"     NONOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of nonoperative management has evolved rapidly in the past several decades, likely due to the increasing incidence of iatrogenic injuries, which are often diagnosed more quickly and are associated with less extraluminal contamination. Essential to nonoperative management is careful patient selection; appropriate patient selection can achieve 100 percent survival rates [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/329/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. This requires clinicians experienced in the care of esophageal pathology, careful patient monitoring, and the early involvement of the appropriate surgical team.",
"   </p>",
"   <p>",
"    Cervical perforation is most commonly considered for nonoperative management due to the anatomic confinement of the esophagus by surrounding surgical structures. Perforation into the pleural or peritoneal cavity is a relative contraindication to nonoperative management due to the difficulties of controlling spillage of contaminated contents in large, free spaces.",
"   </p>",
"   <p>",
"    Evidenced based criteria for patient selection for nonoperative management and the medical management of an esophageal perforation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link&amp;anchor=H6#H6\">",
"     \"Complications of endoscopic esophageal stricture dilation\", section on 'Medical management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=see_link&amp;anchor=H7#H7\">",
"     \"Complications of endoscopic esophageal stricture dilation\", section on 'Approach to medical management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The authors utilize nonoperative management in patients diagnosed early in settings where there is evidence of contained perforations and limited extraluminal soilage. Patients are maintained on intravenous fluids, NPO, and broad spectrum antibiotics for five to seven days. As long as patients remain clinically stable, contrast esophagography is performed at five to seven days and resumption of oral intake under observation is considered depending on the results. We generally do not utilize parenteral nutrition unless the patient has evidence of malnutrition prior to diagnosis. Patients who show evidence of clinical deterioration require surgical intervention to control extraluminal contamination and to restore luminal integrity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H359221465\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal perforation is a diagnostic and therapeutic challenge because of the rarity of the condition and the variability in presentation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prompt diagnosis and management is critical to minimizing mortality. A delay of greater than 24 hours in diagnosis and treatment of an esophageal perforation is associated with a higher mortality rate compared with an early diagnosis and treatment initiation (27 versus 14 percent). (See",
"      <a class=\"local\" href=\"#H359220294\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mortality rate following operative management of an esophageal perforation is dependent on location of the perforation, with cervical perforations having the lowest mortality rate (6 percent) compared with thoracic perforations (27 to 34 percent), and intra-abdominal perforations (21 to 29 percent). (See",
"      <a class=\"local\" href=\"#H359220268\">",
"       'Outcomes following operative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A primary repair is the gold standard of care and should be utilized for perforations of the thoracic and abdominal esophagus and for visualized perforations of the cervical esophagus. (See",
"      <a class=\"local\" href=\"#H359219748\">",
"       'Primary surgical repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drainage alone should only be performed for perforation of the cervical esophagus when the perforation cannot be visualized and when there is no distal obstruction. (See",
"      <a class=\"local\" href=\"#H3823780\">",
"       'Drainage only'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diversion is reserved for patients who present with clinical instability and more extensive operative procedure is not possible or when extensive esophageal damage precludes a primary repair. (See",
"      <a class=\"local\" href=\"#H3823787\">",
"       'Diversion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While no guidelines exist, esophageal stents may be appropriate for patients with extensive comorbidities, advanced mediastinal sepsis, or large esophageal defects and the patient&rsquo;s inability to tolerate more extensive surgery. (See",
"      <a class=\"local\" href=\"#H3823794\">",
"       'Endoscopic stent placement'",
"      </a>",
"      above.) The stent should be placed by a clinician experienced with this procedure.",
"     </li>",
"     <li>",
"      Esophagectomy should be performed when the patient presents with malignancy, extensive esophageal damage that precludes repair, or end-stage benign esophageal disease. (See",
"      <a class=\"local\" href=\"#H3823801\">",
"       'Esophagectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonoperative management should be reserved for clinically stable patients with no evidence of systemic inflammation, expediently diagnosed perforations, and no drainage of any collection into the pleura or peritoneum. (See",
"      <a class=\"local\" href=\"#H359219188\">",
"       'Nonoperative management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/1\">",
"      Cooke DT, Lau CL. Primary repair of esophageal perforation. Operative Techniques in Thoracic and Cardiovascular Surgery 2008; 13:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/2\">",
"      Brinster CJ, Singhal S, Lee L, et al. Evolving options in the management of esophageal perforation. Ann Thorac Surg 2004; 77:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/3\">",
"      Helton WB, Unnikrishnan R, Gal T. Cervical esophageal perforation and cricopharyngeal dysfunction. Ear Nose Throat J 2011; 90:E8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/4\">",
"      Merchea A, Cullinane DC, Sawyer MD, et al. Esophagogastroduodenoscopy-associated gastrointestinal perforations: a single-center experience. Surgery 2010; 148:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/5\">",
"      Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med 2011; 364:1807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/6\">",
"      Kavic SM, Basson MD. Complications of endoscopy. Am J Surg 2001; 181:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/7\">",
"      Bufkin BL, Miller JI Jr, Mansour KA. Esophageal perforation: emphasis on management. Ann Thorac Surg 1996; 61:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/8\">",
"      Curci JJ, Horman MJ. Boerhaave's syndrome: The importance of early diagnosis and treatment. Ann Surg 1976; 183:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/9\">",
"      de Schipper JP, Pull ter Gunne AF, Oostvogel HJ, van Laarhoven CJ. Spontaneous rupture of the oesophagus: Boerhaave's syndrome in 2008. Literature review and treatment algorithm. Dig Surg 2009; 26:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/10\">",
"      Shaker H, Elsayed H, Whittle I, et al. The influence of the 'golden 24-h rule' on the prognosis of oesophageal perforation in the modern era. Eur J Cardiothorac Surg 2010; 38:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/11\">",
"      Vallb&ouml;hmer D, H&ouml;lscher AH, H&ouml;lscher M, et al. Options in the management of esophageal perforation: analysis over a 12-year period. Dis Esophagus 2010; 23:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/12\">",
"      Salo JA, Isolauri JO, Heikkil&auml; LJ, et al. Management of delayed esophageal perforation with mediastinal sepsis. Esophagectomy or primary repair? J Thorac Cardiovasc Surg 1993; 106:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/13\">",
"      Kim-Deobald J, Kozarek RA. Esophageal perforation: an 8-year review of a multispecialty clinic's experience. Am J Gastroenterol 1992; 87:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/14\">",
"      Wright CD, Mathisen DJ, Wain JC, et al. Reinforced primary repair of thoracic esophageal perforation. Ann Thorac Surg 1995; 60:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/15\">",
"      Raymond DP, Watson TJ. Esophageal diversion. Operative Techniques in Thoracic and Cardiovascular Surgery 2008; 13:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/16\">",
"      Mirilas P, Skandalakis JE. Benign anatomical mistakes: right and left coronary ligaments. Am Surg 2002; 68:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/17\">",
"      F&uuml;rst H, Hartl WH, L&ouml;he F, Schildberg FW. Colon interposition for esophageal replacement: an alternative technique based on the use of the right colon. Ann Surg 2000; 231:173.",
"     </a>",
"    </li>",
"    <li>",
"     Rice TW. Colon replacement. In: Esophageal surgery, Pearson FG, Deslauriers J, Ginsberg RJ, et al (Eds), Churchill Livingstone, New York 1995. p.761.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/19\">",
"      Naylor AR, Walker WS, Dark J, Cameron EW. T tube intubation in the management of seriously ill patients with oesophagopleural fistulae. Br J Surg 1990; 77:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/20\">",
"      Barkley C, Orringer MB, Iannettoni MD, Yee J. Challenges in reversing esophageal discontinuity operations. Ann Thorac Surg 2003; 76:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/21\">",
"      Thomas P, Fuentes P, Giudicelli R, Reboud E. Colon interposition for esophageal replacement: current indications and long-term function. Ann Thorac Surg 1997; 64:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/22\">",
"      Fischer A, Thomusch O, Benz S, et al. Nonoperative treatment of 15 benign esophageal perforations with self-expandable covered metal stents. Ann Thorac Surg 2006; 81:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/23\">",
"      Freeman RK, Van Woerkom JM, Ascioti AJ. Esophageal stent placement for the treatment of iatrogenic intrathoracic esophageal perforation. Ann Thorac Surg 2007; 83:2003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/24\">",
"      Salminen P, Gullichsen R, Laine S. Use of self-expandable metal stents for the treatment of esophageal perforations and anastomotic leaks. Surg Endosc 2009; 23:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/25\">",
"      Schmidt SC, Strauch S, R&ouml;sch T, et al. Management of esophageal perforations. Surg Endosc 2010; 24:2809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/26\">",
"      Jones WG 2nd, Ginsberg RJ. Esophageal perforation: a continuing challenge. Ann Thorac Surg 1992; 53:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/27\">",
"      Safavi A, Wang N, Razzouk A, et al. One-stage primary repair of distal esophageal perforation using fundic wrap. Am Surg 1995; 61:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/28\">",
"      Skinner DB, Little AG, DeMeester TR. Management of esophageal perforation. Am J Surg 1980; 139:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/29\">",
"      Port JL, Kent MS, Korst RJ, et al. Thoracic esophageal perforations: a decade of experience. Ann Thorac Surg 2003; 75:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/30\">",
"      Altorjay A, Kiss J, V&ouml;r&ouml;s A, Boh&aacute;k A. Nonoperative management of esophageal perforations. Is it justified? Ann Surg 1997; 225:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/31\">",
"      Cameron JL, Kieffer RF, Hendrix TR, et al. Selective nonoperative management of contained intrathoracic esophageal disruptions. Ann Thorac Surg 1979; 27:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/329/abstract/32\">",
"      Vogel SB, Rout WR, Martin TD, Abbitt PL. Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality. Ann Surg 2005; 241:1016.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15066 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-A3347AB727-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_329=[""].join("\n");
var outline_f0_20_329=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H359221465\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H359219675\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H359219173\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3822727\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H359219180\">",
"      PRIMARY MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H359220294\">",
"      Initial management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3823140\">",
"      Selection of operative candidates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3823291\">",
"      PRINCIPLES OF SURGICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H359219748\">",
"      Primary surgical repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527634957\">",
"      - General principles for esophageal repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H359219755\">",
"      - Cervical perforation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H359219762\">",
"      - Thoracic perforation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527634015\">",
"      - Abdominal perforation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H527633838\">",
"      - Postoperative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3823773\">",
"      Alternatives to primary surgical repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3823780\">",
"      - Drainage only",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3823787\">",
"      - Diversion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3823794\">",
"      - Endoscopic stent placement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3823801\">",
"      - Esophagectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H359220268\">",
"      OUTCOMES FOLLOWING OPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H359219188\">",
"      NONOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H359221465\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15066\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15066|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/2/32814\" title=\"diagnostic image 1\">",
"      Esophageal perforation UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/2/14383\" title=\"diagnostic image 2\">",
"      Esophageal perf sclerotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/43/41651\" title=\"diagnostic image 3\">",
"      Esophageal perforation PA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15066|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/16/15620\" title=\"figure 1\">",
"      Anatomy of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/53/36689\" title=\"figure 2\">",
"      Perforation of the cervical esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/44/29390\" title=\"figure 3\">",
"      Mortality rates for esophageal perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/60/38849\" title=\"figure 4\">",
"      Debridement and primary repair of esophageal perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/44/14018\" title=\"figure 5\">",
"      Intercostal muscle flap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/7/18545\" title=\"figure 6\">",
"      Esophageal perforation buttressed with intercostal muscle flap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/2/9253\" title=\"figure 7\">",
"      Anatomy of the cervical esophagus - longitudinal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/62/25583\" title=\"figure 8\">",
"      Operative approach to the left cervical esophagus - positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/14/31968\" title=\"figure 9\">",
"      Operative repair of the perforated cervical esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/60/31684\" title=\"figure 10\">",
"      Anatomy of the thoracic esophagus anterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/19/34111\" title=\"figure 11\">",
"      Position for left thoracotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/37/15953\" title=\"figure 12\">",
"      Perforation of the distal esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/39/7807\" title=\"figure 13\">",
"      Perforation of distal thoracic esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/62/35823\" title=\"figure 14\">",
"      Pleural flap buttress of thoracic esophageal perforation repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/63/26610\" title=\"figure 15\">",
"      Anatomy of the intra-abdominal esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/27/38324\" title=\"figure 16\">",
"      Anatomy of the liver - posterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/59/41907\" title=\"figure 17\">",
"      Anatomy of the stomach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/45/9938\" title=\"figure 18\">",
"      Exclusion of the distal esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/18/28975\" title=\"figure 19\">",
"      Mobilization of the cervical esophagus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/44/31439\" title=\"figure 20\">",
"      Creation of a cervical esophagostomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/18/26926\" title=\"figure 21\">",
"      Cervical esophagostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15066|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/40/35467\" title=\"table 1\">",
"      Esophageal perforation prognostic variables",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/58/29606?source=related_link\">",
"      Boerhaave's syndrome: Effort rupture of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=related_link\">",
"      Chest pain of esophageal origin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/57/10137?source=related_link\">",
"      Complications of endoscopic esophageal stricture dilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33592?source=related_link\">",
"      Enteral feeding: Gastric versus post-pyloric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20090?source=related_link\">",
"      Evaluation of chest pain in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/41/6809?source=related_link\">",
"      Expandable stents in the treatment of esophageal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/22/1386?source=related_link\">",
"      Foreign bodies of the esophagus and gastrointestinal tract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/54/21353?source=related_link\">",
"      Ingested foreign bodies and food impactions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34426?source=related_link\">",
"      Initial evaluation and management of blunt thoracic trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=related_link\">",
"      Negative pressure wound therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/17/34073?source=related_link\">",
"      Nutrition support in critically ill patients: Enteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19001?source=related_link\">",
"      Operative management of achalasia: Laparoscopic and open Heller myotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/9/12442?source=related_link\">",
"      Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=related_link\">",
"      Penetrating neck injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_20_330="Pathophysiology, clinical features, and diagnosis of spontaneous low cerebrospinal fluid pressure headache";
var content_f0_20_330=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathophysiology, clinical features, and diagnosis of spontaneous low cerebrospinal fluid pressure headache",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/330/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/330/contributors\">",
"     Christina Sun-Edelstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/330/contributors\">",
"     Christine L Lay, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/330/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/330/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/20/330/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/20/330/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/20/330/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 17, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The production, absorption, and flow of cerebrospinal fluid (CSF) play key roles in the dynamics of intracranial pressure. Alterations in CSF pressure can lead to neurologic symptoms, the most common being headache. Most often, the headaches associated with low CSF pressure are orthostatic and occur after lumbar puncture, but similar headaches occur with spontaneous low CSF pressure due to spinal CSF leaks and with CSF shunt overdrainage. In addition, trauma, surgery, and other medical conditions have also been associated with low CSF pressure headache [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spontaneous low CSF pressure headache is being recognized with increasing frequency. Orthostatic headache, low CSF pressure, and diffuse meningeal enhancement on brain magnetic resonance imaging (MRI) are the major features of the classic syndrome. However, some cases have nonorthostatic headache, normal CSF pressure, or no evidence of diffuse meningeal enhancement [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our understanding of this syndrome is still evolving, and historically a number of terms have been used to describe it:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Spontaneous (or idiopathic) low CSF pressure headache",
"     </li>",
"     <li>",
"      Spontaneous (or primary) intracranial hypotension",
"     </li>",
"     <li>",
"      Low CSF volume headache",
"     </li>",
"     <li>",
"      Hypoliquorrhoeic headache",
"     </li>",
"     <li>",
"      Aliquorrhea",
"     </li>",
"     <li>",
"      CSF leak headache",
"     </li>",
"     <li>",
"      CSF hypovolemia",
"     </li>",
"     <li>",
"      CSF volume depletion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will discuss the pathophysiology, epidemiology, clinical features, and diagnosis of spontaneous low CSF pressure headache. Treatment is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13126?source=see_link\">",
"     \"Treatment and prognosis of spontaneous low cerebrospinal fluid pressure headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Post-lumbar puncture headache is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20198?source=see_link\">",
"     \"Post-lumbar puncture headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the intact craniospinal vault, the brain is supported by the cerebrospinal fluid (CSF), such that a brain weight of 1500 g in air is only 48 g in CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/3\">",
"     3",
"    </a>",
"    ]. As the CSF pressure decreases, there is a reduction in the buoyancy of the brain's supportive cushion. As a result, the brain \"sags\" in the cranial cavity, causing traction on the anchoring and supporting structures of the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/4-7\">",
"     4-7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107340173\">",
"    <span class=\"h2\">",
"     Cause of headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traction on pain-sensitive intracranial and meningeal structures, particularly sensory nerves and bridging veins, is thought to cause headache and some of the associated symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/6\">",
"     6",
"    </a>",
"    ]. In the upright position this traction is exaggerated, hence the postural component of the headache. Secondary vasodilation of the cerebral vessels to compensate for the low CSF pressure may contribute to the vascular component of the headache by increasing brain volume [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/5\">",
"     5",
"    </a>",
"    ]. Because jugular venous compression increases headache severity, it seems likely that venodilation is a contributing factor to the headache.",
"   </p>",
"   <p>",
"    CSF hypovolemia, rather than CSF hypotension per se, has been proposed as the underlying cause of the headache syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/2\">",
"     2",
"    </a>",
"    ], as patients with normal CSF pressure have been described who have clinical and radiographic features that are otherwise typical of orthostatic headache [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/2,8-10\">",
"     2,8-10",
"    </a>",
"    ]. In this paradigm, the CSF pressures, clinical manifestations, and imaging abnormalities of the syndrome are thought to be variables dependent on CSF volume [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/11\">",
"     11",
"    </a>",
"    ]. Some authors [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/12\">",
"     12",
"    </a>",
"    ] have therefore advocated the name \"CSF hypovolemia syndrome\" for the constellation of symptoms associated with CSF leakage.",
"   </p>",
"   <p>",
"    An alternative hypothesis is that spinal loss of CSF results in an increased compliance at the caudal end of the spinal CSF space, and the abnormal distribution of craniospinal elasticity causes the headache syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/13\">",
"     13",
"    </a>",
"    ]. This explanation is compatible with the observation that spinal sites of CSF leakage commonly produce orthostatic headache, whereas cranial sites of CSF leakage (eg, seen with spontaneous CSF rhinorrhea or CSF otorrhea) are less likely to do so.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Cause of low CSF pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1891 Quincke introduced the lumbar puncture (LP) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/14\">",
"     14",
"    </a>",
"    ], and in 1898 Bier suffered and was the first to report post-LP headache [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/15\">",
"     15",
"    </a>",
"    ]. He proposed that ongoing leakage of cerebrospinal fluid (CSF) through the dural puncture site was the cause of the headache. This belief is still held today. It is thought that leakage of CSF through the dural rent made by the LP needle exceeds the rate of CSF production, resulting in low CSF volume and pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20198?source=see_link\">",
"     \"Post-lumbar puncture headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical syndrome of spontaneous low CSF pressure has been recognized for many years. The syndrome was first proposed in 1938 by Schaltenbrand [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], who termed it aliquorrhea, and described a headache syndrome virtually identical to that following LP. He proposed three possible mechanisms (decreased CSF production by the choroid plexus, increased CSF absorption, and CSF leakage through small tears) to explain the symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107340188\">",
"    <span class=\"h3\">",
"     CSF leak",
"    </span>",
"    &nbsp;&mdash;&nbsp;Today, the prevailing etiology is that of CSF leakage, which may occur in the context of rupture of an arachnoid membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/19\">",
"     19",
"    </a>",
"    ]. An underlying connective tissue disorder may result in dural weakness and play a role in the development of spontaneous low CSF pressure, as suggested by studies reporting abnormal connective tissue abnormalities in patients with spontaneous CSF leaks [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    deficient fibrillin, elastin, or both in dermal fibroblast cultures from such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/22\">",
"     22",
"    </a>",
"    ]. Meningeal diverticula, often seen in patients with CSF leaks, may be related to this connective tissue problem [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/23\">",
"     23",
"    </a>",
"    ], and meningeal diverticula have been described in patients with Marfan's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potential contributing factor to the development of spontaneous low CSF pressure is that of minor trauma or an inciting event, including a fall, a sudden twist or stretch, sexual intercourse or orgasm, a sudden sneeze, sports activity, or \"trivial trauma\" [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/24\">",
"     24",
"    </a>",
"    ]. These relatively minor events may cause rupture of spinal epidural cysts (formed during fetal development) or perineural (Tarlov) cysts, or may cause a tear in a dural nerve sheath [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/19\">",
"     19",
"    </a>",
"    ] with resultant cryptic CSF leakage.",
"   </p>",
"   <p>",
"    Finally, degenerative disc disease and osseous spurs may rarely cause spontaneous low CSF pressure headache, presumably by causing dural tears [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H107340219\">",
"    <span class=\"h3\">",
"     Low venous pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative hypothesis postulates that spontaneous intracranial hypotension results primarily from the lowering of venous pressure within the inferior vena cava system, amplified by the displacement of blood toward the heart that occurs due to the activation of leg muscles during standing and walking [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/29\">",
"     29",
"    </a>",
"    ]. &nbsp;The lower pressure in the inferior vena cava leads to epidural venous hypotension and outflow of CSF along the spinal cavity, and in some cases precipitates actual CSF leaks from existing radicular arachnoid diverticula or cysts. In this paradigm, dural tears are not the cause of the condition but instead are a result of the low epidural pressure. Blood patching at the epidural lumbar space used to treat the condition does not work by sealing CSF leaks, but instead is effective because it disconnects the low-pressure epidural lumbar venous network that drains to the inferior vena cava and diverts venous return to the epidural thoracic and cervical venous network that drains to the superior vena cava.",
"   </p>",
"   <p>",
"    This hypothesis has been challenged by experts who dispute a number of its assumptions regarding the anatomic and pathophysiologic characteristics of the spinal epidural veins [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/30\">",
"     30",
"    </a>",
"    ]. In addition, the skeptics point out radiologic evidence that epidural veins are distended and the epidural sac is collapsed in patients with spontaneous intracranial hypotension prior to treatment, and that the epidural veins and dural sac return to normal proportions after treatment with blood patch [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/31\">",
"     31",
"    </a>",
"    ]. These pre-treatment observations are best explained by CSF hypotension with dural sac collapse and expansion of the extradural space [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data regarding the incidence of low cerebrospinal fluid (CSF) pressure headache. In a systematic review published in 2006, the following observations were made [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The estimated annual incidence is 5 per 100,000",
"     </li>",
"     <li>",
"      The peak incidence is around age 40, but children and elderly are also affected",
"     </li>",
"     <li>",
"      Women are affected more frequently than men, with a female to male ratio of 2:1",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The author concluded that spontaneous intracranial hypotension should be considered an important cause of new daily persistent headaches, particularly among young and middle-aged patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2968?source=see_link\">",
"     \"New daily persistent headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postural headache is usually but not always the major manifestation of spontaneous low cerebrospinal fluid (CSF) pressure. Occasional patients report no headache, typically when other symptoms of low CSF pressure are predominant [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Associated symptoms and complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;The headache caused by low CSF pressure may be of sudden or gradual onset. Rarely, it starts as a thunderclap headache [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link\">",
"     \"Thunderclap headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Headache pain with this syndrome is often described as an intense, throbbing, or dull pain that may be generalized or focal. However, headache severity is widely variable and ranges from mild to incapacitating [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]. Frontal pain is reported by patients as often as occipital and diffuse pain [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Headache relief is typically obtained with recumbency, usually within minutes. In rare cases associated with an asymmetric cervical CSF leak, headache relief occurs only with lying on one side of the body [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/33\">",
"     33",
"    </a>",
"    ]. The headache is seldom relieved with analgesics. Exacerbating factors include erect posture, head movement, coughing, straining, sneezing, jugular venous compression, and high altitude [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the course of the illness, the orthostatic features may disappear, and a chronic daily headache may develop [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/23\">",
"     23",
"    </a>",
"    ]. On occasion, the postural component may not be present at all. Furthermore, paradoxical headache, worse with recumbency and better with the upright position, has been reported in rare patients with spontaneous low CSF pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. In other cases, the headache can mimic a primary headache syndrome, such as primary cough headache [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/37\">",
"     37",
"    </a>",
"    ] or primary exertional headache [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/38\">",
"     38",
"    </a>",
"    ]. These primary headache syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/37/22101?source=see_link\">",
"     \"Primary cough headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most CSF leaks occur at the thoracic or cervicothoracic junction. Leakage of CSF into the petrous or ethmoidal regions or through the cribriform plate can also occur, and although overt CSF otorrhea and CSF rhinorrhea may result, it is not uncommon for the patient to swallow the fluid and be unaware of the leak.",
"   </p>",
"   <p>",
"    Low CSF pressure headache may spontaneously resolve within two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/39\">",
"     39",
"    </a>",
"    ]. In some cases, it lasts months or rarely years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Associated symptoms and complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1825, Magendie described vertigo and unsteadiness in a patient following the removal of CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/40\">",
"     40",
"    </a>",
"    ]. Today, the list of reported associated symptoms is varied and extensive. The most common associated symptoms with spontaneous low CSF pressure headache, reported in about half of patients, are [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neck pain or stiffness",
"     </li>",
"     <li>",
"      Nausea",
"     </li>",
"     <li>",
"      Vomiting",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other associated symptoms include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Change in hearing (eg, hyperacusis, echoing, or tinnitus) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/2,14,24\">",
"       2,14,24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Anorexia",
"     </li>",
"     <li>",
"      Vertigo",
"     </li>",
"     <li>",
"      Dizziness",
"     </li>",
"     <li>",
"      Diaphoresis",
"     </li>",
"     <li>",
"      Blurred vision",
"     </li>",
"     <li>",
"      Diplopia",
"     </li>",
"     <li>",
"      Transient visual obscurations [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Photophobia",
"     </li>",
"     <li>",
"      Unsteadiness or staggering gait [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hiccups",
"     </li>",
"     <li>",
"      Dysgeusia [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other rare symptoms associated with the syndrome are probably due to distortion or compression of brain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spinal cord structures. These rare manifestations (and associated central nervous system structures) are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Galactorrhea and hyperprolactinemia (pituitary stalk)",
"     </li>",
"     <li>",
"      Ataxia (posterior fossa)",
"     </li>",
"     <li>",
"      Quadriparesis (brainstem and upper cervical spinal cord) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cerebellar hemorrhage (cerebellar bridging veins) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Parkinsonism [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/42\">",
"       42",
"      </a>",
"      ] and chorea [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/43\">",
"       43",
"      </a>",
"      ] (deep midline structures)",
"     </li>",
"     <li>",
"      Hypoactive, hypoalert behavior (pons and midbrain) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/44\">",
"       44",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Stupor and coma (diencephalon) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Except for hemorrhage, these manifestations are typically reversible with successful treatment of the CSF leak.",
"   </p>",
"   <p>",
"    Subtle cognitive deficits may be associated with the syndrome and are typically reversible with successful treatment of the CSF leak [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]. Frank dementia is rare, but a case of reversible frontotemporal dementia attributed to low CSF pressure has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/47\">",
"     47",
"    </a>",
"    ]. Another report described eight patients with &ldquo;frontotemporal brain sagging syndrome&rdquo; (FBSS) who presented with progressive behavioral symptoms and cognitive dysfunction suggestive of behavioral variant frontotemporal dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/48\">",
"     48",
"    </a>",
"    ]. Atypical clinical features included headache and daytime somnolence. MRI in all cases revealed sagging of the frontal and temporal lobes with downward displacement of the cerebellar tonsils, swelling of the midbrain, flattening of the ventral pons and effacement of the basal cisterns. Two patients had pachymeningeal enhancement. Treatments directed at intracranial hypotension led to unsustained improvement in a few patients. Frontotemporal dementia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12618?source=see_link\">",
"     \"Frontotemporal dementia: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurologic examination is typically normal [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/39\">",
"     39",
"    </a>",
"    ]. Unilateral or bilateral abducens palsies have been reported, as have visual field defects [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/3\">",
"     3",
"    </a>",
"    ]. A slow pulse, or vagus pulse, has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cerebrospinal fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The opening pressure with lumbar puncture (LP) in patients with spontaneous intracranial hypotension usually ranges from 0 to 70 mmH20 [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/4\">",
"     4",
"    </a>",
"    ], whereas normal opening pressure is generally considered to be 60 to 200 mmH2O in adults and children; opening pressures up to 250 mmH2O may be normal in obese people. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=see_link&amp;anchor=H2#H2\">",
"     \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\", section on 'Physiology of CSF formation and flow'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The opening pressure is in the normal range in some cases of proven spontaneous intracranial hypotension, especially if the measurement is made after a period of recumbency, or if the CSF leak is intermittent. Even within the same patient, the CSF pressure may vary from LP to LP.",
"   </p>",
"   <p>",
"    In patients with spontaneous intracranial hypotension, LPs are often difficult. Repeated attempts may be needed to obtain CSF, and traumatic blood-tinged fluid may result. In addition, so-called \"dry taps\" may be encountered, requiring cisternal taps to collect the fluid. In rare instances, the CSF pressure is negative (below that of atmospheric pressure), and a sucking noise may be heard when the stylet is removed from the LP needle.",
"   </p>",
"   <p>",
"    The CSF is typically clear and colorless. Common CSF abnormalities include a moderate lymphocytic pleocytosis (up to 50",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ),",
"    </span>",
"    the presence of red blood cells, and elevated protein (commonly up to 100",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/8\">",
"     8",
"    </a>",
"    ]. The CSF pleocytosis likely reflects a reactive phenomenon secondary to hydrostatic pressure changes [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/39\">",
"     39",
"    </a>",
"    ]. The elevated protein may be related to lowered CSF pressure leading to disruption of normal hydrostatic and oncotic pressure across the venous sinus and arachnoid villi, resulting in the passage of serum protein into the CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CSF cytology and microbiology is always normal and CSF glucose is never low [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Brain MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advent of MRI has greatly improved the diagnosis of low CSF headaches. While brain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spine MRI is abnormal in most patients with spontaneous intracranial hypotension, a systematic review estimated that brain MRI remains normal in up to 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prominent abnormal features on brain MRI include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diffuse meningeal enhancement (DME) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55516 \" href=\"UTD.htm?29/23/30068\">",
"       image 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/50\">",
"       50",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Subdural hematomas or hygromas, presumably from rupture of the bridging veins as the CSF volume decreases [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/40,51\">",
"       40,51",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      \"Sagging\" of the brain, with cerebellar tonsillar herniation and descent of the brainstem mimicking a Chiari I malformation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77679 \" href=\"UTD.htm?23/42/24227\">",
"       image 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/52\">",
"       52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Engorgement of cerebral venous sinuses [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pituitary enlargement [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/54,55\">",
"       54,55",
"      </a>",
"      ], flattening of the optic chiasm, and increased anteroposterior diameter of the brainstem",
"     </li>",
"     <li>",
"      Decrease in the size of cisterns and ventricles",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The acronym SEEPS (for Subdural fluid collections, Enhancement of the pachymeninges, Engorgement of the venous structures, Pituitary enlargement, and Sagging of the brain) recalls the major features of spontaneous intracranial hypotension on brain MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Meningeal enhancement involves the pachymeninges and spares the leptomeninges, without abnormal enhancement in the depth of the cortical sulci or around the brainstem (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55516 \" href=\"UTD.htm?29/23/30068\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/8,50,56-58\">",
"     8,50,56-58",
"    </a>",
"    ]. It is also contiguous (without skip areas), non-nodular, and involves both supratentorial and infratentorial compartments. The enhancement is often thick and obvious, but sometimes can be quite thin. Diffuse meningeal enhancement may improve or resolve with resolution of the headache.",
"   </p>",
"   <p>",
"    Diffuse meningeal enhancement is believed to be secondary to vascular dilatation. According to the Monro-Kellie doctrine [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/59\">",
"     59",
"    </a>",
"    ], any decrease in CSF volume must be compensated given the noncompressible nature of the skull. As a result, loss of CSF volume results in an increase in intracranial blood volume, and venous engorgement results in a greater concentration of gadolinium in the dural vasculature and interstitial fluid of the dura.",
"   </p>",
"   <p>",
"    A minority of patients with spontaneous intracranial hypotension may present with swelling of the upper brainstem and diencephalon, but limited to absent DME and subdural fluid collections on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/60\">",
"     60",
"    </a>",
"    ]. The upper brainstem swelling is hypothesized to be a manifestation of venous stagnation caused by downward stretching of the vein of Galen, which results in a functional stenosis where the vein of Galen joins the straight sinus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Head CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head computed tomography (CT) in patients with CSF leaks is usually normal. However, subdural fluid collections or increased tentorial enhancement may be noted [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/61\">",
"     61",
"    </a>",
"    ]. In addition, slit-shaped ventricles have been reported, with associated tight basal cisterns and scant CSF over the cortex [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/62\">",
"     62",
"    </a>",
"    ]. These changes resolve after resolution of the headache and are believed to be secondary to brain edema, perhaps itself secondary to venous dilatation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of low cerebrospinal fluid (CSF) pressure headache should be considered in patients who present with positional orthostatic headache, with or without associated symptoms, perhaps in the setting of minor trauma, and in the absence of a history of dural puncture or other cause of CSF fistula. Low CSF pressure headache following a lumbar puncture (LP) rarely creates a clinical dilemma.",
"   </p>",
"   <p>",
"    Confirmation of the diagnosis requires evidence of low CSF pressure by MRI (eg, pachymeningeal enhancement) or LP,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    evidence of a CSF leak on neuroimaging studies, mainly computed tomographic (CT) myelography or, less often, radioisotope cisternography.",
"   </p>",
"   <p>",
"    For patients with suspected CSF pressure headache, we recommend brain MRI with gadolinium to assess for the typical features. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Brain MRI'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Neuroimaging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria for \"headache attributed to spontaneous (or idiopathic) low cerebrospinal fluid (CSF) pressure,\" as delineated in the second edition of the International Classification of Headache Disorders, are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/63\">",
"     63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A. Diffuse",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dull headache that worsens within 15 minutes after sitting or standing, with at least one of the following (and fulfilling criterion D):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Neck stiffness",
"     </li>",
"     <li>",
"      Tinnitus",
"     </li>",
"     <li>",
"      Hypacusia",
"     </li>",
"     <li>",
"      Photophobia",
"     </li>",
"     <li>",
"      Nausea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      B. At least one of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Evidence of low CSF pressure on MRI (eg, pachymeningeal enhancement)",
"     </li>",
"     <li>",
"      Evidence of CSF leakage on conventional myelography, CT myelography, or cisternography",
"     </li>",
"     <li>",
"      CSF opening pressure &lt;60 mmH2O in sitting position",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      C. No history of dural puncture or other cause of CSF fistula",
"     </li>",
"     <li>",
"      D. Headache resolves within 72 hours after epidural blood patching",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A separate set of criteria exists for post-dural (post-lumbar) puncture headache.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advent of brain MRI has greatly improved the diagnosis of low CSF headaches. Spine MRI, radioisotope cisternography, and CT myelography can be useful in evaluating patients with spontaneous low pressure headache, particularly when brain MRI is nondiagnostic. These imaging studies are generally not done in patients with post-lumbar puncture headache, where the diagnosis is more obvious.",
"   </p>",
"   <p>",
"    The utility of head CT for confirming the diagnosis is limited, as head CT is often normal in patients with spontaneous low CSF pressure headache. However, head CT may suggest the diagnosis by demonstrating subdural fluid collections, slit-shaped ventricles, tight basal cisterns, scant CSF over the cortex, or increased tentorial enhancement [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Head CT'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     MRI of brain and spine",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with suspected low CSF pressure headache, we recommend obtaining brain MRI with gadolinium to assess for the typical features of the syndrome, which are diffuse pachymeningeal enhancement (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55516 \" href=\"UTD.htm?29/23/30068\">",
"     image 1",
"    </a>",
"    ), \"sagging\" of the brain, tonsillar descent, and posterior fossa crowding (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77679 \" href=\"UTD.htm?23/42/24227\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Brain MRI'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    While brain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spine MRI is abnormal in most patients with spontaneous intracranial hypotension, a systematic review published in 2006 estimated that brain MRI remains normal in up to 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"     32",
"    </a>",
"    ]. A subsequent report evaluated 18 patients with spontaneous intracranial hypotension and found that the sensitivities of brain and spine MRI were 83 and 94 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spinal MRI may be helpful for confirming the diagnosis and for identifying the exact location of the CSF leakage. Such studies may reveal [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/49\">",
"     49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extra-arachnoid fluid collections",
"     </li>",
"     <li>",
"      Collapse of the dural sac and engorgement of the epidural venous plexus",
"     </li>",
"     <li>",
"      Meningeal diverticula",
"     </li>",
"     <li>",
"      Extradural extravasation of fluid",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a series of 10 women who had characteristic orthostatic headache without a previous history of dural tear, spinal MRI revealed dilated cervical epidural veins [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/12\">",
"     12",
"    </a>",
"    ]. The authors concluded that this finding is an indicator of CSF hypovolemia and can be used to differentiate spontaneous low CSF pressure from the other causes of diffuse meningeal enhancement.",
"   </p>",
"   <p>",
"    Subtraction MRI employs rapid postprocessing image analysis of standard T2 and T1 MRI sequences in order to delineate the dural sac of the spinal cord and distinguish between fluid and fat. In a report of 17 patients with spontaneous intracranial hypotension, subtraction MRI of the spinal cord identified the epidural CSF fluid collection in all patients, although the site of the CSF leak was not detected [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/64\">",
"     64",
"    </a>",
"    ]. Additional studies are needed to determine the sensitivity and specificity of this method.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Radioisotope cisternography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radioisotope cisternography is particularly useful for identifying CSF leaks. It is usually obtained as the next step if a CSF leak is suspected and MRI is normal or nondiagnostic.",
"   </p>",
"   <p>",
"    Since a lumbar puncture is required as part of the procedure, opening CSF pressure is measured, and CSF is sent for analysis at the same time. Placement of numbered cotton pledgets in the nose for subsequent detection of radioactivity aids in detection and localization of CSF leakage through the paranasal sinuses.",
"   </p>",
"   <p>",
"    Normal CSF flow involves cephalad migration from the site of injection to the cerebral convexities and the sylvian fissures [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/5\">",
"     5",
"    </a>",
"    ], and, therefore, the most common cisternographic abnormality in CSF leaks is the absence or paucity of activity over the cerebral convexities [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. It is advisable to look for early accumulation within the bladder and kidneys, or leakage of isotope outside of the normal confines of the subarachnoid space. Early soft tissue uptake of radioisotope may also be suggestive of CSF leak, perhaps reflecting unusually rapid uptake of the radioisotope into the bloodstream through the epidural venous plexus [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a small retrospective study of patients with spontaneous CSF leaks, the diagnosis of intracranial hypotension was supported in all 10 patients who had radionucleotide cisternography, which showed early bladder accumulation of the nucleotide and reduced activity over the cerebral hemispheres, consistent with rapid uptake of the tracer in the bloodstream [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/68\">",
"     68",
"    </a>",
"    ]. In addition, the location of the leaks was identified in 7 of the 10 patients with this method.",
"   </p>",
"   <p>",
"    Iatrogenic CSF leak from the lumbar puncture is a potential complication of radioisotope cisternography [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     CT myelography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomographic (CT) myelography is the best test to identify the site of the leak. CT myelography is most commonly used in order to localize the level of the spinal leak when treatment beyond epidural blood patch (such as surgery or fibrin glue injection) is contemplated.",
"   </p>",
"   <p>",
"    Both early and delayed cuts should be obtained at each spinal level, since CSF leaks may be rapid or slow. In cases where radiocisternography or spinal MRI has identified the approximate level of the leak, focused CT cuts can be used to locate the source more precisely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     MR myelography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preliminary evidence suggests that magnetic resonance (MR) myelography using heavily T2-weighted sequences may be an alternative to CT myelography for detecting the level of CSF leaks.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 19 patients with spontaneous intracranial hypotension, the accuracy of MR myelography for demonstrating and localizing CSF leaks was similar to CT myelography [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study involving 17 patients with spontaneous intracranial hypotension, characteristic imaging features of spontaneous intracranial hypotension were seen on initial brain MRI in 13 patients (76 percent), and abnormal CSF collections were seen on MR myelography in the four patients (24 percent) whose initial head MRI was negative [",
"      <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/71\">",
"       71",
"      </a>",
"      ]. The authors suggested that the combination of brain MRI and MR myelography may improve the early diagnostic rate for spontaneous intracranial hypotension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lumbar puncture (LP) can document low CSF pressure in suspected cases of spontaneous low CSF pressure headache, and may be diagnostically useful when MRI is not available or is not tolerated. However, LP is generally not necessary in cases where MRI is consistent with low CSF pressure headache. There is also concern that dural puncture from the procedure could potentially worsen the low CSF pressure and exacerbate the syndrome. In addition, the opening pressure is normal in some patients with proven spontaneous intracranial hypotension. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Cerebrospinal fluid analysis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although current diagnostic criteria define low CSF pressure based upon measurements taken in the sitting position [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/63\">",
"     63",
"    </a>",
"    ], we recommend using the lateral decubitus position for greater accuracy. To ascertain correct placement of the spinal needle, CSF flow should be observed either spontaneously, with gentle aspiration, or with Valsalva maneuver [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have CSF shunts placed for various neurosurgical indications may develop a syndrome identical to that of spontaneous intracranial hypotension, probably secondary to overdrainage (overshunting) of CSF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Orthostatic headache in the absence of CSF leak may also be a manifestation of the postural tachycardia syndrome or orthostatic intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=see_link\">",
"     \"Postural tachycardia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One case report described spontaneous orthostatic headache and a \"dry tap\" at lumbar puncture that was attributed to an intradural myxopapillary ependymoma [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Misdiagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The syndrome of spontaneous low CSF pressure headache has been under-recognized, in part because headache in general is a common ailment, and because patients with low CSF pressure headache typically present with a normal neurologic examination. The diagnosis was often missed prior to the advancement of MRI imaging and the specific MRI findings associated with low CSF pressure headache. Even in the modern era of MRI availability, misdiagnosis is common [",
"    <a class=\"abstract\" href=\"UTD.htm?0/20/330/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inappropriate and unnecessary clinical investigations may result if the diagnosis of spontaneous low CSF pressure headache is not considered. As an example, before diffuse meningeal enhancement on brain MRI was a recognized feature of spontaneous intracranial hypotension, patients with this finding were often subjected to extensive testing to rule out other causes such as meningeal carcinomatosis, meningitis, subarachnoid hemorrhage, neuroborreliosis, and neurosarcoidosis. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Brain MRI'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major features of the classic spontaneous low cerebrospinal fluid (CSF) pressure headache syndrome are orthostatic headache, low CSF pressure, and diffuse meningeal enhancement on brain MRI. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction and terminology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prevailing etiology is CSF leakage, which may occur in the context of rupture of an arachnoid membrane. An alternative hypothesis is that low CSF pressure is caused by epidural venous hypotension from the lowering of venous pressure within the inferior vena cava system. Most CSF leaks occur at the thoracic or cervicothoracic junction. An underlying connective tissue disorder may play a role in the development of CSF leaks. Other potential contributing factors are minor trauma, degenerative disc disease, and osseous spurs. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The estimated annual incidence of spontaneous low CSF pressure headache is 5 per 100,000, with a peak incidence around age 40 and a female to male ratio of 2:1. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The headache caused by low CSF pressure may be sudden or gradual in onset, and severity is widely variable. The headache is typically relieved with recumbency and exacerbated with upright posture. Other headache patterns have also been reported with this syndrome. Commonly associated symptoms are neck pain or stiffness, nausea and vomiting, change in hearing, and photophobia. There is a varied and extensive list of additional associated symptoms. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Headache'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Associated symptoms and complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Traction on pain-sensitive intracranial and meningeal structures, particularly sensory nerves and bridging veins, is thought to cause headache and some of the associated symptoms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some rare but serious symptoms (eg, altered level of consciousness, parkinsonism) associated with the syndrome are probably caused by distortion or compression of brain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      spinal cord structures. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Associated symptoms and complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with suspected low CSF pressure headache, we recommend brain MRI with gadolinium to assess for the typical features, which include diffuse meningeal enhancement (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55516 \" href=\"UTD.htm?29/23/30068\">",
"       image 1",
"      </a>",
"      ), subdural hematomas or hygromas, sagging of the brain (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77679 \" href=\"UTD.htm?23/42/24227\">",
"       image 2",
"      </a>",
"      ), engorgement of cerebral venous sinuses, and pituitary enlargement. Brain MRI remains normal in up to 20 percent of patients with low CSF pressure headache. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Brain MRI'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of low CSF pressure headache should be considered in patients who present with positional orthostatic headache, with or without associated symptoms, perhaps in the setting of minor trauma, and in the absence of a history of dural puncture or other cause of CSF fistula. Confirmation of the diagnosis requires evidence of low CSF pressure by MRI or lumbar puncture",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      evidence of a CSF leak on CT myelography or radioisotope cisternography. Low CSF pressure headache following a lumbar puncture rarely creates a clinical dilemma. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic criteria for headache attributed to spontaneous low CSF pressure are discussed above. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who have CSF shunts in place may develop a syndrome identical to that of spontaneous intracranial hypotension, probably secondary to overdrainage (overshunting) of CSF. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial therapy for most patients with a confirmed diagnosis of spontaneous low CSF pressure headache consists of conservative measures",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      epidural blood path therapy. For patients who fail these treatments, additional options include continuous epidural saline infusion, epidural fibrin glue, or surgical repair of the defect. Treatment of spontaneous low CSF pressure headache is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13126?source=see_link\">",
"       \"Treatment and prognosis of spontaneous low cerebrospinal fluid pressure headache\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/1\">",
"      Schievink WI, Reimer R, Folger WN. Surgical treatment of spontaneous intracranial hypotension associated with a spinal arachnoid diverticulum. Case report. J Neurosurg 1994; 80:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/2\">",
"      Mokri B. Spontaneous cerebrospinal fluid leaks: from intracranial hypotension to cerebrospinal fluid hypovolemia--evolution of a concept. Mayo Clin Proc 1999; 74:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/3\">",
"      Horton JC, Fishman RA. Neurovisual findings in the syndrome of spontaneous intracranial hypotension from dural cerebrospinal fluid leak. Ophthalmology 1994; 101:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/4\">",
"      Lipman IJ. Primary intracranial hypotension: the syndrome of spontaneous low cerebospinal fluid pressure with traction headache. Dis Nerv Syst 1977; 38:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/5\">",
"      Marcelis J, Silberstein SD. Spontaneous low cerebrospinal fluid pressure headache. Headache 1990; 30:192.",
"     </a>",
"    </li>",
"    <li>",
"     Swanson JW, Dodick DW, Capobianco DJ. Headache and other craniofacial pain. In: Neurology in Clinical Practice, Bradley WG, Daroff RB, Fenichel GM, Marsden CD.  (Eds), Butterworth, Boston 2000. p.1832.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/7\">",
"      Capobianco DJ, Kuczler FJ Jr. Case report: primary intracranial hypotension. Mil Med 1990; 155:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/8\">",
"      Mokri B, Piepgras DG, Miller GM. Syndrome of orthostatic headaches and diffuse pachymeningeal gadolinium enhancement. Mayo Clin Proc 1997; 72:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/9\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-1998. A 50-year-old woman with increasing headache and a left abducent-nerve palsy. N Engl J Med 1998; 338:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/10\">",
"      Mokri B, Hunter SF, Atkinson JL, Piepgras DG. Orthostatic headaches caused by CSF leak but with normal CSF pressures. Neurology 1998; 51:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/11\">",
"      Chung SJ, Kim JS, Lee MC. Syndrome of cerebral spinal fluid hypovolemia: clinical and imaging features and outcome. Neurology 2000; 55:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/12\">",
"      Miyazawa K, Shiga Y, Hasegawa T, et al. CSF hypovolemia vs intracranial hypotension in \"spontaneous intracranial hypotension syndrome\". Neurology 2003; 60:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/13\">",
"      Levine DN, Rapalino O. The pathophysiology of lumbar puncture headache. J Neurol Sci 2001; 192:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/14\">",
"      Silberstein SD, Marcelis J. Headache associated with changes in intracranial pressure. Headache 1992; 32:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/15\">",
"      Raskin NH. Lumbar puncture headache: a review. Headache 1990; 30:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/16\">",
"      Fern&aacute;ndez E. Headaches associated with low spinal fluid pressure. Headache 1990; 30:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/17\">",
"      Schaltenbrand, G. Neuere Anschauungen zur Pathophysiologie der Liquorzirkulation. Zentralbl Neurochir 1938; 3:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/18\">",
"      SCHALTENBRAND G. Normal and pathological physiology of the cerebrospinal fluid circulation. Lancet 1953; 1:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/19\">",
"      Lasater GM. Primary intracranial hypotension. The low spinal fluid pressure syndrome. Headache 1970; 10:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/20\">",
"      Mokri B, Maher CO, Sencakova D. Spontaneous CSF leaks: underlying disorder of connective tissue. Neurology 2002; 58:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/21\">",
"      Ferrante E, Citterio A, Savino A, Santalucia P. Postural headache in a patient with Marfan's syndrome. Cephalalgia 2003; 23:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/22\">",
"      Schrijver I, Schievink WI, Godfrey M, et al. Spontaneous spinal cerebrospinal fluid leaks and minor skeletal features of Marfan syndrome: a microfibrillopathy. J Neurosurg 2002; 96:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/23\">",
"      Grimaldi D, Mea E, Chiapparini L, et al. Spontaneous low cerebrospinal pressure: a mini review. Neurol Sci 2004; 25 Suppl 3:S135.",
"     </a>",
"    </li>",
"    <li>",
"     Lay CL, Campbell JK, Mokri B. Low cerebrospinal fluid pressure headache. In: Headache, Goadsby PJ, Silberstein SD (Eds), Butterworth-Heinemann, Boston 1997. p.355.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/25\">",
"      Vishteh AG, Schievink WI, Baskin JJ, Sonntag VK. Cervical bone spur presenting with spontaneous intracranial hypotension. Case report. J Neurosurg 1998; 89:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/26\">",
"      Eross EJ, Dodick DW, Nelson KD, et al. Orthostatic headache syndrome with CSF leak secondary to bony pathology of the cervical spine. Cephalalgia 2002; 22:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/27\">",
"      Winter SC, Maartens NF, Anslow P, Teddy PJ. Spontaneous intracranial hypotension due to thoracic disc herniation. Case report. J Neurosurg 2002; 96:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/28\">",
"      Rapport RL, Hillier D, Scearce T, Ferguson C. Spontaneous intracranial hypotension from intradural thoracic disc herniation. Case report. J Neurosurg 2003; 98:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/29\">",
"      Franzini A, Messina G, Nazzi V, et al. Spontaneous intracranial hypotension syndrome: a novel speculative physiopathological hypothesis and a novel patch method in a series of 28 consecutive patients. J Neurosurg 2010; 112:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/30\">",
"      Groen RJ, Hoogland PV. Spontaneous intracranial hypotension. J Neurosurg 2010; 113:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/31\">",
"      Watanabe A, Horikoshi T, Uchida M, et al. Diagnostic value of spinal MR imaging in spontaneous intracranial hypotension syndrome. AJNR Am J Neuroradiol 2009; 30:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/32\">",
"      Schievink WI. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA 2006; 295:2286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/33\">",
"      Schievink WI. Headache relief from lateralizing head and neck positions in spontaneous intracranial hypotension. Neurology 2011; 77:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/34\">",
"      Batsis JA, Phy MP. Intracranial hypotension: aggravation of headache at high altitude. Headache 2005; 45:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/35\">",
"      Mokri B, Aksamit AJ, Atkinson JL. Paradoxical postural headaches in cerebrospinal fluid leaks. Cephalalgia 2004; 24:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/36\">",
"      Schievink WI, Maya MM. Quadriplegia and cerebellar hemorrhage in spontaneous intracranial hypotension. Neurology 2006; 66:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/37\">",
"      Evans RW, Boes CJ. Spontaneous low cerebrospinal fluid pressure syndrome can mimic primary cough headache. Headache 2005; 45:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/38\">",
"      Mokri B. Spontaneous CSF leaks mimicking benign exertional headaches. Cephalalgia 2002; 22:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/39\">",
"      Rando TA, Fishman RA. Spontaneous intracranial hypotension: report of two cases and review of the literature. Neurology 1992; 42:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/40\">",
"      PAGE F. Intracranial hypotension. Lancet 1953; 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/41\">",
"      Mokri B. Spontaneous intracranial hypotension. Curr Pain Headache Rep 2001; 5:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/42\">",
"      Pakiam AS, Lee C, Lang AE. Intracranial hypotension with parkinsonism, ataxia, and bulbar weakness. Arch Neurol 1999; 56:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/43\">",
"      Mokri B, Ahlskog JE, Luetmer PH. Chorea as a manifestation of spontaneous CSF leak. Neurology 2006; 67:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/44\">",
"      Vetrugno R, Mascalchi M, Chierichetti F, et al. Hypoactive-hypoalert behavior (\"psychic akinesia\") in intracranial hypotension syndrome. Neurology 2008; 71:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/45\">",
"      Pleasure SJ, Abosch A, Friedman J, et al. Spontaneous intracranial hypotension resulting in stupor caused by diencephalic compression. Neurology 1998; 50:1854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/46\">",
"      Kashmere JL, Jacka MJ, Emery D, Gross DW. Reversible coma: a rare presentation of spontaneous intracranial hypotension. Can J Neurol Sci 2004; 31:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/47\">",
"      Hong M, Shah GV, Adams KM, et al. Spontaneous intracranial hypotension causing reversible frontotemporal dementia. Neurology 2002; 58:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/48\">",
"      Wicklund MR, Mokri B, Drubach DA, et al. Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD. Neurology 2011; 76:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/49\">",
"      Mokri B. Low cerebrospinal fluid pressure syndromes. Neurol Clin 2004; 22:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/50\">",
"      Mokri, B, Krueger, BR, Miller, GM, Piepgras, DG. Meningeal gadolinium enhancement in low-pressure headaches. J Neuroimaging 1993; 3:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/51\">",
"      Chung SJ, Lee JH, Kim SJ, et al. Subdural hematoma in spontaneous CSF hypovolemia. Neurology 2006; 67:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/52\">",
"      Atkinson JL, Weinshenker BG, Miller GM, et al. Acquired Chiari I malformation secondary to spontaneous spinal cerebrospinal fluid leakage and chronic intracranial hypotension syndrome in seven cases. J Neurosurg 1998; 88:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/53\">",
"      Bakshi R, Mechtler LL, Kamran S, et al. MRI findings in lumbar puncture headache syndrome: abnormal dural-meningeal and dural venous sinus enhancement. Clin Imaging 1999; 23:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/54\">",
"      Mokri B, Atkinson JL. False pituitary tumor in CSF leaks. Neurology 2000; 55:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/55\">",
"      Alvarez-Linera J, Escribano J, Benito-Le&oacute;n J, et al. Pituitary enlargement in patients with intracranial hypotension syndrome. Neurology 2000; 55:1895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/56\">",
"      Pannullo SC, Reich JB, Krol G, et al. MRI changes in intracranial hypotension. Neurology 1993; 43:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/57\">",
"      Spelle L, Boulin A, Tainturier C, et al. Neuroimaging features of spontaneous intracranial hypotension. Neuroradiology 2001; 43:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/58\">",
"      Lin WC, Lirng JF, Fuh JL, et al. MR findings of spontaneous intracranial hypotension. Acta Radiol 2002; 43:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/59\">",
"      Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology 2001; 56:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/60\">",
"      Savoiardo M, Minati L, Farina L, et al. Spontaneous intracranial hypotension with deep brain swelling. Brain 2007; 130:1884.",
"     </a>",
"    </li>",
"    <li>",
"     Mokri B. Headaches associated with abnormalities in intracranial structure and function: low cerebrospinal fluid pressure headaches. In: Wolff's headache and other head pain, Silberstein SD, Lipton RB, Dalessio DJ.  (Eds), Oxford University Press, New York 2001. p.417.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/62\">",
"      Murros K, Fogelholm R. Spontaneous intracranial hypotension with slit ventricles. J Neurol Neurosurg Psychiatry 1983; 46:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/63\">",
"      Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/64\">",
"      Bonetto N, Manara R, Citton V, Cagnin A. Spinal subtraction MRI for diagnosis of epidural leakage in SIH. Neurology 2011; 77:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/65\">",
"      Molins A, Alv&aacute;rez J, Sumalla J, et al. Cisternographic pattern of spontaneous liquoral hypotension. Cephalalgia 1990; 10:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/66\">",
"      Bai J, Yokoyama K, Kinuya S, et al. Radionuclide cisternography in intracranial hypotension syndrome. Ann Nucl Med 2002; 16:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/67\">",
"      Sakurai K, Nishio M, Yamada K, et al. Comparison of the radioisotope cisternography findings of spontaneous intracranial hypotension and iatrogenic cerebrospinal fluid leakage focusing on chronological changes. Cephalalgia 2012; 32:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/68\">",
"      Schievink WI, Meyer FB, Atkinson JL, Mokri B. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. J Neurosurg 1996; 84:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/69\">",
"      Sakurai K, Nishio M, Sasaki S, et al. Postpuncture CSF leakage: a potential pitfall of radionuclide cisternography. Neurology 2010; 75:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/70\">",
"      Wang YF, Lirng JF, Fuh JL, et al. Heavily T2-weighted MR myelography vs CT myelography in spontaneous intracranial hypotension. Neurology 2009; 73:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/71\">",
"      Tsai PH, Fuh JL, Lirng JF, Wang SJ. Heavily T2-weighted MR myelography in patients with spontaneous intracranial hypotension: a case-control study. Cephalalgia 2007; 27:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/72\">",
"      Mokri B, Low PA. Orthostatic headaches without CSF leak in postural tachycardia syndrome. Neurology 2003; 61:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/73\">",
"      Schievink WI, Akopov SE. Filum ependymoma mimicking spontaneous intracranial hypotension. Headache 2005; 45:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/20/330/abstract/74\">",
"      Schievink WI. Misdiagnosis of spontaneous intracranial hypotension. Arch Neurol 2003; 60:1713.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3359 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-210.101.131.232-9BEAA163C5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_330=[""].join("\n");
var outline_f0_20_330=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H107340173\">",
"      Cause of headache",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Cause of low CSF pressure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H107340188\">",
"      - CSF leak",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H107340219\">",
"      - Low venous pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Headache",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Associated symptoms and complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cerebrospinal fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Brain MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Head CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - MRI of brain and spine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Radioisotope cisternography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - CT myelography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - MR myelography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Misdiagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/3359\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/3359|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/23/30068\" title=\"diagnostic image 1\">",
"      MRI diffuse meningeal enhancement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/42/24227\" title=\"diagnostic image 2\">",
"      MRI brain sagging",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=related_link\">",
"      Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12618?source=related_link\">",
"      Frontotemporal dementia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=related_link\">",
"      Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2968?source=related_link\">",
"      New daily persistent headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/46/20198?source=related_link\">",
"      Post-lumbar puncture headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=related_link\">",
"      Postural tachycardia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/37/22101?source=related_link\">",
"      Primary cough headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=related_link\">",
"      Thunderclap headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13126?source=related_link\">",
"      Treatment and prognosis of spontaneous low cerebrospinal fluid pressure headache",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_20_331="Chance of pregnancy PI";
var content_f0_20_331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F71494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F71494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Probability of pregnancy after unprotected intercourse by timing of coitus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_left\">",
"       3 days before ovulation",
"      </td>",
"      <td>",
"       15 percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\">",
"       1 or 2 days before ovulation",
"      </td>",
"      <td>",
"       30 percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\">",
"       day of ovulation",
"      </td>",
"      <td>",
"       12 percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\">",
"       1 or 2 days after ovulation",
"      </td>",
"      <td>",
"       near zero",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Trusell, J, et al. Contraception 1998; 57:363.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_331=[""].join("\n");
var outline_f0_20_331=null;
var title_f0_20_332="Rush VIT - one-day";
var content_f0_20_332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F70301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F70301&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    One-day rush schedule for venom immunotherapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Time (min)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume (mL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Concentration (micrograms/mL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        0.05",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        45",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        0.08",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        75",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        105",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        120",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        135",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Once the above doses have been administered, the patient receives weekly injections to continue the buildup for the next eight weeks. After that, injections are administered once every four weeks.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Bernstein JA, Kagen SL, Bernstein DI, Bernstein IL. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis. Ann Allergy 1994; 73:423. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_332=[""].join("\n");
var outline_f0_20_332=null;
var title_f0_20_333="Regression of atherosclerosis";
var content_f0_20_333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64360&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64360&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Regression of coronary atherosclerosis with lipid lowering",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Trial",
"       </td>",
"       <td class=\"subtitle2\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle2\">",
"        LDL, percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        HDL, percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Regression, percent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Progression, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"2\">",
"        NHLBI",
"       </td>",
"       <td>",
"        Diet",
"       </td>",
"       <td>",
"        -5",
"       </td>",
"       <td>",
"        NC",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholestyramine",
"       </td>",
"       <td>",
"        -26",
"       </td>",
"       <td>",
"        +8",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"2\">",
"        CLAS I",
"       </td>",
"       <td>",
"        Diet",
"       </td>",
"       <td>",
"        -5",
"       </td>",
"       <td>",
"        +2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        61",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colestipol + NA",
"       </td>",
"       <td>",
"        -43",
"       </td>",
"       <td>",
"        +37",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"3\">",
"        FATS",
"       </td>",
"       <td>",
"        Diet + Colestipol",
"       </td>",
"       <td>",
"        -7",
"       </td>",
"       <td>",
"        +5",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        46",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lovastatin + Colestipol",
"       </td>",
"       <td>",
"        -46",
"       </td>",
"       <td>",
"        +15",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NA + Colestipol",
"       </td>",
"       <td>",
"        -32",
"       </td>",
"       <td>",
"        +43",
"       </td>",
"       <td>",
"        39",
"       </td>",
"       <td>",
"        25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"2\">",
"        UCSF-SCOR",
"       </td>",
"       <td>",
"        Diet",
"       </td>",
"       <td>",
"        -11",
"       </td>",
"       <td>",
"        NC",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        41",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholestyramine + NA &plusmn; Lovastatin",
"       </td>",
"       <td>",
"        -38",
"       </td>",
"       <td>",
"        +26",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"1\" rowspan=\"2\">",
"        MARS",
"       </td>",
"       <td>",
"        Diet",
"       </td>",
"       <td>",
"        NC",
"       </td>",
"       <td>",
"        NC",
"       </td>",
"       <td>",
"        12",
"       </td>",
"       <td>",
"        41",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lovastatin",
"       </td>",
"       <td>",
"        -38",
"       </td>",
"       <td>",
"        +10",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        29",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NA: nicotinic acid.",
"     <br>",
"      Summary of the results of five different trials in patients with hypercholesterolemia comparing the results of moderate dietary modification with pharmacologic intervention on the course of coronary atherosclerosis at two to five years. Drug therapy was associated with a greater reduction in LDL-cholesterol, a modest increase in HDL-cholesterol, a greater likelihood of coronary regression, and less frequent coronary progression than seen with diet alone.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     <br>",
"      Data from Rosenson, RS, The Physician and Sportsmedicine 1994; 22:59.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_333=[""].join("\n");
var outline_f0_20_333=null;
var title_f0_20_334="Hereditary renal cystic disease and genes";
var content_f0_20_334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hereditary renal cystic disease and their underlying gene defect",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Main features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Genes involved",
"       </td>",
"       <td class=\"subtitle1\">",
"        Corresponding protein",
"       </td>",
"       <td class=\"subtitle1\">",
"        Protein localization",
"       </td>",
"       <td class=\"subtitle1\">",
"        Postulated functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autosomal recessive PKD (ARPKD)",
"       </td>",
"       <td>",
"        Renal cyst, enlarged kidneys, hepatic fibrosis",
"       </td>",
"       <td>",
"        <em>",
"         PKHD1",
"        </em>",
"       </td>",
"       <td>",
"        Fibrocystin/polyductin (FPC)",
"       </td>",
"       <td>",
"        Cilia and secreted",
"       </td>",
"       <td>",
"        Calcium response; proliferation/differentiation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Autosomal dominant PKD (ADPKD)",
"       </td>",
"       <td>",
"        Renal, hepatic, pancreatic and brain cysts",
"       </td>",
"       <td>",
"        <em>",
"         PKD1",
"        </em>",
"        ,",
"        <em>",
"         PKD2",
"        </em>",
"       </td>",
"       <td>",
"        Polycystin 1 (PC1), Polycystin 2 (PC2)",
"       </td>",
"       <td>",
"        Cilia, Golgi apparatus, focal adhesions",
"       </td>",
"       <td>",
"        Calcium response; proliferation/differentiation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Nephronophthisis (NPHP) and Senior L&oslash;ken Syndrome (SNLS)",
"       </td>",
"       <td>",
"        Renal fibrosis, renal cysts, tubular atrophy, retinal dystrophy (in SNLS)",
"       </td>",
"       <td>",
"        <em>",
"         NPHP1-NPHP11",
"        </em>",
"       </td>",
"       <td>",
"        Nephrocystin-1, 2/inversin, 3, 4, 5, 6/CEP290, 7/GLIS2, 8/RPGRIP1L, 9/NEK8, 11/Meckelin",
"       </td>",
"       <td>",
"        Cilia, basal bodies, centrosomes, focal adhesions",
"       </td>",
"       <td>",
"        Cell-cell and cell-matrix adhesion; actin cytoskeleton; cell division; Wnt and Shh signaling",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Joubert syndrome (JS)",
"       </td>",
"       <td>",
"        NPHP and cerebellar ataxia",
"       </td>",
"       <td>",
"        <em>",
"         AHI1",
"        </em>",
"        ,",
"        <em>",
"         NPHP1",
"        </em>",
"        ,",
"        <em>",
"         CEP290",
"        </em>",
"        ,",
"        <em>",
"         JBTS6/TMEM67",
"        </em>",
"        ,",
"        <em>",
"         RPGRIP1L",
"        </em>",
"        ,",
"        <em>",
"         ARL13B",
"        </em>",
"        ,",
"        <em>",
"         CC2D2A",
"        </em>",
"        ,",
"        <em>",
"         INPP5E",
"        </em>",
"        ,",
"        <em>",
"         JBTS2/TMEM216",
"        </em>",
"       </td>",
"       <td>",
"        Jouberin, Nephrocystin, CEP290, Meckelin, RPGRIP1L, ARL13B, CC2D2A, INPP5E, TMEM216",
"       </td>",
"       <td>",
"        Cilia, basal bodies, centrosomes, cell junctions",
"       </td>",
"       <td>",
"        Ciliogenesis, Sonic Hedgehog signaling",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Bardet-Biedl syndrome (BBS)",
"       </td>",
"       <td>",
"        Renal cysts, obesity, polydactyly, retinal dystrophy, mental retardation",
"       </td>",
"       <td>",
"        <em>",
"         BBS1-12",
"        </em>",
"        ,",
"        <em>",
"         MKS1",
"        </em>",
"        ,",
"        <em>",
"         CEP290",
"        </em>",
"        ,",
"        <em>",
"         FRITZ",
"        </em>",
"        ,",
"        <em>",
"         SDCCAG8",
"        </em>",
"       </td>",
"       <td>",
"        BBS1-12, MKS1, CEP290, FRITZ, SDCCAG8",
"       </td>",
"       <td>",
"        Centrosomes, basal bodies",
"       </td>",
"       <td>",
"        Pericentriolar organization, ciliogenesis, Wnt signaling",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Meckel-Gruber syndrome (MKS)",
"       </td>",
"       <td>",
"        Occipital meningoencephalocele, cystic kidneys, liver fibrosis, polydactyly",
"       </td>",
"       <td>",
"        <em>",
"         MKS1",
"        </em>",
"        ,",
"        <em>",
"         MKS3/TMEM67",
"        </em>",
"        ,",
"        <em>",
"         NPHP3",
"        </em>",
"        ,",
"        <em>",
"         CEP290",
"        </em>",
"        ,",
"        <em>",
"         RPGRIP1L",
"        </em>",
"        ,",
"        <em>",
"         CC2D2A",
"        </em>",
"        ,",
"        <em>",
"         MKS2/TMEM216",
"        </em>",
"       </td>",
"       <td>",
"        MKS1, Meckelin, Nephrocystin 3, CEP290, RPGRIP1L, CC2D2A, TMEM216",
"       </td>",
"       <td>",
"        Centrosomes, cilia, plasma membrane",
"       </td>",
"       <td>",
"        Basal body localization, ciliogenesis, Hedgehog signaling",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Oral-facial-digital syndrome 1 (OFD1)",
"       </td>",
"       <td>",
"        Malformations of face, oral cavity and digits, renal cysts, polydactyly",
"       </td>",
"       <td>",
"        <em>",
"         OFD1",
"        </em>",
"       </td>",
"       <td>",
"        OFD1",
"       </td>",
"       <td>",
"        Cilia, basal bodies, centrosomes, nucleus",
"       </td>",
"       <td>",
"        Ciliogenesis, L-R asymmetry, possibly gene regulation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Short-Rib Polydactily (incl. Jeune Asphyxiating Thoracic Dystrophy)",
"       </td>",
"       <td>",
"        Renal cysts, shortened bones, polydactyly, situs inversus",
"       </td>",
"       <td>",
"        <em>",
"         DYN2CH1",
"        </em>",
"        ,",
"        <em>",
"         IFT80",
"        </em>",
"       </td>",
"       <td>",
"        Cytoplasmic dynein 2 heavy chain, IFT80",
"       </td>",
"       <td>",
"        Chondrocyte cilia, basal bodies",
"       </td>",
"       <td>",
"        Intraflagelar transport, Hedgehog signaling",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Tuberous sclerosis complex",
"       </td>",
"       <td>",
"        Renal cysts, beningn tumors in multiple organs, dermatologic abnormalities inlcuding hypopigmented macules (ash-leaf spots), angiofibromas, shagreen patches, and brown fibrous plaque of the forehead",
"       </td>",
"       <td>",
"        <em>",
"         TSC1, TSC2",
"        </em>",
"       </td>",
"       <td>",
"        Hamartin (",
"        <em>",
"         TSC1",
"        </em>",
"        ), Tuberin (",
"        <em>",
"         TSC2",
"        </em>",
"        )",
"       </td>",
"       <td>",
"        Centrosome, cytoplasm,",
"       </td>",
"       <td>",
"        Cellular signaling by regulating the mammalian target of rapamycin (mTOR) signaling pathway",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Uromodulin associated kidney diseases (MCKD2, FJHN, GCKD)",
"       </td>",
"       <td>",
"        Renal cysts, fibrosis, hypertension, hypoeruricemia",
"       </td>",
"       <td>",
"        <em>",
"         UMOD",
"        </em>",
"        ,",
"        <em>",
"         MCKD1",
"        </em>",
"        ,",
"        <em>",
"         MCKD2",
"        </em>",
"       </td>",
"       <td>",
"        Uromodulin",
"       </td>",
"       <td>",
"        Cilia, basal bodies, centrosomes, secreted",
"       </td>",
"       <td>",
"        Unknown ciliary role",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Hereditary cystic diseases of the kidney; their causal genes, encoded proteins, localization, and proposed function.",
"    <div class=\"footnotes\">",
"     PKD: polycystic kidney disease; MCKD2: medullary cystic kidney disease type 2; FJHN: familial juvenile hyperuricemic nephropathy; GCKD: glomerulocystic kidney disease.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Gascue C, Katsanis N, Badano JL. Cystic disease of the kidney: ciliary dysfucntion and cytogenetic mechanisms. Pediatr Nephrol 2011; 26:1181, with kind permission from Springer Science + Business Media B.V. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_334=[""].join("\n");
var outline_f0_20_334=null;
var title_f0_20_335="Plasmodium vivax thin smear";
var content_f0_20_335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F59872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F59872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plasmodium vivax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Giemsa-stained thin smear of blood (x1000) shows a ring trophozoite of Plasmodium vivax. Red blood cells infected by P. vivax are enlarged and contain Sch&uuml;ffner's dots.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_20_335=[""].join("\n");
var outline_f0_20_335=null;
